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Abstract 
The synthesis of amphiphilic hyperbranched glycopolydendrons bearing multivalent 
surface functionalities has yielded materials with potential nanomedical drug-delivery 
applications that may also be capable of actively targeting disease sites. The 
development of the hydrophilic surface functionalities (based on PEG, galactose and 
mannose moieties) and hydrophobic core functionalities (based on poly(n-butyl 
methacrylate)) are presented. 
Despite methanol (MeOH) being widely regarded as an antisolvent for p(nBuMA), 
Cu-catalysed ATRP of nBuMA has been performed utilising anhydrous MeOH as the 
reaction solvent. Successful polymerisation was achieved at 60 °C and 25 °C using 
ethyl 2-bromoisobutyrate as the initiator, yielding well-defined polymers with high 
molecular weights (up to Mn = 75 880 g mol-1) and low dispersities (as low as 
Ɖ = 1.02). The effect of monomer co-solvency was investigated by determining the 
cloud point behaviour (upper critical solution temperature) of p(nBuMA) within the 
methanolic environment, and the effect of the ligand on the control of the 
polymerisation was also investigated. Successful polymerisation was also extended to 
RAFT, yielding low dispersity polymers that were analogous to those obtained by 
ATRP. 
The methanolic polymerisation by Cu-catalysed ATRP was utilised to exploit the 
hydrophobic nature of p(nBuMA) as the core functionality of amphiphilic branched 
copolymer nanoparticles bearing PEG surface functionalities. The nanoparticles were 
prepared via a rapid nanoprecipitation approach, however, their small hydrodynamic 
diameters (Dn = 17 nm-27 nm) suggested nanoparticle formation by a solvent-switch 
rather than a nucleation/growth mechanism that is normally associated with this 
technique. 
Dendritic ATRP initiators bearing multivalent protected galactose functionalities, also 
varying in generation number, were obtained by aza-Michael-type additions and used 
within the branched methanolic ATRP of nBuMA. Deprotection of the isopropylidene 
protecting groups was achieved under acidic reaction conditions using para-toluene 
sulfonic acid monohydrate; nanoprecipitation of the resulting galactosylated hyp-
glycopolydendrons yielded charge-stabilised nanoparticles with Dz = 43-46 nm and 
highly negative zeta potentials. Comparisons to their protected equivalents were made. 
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1.1. Conventional medicine 
Conventional clinical medicine can successfully diagnose, treat, and prevent many 
forms of infection and disease; however, serious issues remain regarding the efficacy 
and economic viability of available treatments. One example is the cancer epidemic: 
according to Cancer Research UK, there were 14.1 million new cases and 8.2 million 
deaths worldwide in 2012 alone - of which the estimates for the UK were over 330,000 
new cases and 161,000 deaths.1 A 2011 Bupa report assessed the current and future 
costs of the diagnosis and treatment of cancer in the UK, and estimated that the annual 
costs may rise from £9.4 billion in 2010 to £15.3 billion in 2021 – a 63% increase over 
the decade – which implies that the average annual cost per patient is likely to rise 
from £30,000 in 2011 to £40,000 in 2021.2 The report concludes that one of the key 
approaches to address this challenge is to find new and innovative ways of diagnosing 
and treating the disease. HIV/AIDS is another global epidemic with similar issues: it 
has been estimated that 37 million people worldwide were living with HIV in 2014, 
of whom only 15 million were receiving anti-retroviral therapy (ART).3 The problems 
of economic viability - a particular issue in developing countries - are being addressed, 
with the estimated annual cost of ART medicines per patient falling from $10,000 
USD in 2001 to $100 USD for first-line regimens in 2014.4,5 However, serious issues 
remain regarding the efficacy of various treatments. 
One key issue is the solubility of drugs in vivo. Drugs with poor solubility in blood are 
rapidly cleared from the systemic circulation primarily via renal clearance or through 
the reticuloendothelial system (RES), which consequently reduces their 
biodistribution and prevents an optimal therapeutic effect. This is compensated with 
high and frequent dosing, which exposes the patient to higher levels of cytotoxicity 
and risk of undesirable side-effects, often resulting in poor patient compliance to short, 
medium and long term dosing regimens. Ultimately, this renders such treatments 
expensive to implement and difficult to maintain. 
To address these issues, research worldwide in both academic and industrial 
institutions is directed towards applying nanotechnology to medicine to provide 
economically viable, cost-effective, high-efficacy diagnosis and treatment of infection 
and disease. 
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1.2. Nanomedicine 
Nanomedicine is an emerging field that applies nanotechnology to medicine. It 
involves the precise engineering of materials at the nanometre scale (1-1000 nm) so 
that the distinctive physicochemical properties of nanoparticles - such as high surface 
area-to-volume ratios, controlled shape and size, and unique optical properties - can 
be utilised to help overcome the problems currently associated with conventional 
medicinal treatments.6 It is a field that is continuously expanding due to its great 
potential in therapeutic,7 diagnostic and theranostic applications; the latter combines 
both therapeutics and diagnostics in a single nanomedicine formulation to enable 
detailed assessment of the biodistribution, pharmacokinetics and target-site 
localisation of a drug.8,9 Given the vast scope of nanomedicine, only the therapeutic 
applications will be reviewed here. 
1.2.1. Therapeutic applications 
Using nanoparticles to transport and deliver drugs to disease sites has proved more 
advantageous than conventional administration for many reasons: they can improve 
the biodistribution of hydrophobic drugs that would otherwise exhibit poor solubility 
in blood, and also reduce immunogenicity and thus prolong the half-life of drugs 
within the systemic circulation. In addition, nanoparticles can enhance drug-efficacy 
and therefore reduce dosage and the frequency of administration, enhance cellular 
uptake and protect drugs from degradation. These advantages are particularly relevant 
for orally administered formulations that are subjected to the harsh conditions of the 
gastrointestinal tract. The release of drugs in a sustained manner, or in response to a 
stimulus, are also target opportunities being investigated and, the targeting of drugs 
specifically to disease sites when functionalised with cell-targeting ligands has been 
shown to reduce cytotoxicity and undesirable side-effects. As a result, there are 
currently more than 40 nanoparticle-based therapeutic products in clinical use after 
having gained approval from regulatory authorities such as the US Food and Drug 
Administration (FDA) and the European Medicines Agency (EMA), with many more 
in clinical trials and pre-clinical development.10 
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1.2.2. Clinically approved nanoparticle-based therapeutics 
The FDA’s Centre for Drug Evaluation and Research (CDER) – employing 
physicians, statisticians, chemists, pharmacologists, among other scientists - reviews 
(pre)clinical data to determine whether the health benefits of a therapeutic product 
outweigh its known risks; if deemed beneficial it will be approved for clinical use. 
Currently there are more than 40 nanoparticle-based therapeutic products that have 
gained approval from regulatory authorities,10 the formulations of which include 
liposomes,11 micelles,12 polymeric drugs,13 polymer-protein/aptamer conjugates14 and 
antibody-drug conjugates.15 
Doxil was the first liposomal-based therapeutic approved by the FDA in 1995 for the 
treatment of AIDS-related Kaposi’s sarcoma – a cancer that can develop after infection 
with human herpes virus 8.11,16–18 The transport and delivery of the anticancer 
chemotherapeutic drug, doxorubicin, was achieved after encapsulation into the 
internal aqueous phase of liposomes (consisting of phosphatidylcholine and 
cholesterol) - driven by a transmembrane ammonium sulphate gradient. Clinical trials 
found that this liposomal formulation dramatically prolonged systemic circulation of 
the drug, reduced cardiotoxicity and resulted in enhanced drug-accumulation in the 
tumour tissue compared to conventional treatment with doxorubicin. The formulation 
was later approved for clinical use in the treatment of ovarian cancer (1999) and 
multiple myeloma (2007).19,20 The clinical success of Doxil in anticancer therapy is 
attributed to two general characteristics of nanoparticles: their size and surface 
functionality. Liposomes are self-assembled phospholipid vesicles with diameters 
typically between 80-200nm; this large size allows them to accumulate extensively in 
solid tumours via extravasation due to the enhanced permeability and retention (EPR) 
effect (Figure 1.1).21,22 The effect exploits: (i) the disorganised ‘leaky’ tumour 
vasculature that exists because of angiogenesis (a process that involves the rapid and 
irregular formation of new blood vessels within the tumour microenvironment), and 
(ii) the impaired lymphatic system associated with tumours that is normally 
responsible for the drainage of macromolecules from the tissue. The greater 
permeability of the vessels and the poor lymphatic drainage thus enables the greater 
accumulation of liposomes in tumours than in healthy tissue. 
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Figure 1.1. a) Graphical representation of the Doxil liposomal formulation encapsulating 
doxorubicin as a crystalline salt, with typical size of 80-200nm and PEG surface functionality; 
b) the enhanced permeability and retention (EPR) effect, showing the extravasation of 
liposomes through the fenestrations in the leaky tumour vasculature and their accumulation as 
a consequence of the poor lymphatic drainage. 
 
Liposomes in their native form are rapidly cleared from systemic circulation via the 
reticuloendothelial system (RES) and the mononuclear phagocytic system (MPS) as 
part of an immune response; this can reduce their possible therapeutic effect.23 To 
overcome this premature clearance, Doxil liposomes are functionalised with 
poly(ethylene glycol) (PEG) which reduces opsonisation and subsequent clearance, 
and therefore prolongs systemic circulation, which is vital to successfully utilise the 
EPR effect.23–25 Despite its clinical success, however, there are two serious side effects 
associated with this treatment: (i) palmar plantar erythrodysthesia, and (ii) 
complement activation-related pseudo allergy.11,26 
Currently, liposomes are the most clinically established ‘nanocarrier’ structure in 
nanomedicine, with therapeutic applications that include the treatment of fungal 
infections, leukaemia, wet age-related macular degeneration, influenza, hepatitis A, 
anaesthesia and post-operative pain relief, (Table 1.1). 
Polymer-protein/aptamer conjugates are another dominant platform in 
clinically-relevant nanomedicine (Table 1.1). They have been grouped together with 
polymeric drugs and polymer-drug conjugates to coin the term ‘polymer therapeutics’, 
to differentiate them from traditional nanocarrier drug-delivery systems 
(e.g. liposomes, micelles).27  
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Table 1.1. Clinically approved nanoparticle-based therapeutics 
Product Clinical Application Admin. 
Liposome 
Doxil/Caelyx AIDS-related Kaposi’s sarcoma, ovarian cancer, 
myeloma, breast cancer 
i.v. 
Abelcet Fungal infection i.v. 
Ambisome Fungal infection i.v. 
Depocyt Malignant lymphomatous meningitis i.t. 
DaunoXome AIDS-related Kaposi’s sarcoma i.v. 
Myocet Metastatic breast cancer i.v. 
Epaxal Hepatitis A i.m. 
Inflexal V Influenza i.m. 
DepoDur Postoperative pain relief Epidural 
Visudyne Age-related macular degeneration, pathologic myopia, 
ocular histoplasmosis 
i.v. 
Marquibo Acute lymphoblastic leukaemia i.v. 
Micelle 
Estrasorb Menopausal therapy Topical 
Taxol Lung cancer, breast cancer, ovarian cancer, 
 AIDS-related Kaposi’s sarcoma 
i.v. 
Taxotere Lung cancer, breast cancer, prostate cancer, stomach 
cancer 
i.v. 
Polymeric drug 
Copaxone Multiple sclerosis s.c. 
Renagel End-stage renal disease Oral 
Welchol Type-2 diabetes oral 
Polymer-protein conjugate 
Adagen Severe combined immunodeficiency syndrome i.m. 
Pegasys Hepatitis C s.c. 
Neulasta Chemotherapy-induced neutropenia s.c. 
Somavert Acromegaly s.c. 
Oncaspar Acute lymphoblastic leukaemia i.v./i.m. 
PEGIntron Hepatitis C s.c. 
Cimzia Rheumatoid arthritis, Crohn’s disease s.c. 
Polymer-aptamer conjugate 
Macugen Age-related macular degeneration i.r. 
Antibody-drug conjugate 
Adcetris Hodgkin lymphoma, anaplastic large cell lymphoma i.v. 
Kadcyla Breast cancer i.v. 
Albumin-bound nanoparticle 
Abraxane Pancreatic cancer, breast cancer, lung cancer i.v. 
i.v. intraveneous, i.t. intrathecal, i.m. intramuscular, s.c. subcutaneous, i.r. intravitreous. Adapted from references 
7, 10, 39 and 159. 
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Oncaspar (PEG-L-asparaginase) gained FDA approval in 1994 for clinical use in the 
treatment of acute lymphoblastic leukaemia.28,29 Its phase I clinical trial showed that 
the conjugation of PEG to the enzyme, asparaginase, greatly increased its plasma half-
life (357 h) compared to the native enzyme (20 h) by reducing opsonisation and 
subsequent clearance by the RES.30 This therefore improved bioavailability, and 
enabled the hydrolysis of asparagine (an amino acid that is essential for tumour 
growth) into aspartic acid and ammonia before its removal from systemic circulation. 
Furthermore, the trial showed that the conjugation of PEG significantly reduced 
hypersensitivity reactions (e.g. anaphylactic shock) compared to the conventional 
treatment with asparaginase. Other polymer-protein/aptamer conjugates in clinical use 
include Somavert,31 Cimzia,32 Adagen,33 Pegasys,33 Neulasta,34 PegIntron,33 and 
Macugen;35 the latter five also utilise PEG-conjugation to reduce immunogenicity and 
prolong systemic circulation. 
Antibody-drug conjugates are a promising new class of nanomedicines that have the 
potential for active targeting (delivery of drugs to specific cells) owing to the 
specificity of the antibodies to relevant antigens.36–38 Their therapeutic application is 
particularly promising for the treatment of cancers and aims to specifically interfere 
with molecular targets and pathways that are important for the proliferation of cancer 
cells; the drug is therefore selectively cytotoxic to tumours. Significant progress has 
been made in the pre-clinical development of these nanomaterials, with particular 
emphasis on the optimisation of antibody specificity, drug potency, linker design and 
site of conjugation. Currently, there are two antibody-drug conjugates that have gained 
FDA approval: Adcetris (2011) and Kadcyla (2013), used in the treatments of 
lymphomas and breast cancer respectively.39  
1.2.3. Nanoparticle-based therapeutics under (pre)clinical evaluation 
Since their approval for clinical use, nanoparticle-based therapeutics have been hugely 
successful in the field of medicine, particularly in the treatment of cancer. In this area, 
nanomaterials such as liposomes and polymer-protein conjugates have been developed 
to avoid recognition by the immune system and to accumulate in solid tumours by 
virtue of the EPR effect. This has resulted in enhanced drug-efficacy and reduced 
cytotoxicity; however, in anti-cancer therapy, even the application of nanomedicine 
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remains suboptimal. A key issue is the poor cellular internalisation of the nanoparticles 
after accumulation in the tumour tissue. Paradoxically, this is attributed to the stealth 
functionalities present on the periphery of the nanoparticles, which are required to 
utilise the EPR effect; this is known as the PEG dilemma.40,41 Other issues include: (i) 
the high dependence on the degree of tumour vascularisation, which means that the 
efficacy of the therapy will vary considerably with tumour type and anatomical site;42–
44 (ii) the heterogeneity of tumour vasculature, which can severely affect the 
distribution of the nanoparticles within the tumour tissue;43–45 and (iii) the 
heterogeneity in human cancer pathology.43–45 
To address these issues, research is now heavily focused on the development of 
nanoparticle-based therapeutics that will promote entry of the drug-carriers into 
specific cells; a concept known as active targeting. It is achieved by functionalising 
the surface of the nanomaterials with targeting ligands (e.g. carbohydrates, peptides, 
vitamins, proteins, antibodies, aptamers and oligonucleotides) that have a high affinity 
for specific cell-receptors; the binding of these ligands to the relevant receptors 
triggers cellular internalisation via receptor-mediated endocytosis, enabling the 
intracellular delivery of the drug.  
Two cellular targets can be distinguished for active targeting in anticancer therapy 
(Figure 1.2): (i) tumour cells (a direct approach), and (ii) tumour endothelium (an 
indirect approach);46 targeting the former aims to increase internalisation of 
nanoparticles directly into tumour cells after accumulation within tumour tissue via 
the EPR effect. It is important to note that this direct approach cannot be achieved 
without passive accumulation of the nanoparticle within the tumour.42 Target 
cell-receptors of interest include transferrin receptors,47,48 folate receptors,49–51 
lectins,52 and epidermal growth factor receptors (EGFR).53,54 The second approach 
aims to remove the blood supply to the tumour by killing blood vessels that were 
formed as a result of angiogenesis. This starves the tumour of oxygen, nutrients, and 
growth factors that are vital for proliferation, consequently inducing apoptosis 
(cell-death) and causing shrinkage of the tumour tissue. 
Targeting the tumour endothelium is interesting for a number of reasons: (i) 
extravasation of the nanoparticles into the tumour tissue is not required, thereby 
avoiding the problems caused by the high interstitial fluid pressures of tumours; 
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 Figure 1.2. Graphical representation of the two cellular targets for active targeting in 
anticancer therapy: (i) targeting of tumour cells (a direct approach) after extravasation through 
leaky tumour vasculature, and (ii) targeting of tumour endothelium (an indirect approach). 
 
(ii) endothelial cell markers are overexpressed in the majority of angiogenic vessels, 
which means that a targeted approach of this kind is not limited to particular forms of 
cancer, and can be effective in anticancer therapy in general; and (iii) the potential risk 
of tumours developing resistance to the anticancer therapy is reduced due to the 
genetic stability of endothelial cells compared to cancerous cells. This approach can 
be achieved by targeting vascular endothelial growth factors (VEGF) and their 
receptors,55,56 αvβ3 integrins,57,58 vascular cell adhesion molecule-1 (VCAM-1)59 and 
matrix metalloproteinases.60,61 
With regards to both direct and indirect active targeting, it remains important to avoid 
premature clearance by the RES and MPS; therefore, the degree of both targeting 
functionality and stealth functionality requires optimisation. 
There are several nanoparticle-based therapeutics, utilising liposomes, polymeric 
micelles and polymeric nanoparticles, currently undergoing various stages of clinical 
trials that have been designed for the active targeting of tumours (Table 1.2). Once 
more, liposomes remain the dominant nanoparticle platform under (pre)clinical 
evaluation. 
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Table 1.2. Overview of actively-targeted nanomedicines under clinical evaluation. 
Therapeutic Payload Ligand Target Clinical 
Application 
Status 
Liposomes 
2B3-101 Doxorubicin Glutathione Glutathione 
transporters 
Brain metastases of 
breast cancer 
Phase 
1/2a 
Anti-EGFR 
Immunoliposomes 
Doxorubicin Antibody 
fragment 
(scFv) 
EGFR Solid tumours Phase 1 
Lipovaxin-MM Melanoma 
antigens and 
IFNγ 
Single domain 
antibody (dAb) 
fragment (VH) 
DC-SIGN Melanoma vaccine Phase 1 
MBP-426 Oxaliplatin Transferrin (Tf) Tf receptor Gastric cancer Phase 2 
MM-302 Doxorubicin Antibody 
fragment 
(scFv) 
HER2 (ErbB2) 
receptor 
ErbB2-positive 
breast cancer 
Phase 1 
SGT-53 p53 plasmid 
DNA 
Antibody 
fragment 
(scFv) 
Tf receptor Solid tumours Phase 1b 
SGT-94 RB94 plasmid 
DNA 
Antibody 
fragment 
(scFv) 
Tf receptor Solid tumours Phase 1 
Polymeric Micelle 
BIND-014 Docetaxel ACUPA PSMA Non-small-cell lung 
cancer, prostate 
cancer 
Phase 1/2 
SP1049C Doxorubicin Pluronic P-glycoprotein Advanced 
adenocarcinoma 
Phase 2/3 
Carbohydrate-based Nanoparticle 
CALAA-01 RRM2 siRNA Transferrin (Tf) Tf receptor Solid tumours Phase 1 
Adapted from references 63 and 159. 
MBP-426 is a liposome loaded with oxaliplatin, currently undergoing phase II clinical 
trials for the treatment of gastric, gastroesophageal and oesophageal adenocarcinomas. 
The surface of the liposome is functionalised with: (i) PEG – to reduce 
immunogenicity, and (ii) transferrin (Tf) – a glycoprotein that can actively target Tf 
receptors overexpressed on the surface of cancer cells. Initial in vivo studies in mice 
found that the encapsulation of oxaliplatin within Tf-PEG-liposomes significantly 
reduced binding to plasma proteins and erythrocytes (red blood cells), resulting in 
enhanced drug-systemic circulation and extravasation in colon 26 tumours. Results 
also indicated that the loaded Tf-PEG-liposomes were more effective at suppressing 
tumour growth compared to the free-drug, bare-liposomes and PEG-liposomes.62 
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Further development of the original formulation yielded a liposomal-therapeutic that 
not only actively targeted tumours but also acted in a stimuli-responsive manner. This 
was achieved by conjugating the Tf-ligand to N-glutaryl-phosphatidylethanolamine 
(NGPE) which caused disassembly of the liposome in a low pH environment; having 
localised in endosomal compartments after receptor-mediated endocytosis, the low pH 
environment caused the liposome to collapse and release the encapsulated oxaliplatin. 
Another liposome nanocarrier under clinical evaluation for the active targeting of solid 
tumours is SGT-53, consisting of cationic lipids that encapsulate wild-type p53 
plasmid DNA responsible for encoding vital tumour suppressor proteins.63 These 
proteins play a critical role in two of the pathways involved in regulating tumour cell 
growth: apoptosis (cell-death) and the regulation of angiogenesis. However, they are 
absent in many human tumours. SGT-53 is therefore designed to deliver this plasmid 
DNA to tumours by actively targeting Tf glycoprotein receptors overexpressed on the 
surface of tumour cells; in this example, the targeting ligand is a single-chain antibody 
fragment (scFv). SGT-94 utilises the same Tf-targeted platform, but it encapsulates a 
gene that encodes the tumour suppressor protein RB94.63 Without such ligand-targeted 
nanoparticle platforms, these genes are unable to pass through cell-membranes and 
consequently cannot reach the intracellular environment. 
As already discussed, the binding of targeting ligands to specific receptors triggers 
cellular internalisation via receptor-mediated endocytosis; however, research has 
shown that the ligand density has a significant effect on the extent of internalisation. 
Polyvalent interactions provide simultaneous multiple binding of ligands to numerous 
cell-receptors, resulting in stronger cellular binding than corresponding monovalent 
interactions and increased probability of endocytosis (Figure 1.3).64 Computational 
studies investigating the role of the physicochemical properties of coating ligands in 
receptor-mediated endocytosis found that both the density and rigidity of the ligand 
enhances their uniform distribution on the nanoparticle surface, and enable multivalent 
binding. This increases the probability of the nanoparticle being totally engulfed, 
leading to cellular internalisation.65 Furthermore, in vitro and in vivo studies on various 
cancer cell-lines - using folic acid, transferrin and antibodies as the targeting ligand 
functionalities - also found that cellular uptake was enhanced with increasing ligand 
density.66,67 
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Figure 1.3. Receptor-mediated endocytosis of nanoparticles via polyvalent interactions.  
 
As greater cellular uptake is generally achieved with higher ligand densities, 
dendrimers and polymers bearing multiple dendrons can be regarded as the ideal 
nanoparticle platform for active targeting in drug-delivery applications. 
1.3. Dendrimers 
Since their introduction in the late 1970’s to mid-1980’s, this unique class of 
polymeric materials have gained considerable interest owing to their potential in a 
variety of applications that include sensing, catalysis, molecular electronics and 
nanomedicine.68–78  
The preparation and characterisation of these well-defined branched structures was 
first reported by Vögtle and coworkers in 1978, who referred to these materials as 
“cascade molecules”, obtained through an iterative synthetic procedure, 
(Scheme 1.1).79  An iterative synthetic methodology was later adopted by Newkome 
et al 80 and Tomalia et al,81 although they termed these well-defined branched 
constructs differently as “arborol systems” and “dendrimers” respectively. At present, 
the word dendrimer is the internationally accepted term for these materials – a word 
derived from Greek that describes a “tree-like” structure (“dendron” meaning “tree”, 
and “meros” meaning “part”). 
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Scheme 1.1. Vögtle’s synthesis of cascade molecules.79 This iterative procedure involved: (i) 
Michael additions between amines and an excess of acrylonitrile, and (ii) activation by 
reduction using sodium borohydride. 
 
Dendrimers are defined as perfectly branched, well-defined synthetic macromolecules 
obtained by a precise and step-wise process to yield monodisperse nanoparticles with 
a three-dimensional globular shape. Their unique architecture consists of three distinct 
domains: (i) a core-functionality, (ii) branching points, emanating from the core - the 
extent of which determines the overall generation of the dendrimer, and (iii) surface 
functionality - the degree of which increases exponentially with each generation, 
(Figure 1.4).  
1.3.1. Synthesis of Dendrimers 
Dendrimers are generally synthesised by one of two conceptually different routes: a 
divergent route or a convergent route. Both proceed via an iterative sequence of 
reactions that consist of a generation growth step followed by an activation step, with 
each iteration leading to a higher generation number. 
1.3.1.1. Divergent Synthesis 
Divergent synthesis begins from a multivalent central core extending outwards by the 
sequential addition of generational layers towards the periphery, (Figure 1.5).  
The first example of divergent synthesis was the “cascade approach” described by 
Vögtle and coworkers (Scheme 1.1), whereby a series of mono- and di-amines were 
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Figure 1.4. Graphical representation of: (i) a G4 dendrimer, showing the core functionality in 
black, the branched functionality in green, and the surface functionality in red; and (ii) the 
corresponding G4 dendron, with the focal point functionality depicted by a black triangle. 
 
 
Figure 1.5. Graphical representation of dendrimer synthesis by divergent growth (adapted 
from ref. 82).  
 
reacted with an excess (greater than two molar equivalents per amine) of acrylonitrile 
by Michael addition.79 The nitrile groups were then reduced using sodium borohydride 
to yield the activated primary amine functionality. This two-step reaction was repeated 
in an iterative fashion to yield the cascade molecules which can essentially be regarded 
as low generation dendritic polyamines.  
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The large-scale divergent synthesis of the poly(propylene imine) (PPI) dendrimers was 
reported by Meijer and coworkers in 1993;82,83 this synthetic procedure was adapted 
from the cascade molecule synthesis described by Vögtle and coworkers in which the 
low yields in the reduction step hindered the synthesis of higher generations. In this 
case, diaminobutane was chosen as the core molecule which was then reacted with an 
excess (greater than 4 molar equivalents) of acrylonitrile by an exhaustive Michael 
addition. The subsequent nitrile functionalities were hydrogenated by heterogeneous 
catalysis to yield amine functionality once more. Repeating this two-step synthesis in 
an iterative fashion on scales ranging from several grams up to several kilograms 
yielded dendrimers up to generation 4.5 with 64 terminal nitrile groups and a 
molecular weight of 6912 g mol-1. DSM commercialised these materials under the 
trademark Astramol™. 
However, the best-known example of divergent growth is the synthesis of the 
commercially available poly(amidoamine) (PAMAM) dendrimers, first reported by 
Tomalia and coworkers in 1985 (Scheme 1.2).81,84 Initially, an amine functionalised 
core molecule (e.g. ammonia, ethylene diamine) was reacted with an excess of methyl  
 
 
Scheme 1.2. Tomalia’s synthesis of PAMAM dendrimers. The iterative reaction sequence 
involved: (i) exhaustive Michael additions between amines and an excess of methyl acrylate, 
and (ii) complete amidations using a vast excess of ethylene diamine. 
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acrylate by an exhaustive Michael addition. Following this, complete amidation of the 
methyl esters was achieved using a vast excess of ethylene diamine to yield the 
activated primary amine functionality. This enabled the two-step reaction to be 
repeated in an iterative fashion, producing high molecular weight dendrimers up to 
generation 10 (MW = 934,720 g mol-1; 4096 peripheral amine groups). Other 
noteworthy examples of dendrimers obtained by divergent synthesis include the 
polyamide arborol systems from Newkome’s group85 and phosphorus-based 
dendrimers from Majoral and coworkers.86  
High generation dendrimers can be obtained when adopting a divergent synthetic 
strategy; however, the purity of divergently synthesised materials remains a significant 
problem. Each increase in generation number results in an increase in steric hindrance 
at the periphery of the dendrimer, therefore, ensuring complete reaction to yield 
defect-free dendrimers at each generation of growth becomes increasingly difficult. 
This effect is known as the “De Gennes dense packing” or “starburst limit effect”, 
based on the work of De Gennes and Hervet.87 As a consequence, vast excesses of 
reagents are required at each synthetic stage to achieve structural perfection; however, 
even this cannot avoid the inevitable formation of defects at higher generations as the 
separation of imperfect dendrimers from a mixture of perfectly branched structures is 
very difficult. The high costs incurred and the lengthy purification procedures required 
therefore often lead to issues with commercialisation. 
1.3.1.2. Convergent Synthesis 
The convergent synthetic approach, first proposed by Hawker and Fréchet in 1990,88 
is in direct contrast to the divergent approach in that growth begins with what will 
eventually constitute the periphery of the dendrimer, and progresses to the core 
coupling step (Figure 1.6). This strategy initially involves the formation of wedge-like 
structures called dendrons and generation growth is obtained by activation of the focal 
point of the dendrons, followed by a coupling reaction to an AB2 monomer (whereby 
the A group is unreactive, and the B groups are reactive). Each repetition of this two-
step synthetic procedure increases the generation number of the dendrons, whose focal 
points can be activated and finally coupled to a multifunctional core molecule to yield 
the desired dendrimer. 
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Figure 1.6. Graphical representation of dendrimer synthesis by convergent growth (adapted 
from ref. 82).  
 
The poly(benzyl ether) dendrimers were the first to be synthesised by the convergent 
synthetic route (Scheme 1.3).88,89 Synthesis began by reacting two equivalents of 
benzyl bromide with the monomer 3,5-dihydroxybenzyl alcohol via a Williamson 
ether coupling to yield the first generation hydroxyl functional benzyl ether dendron. 
Further reaction with carbon tetrabromide and triphenylphosphine restored the 
reactive benzyl bromide functionality at the focal point, and enabled the two-step 
reaction sequence to be repeated iteratively to yield higher generation dendrons. The 
final step involved coupling the benzyl ether dendrons to a multifunctional core - in 
this case 1,1,1-tris(4’-hydroxyphenyl)ethane - utilising the Williamson ether reaction 
once more to yield dendrimers up to generation six (G6).  
Due to the small number of coupling reactions per generation growth step, this 
convergent approach minimises the possible introduction of structural defects, avoids 
large excesses of reagents, simplifies purification, and ultimately presents greater 
synthetic control compared to the divergent method. However, this route also has its 
limitations: as the dendron increases in size with each iterative reaction sequence, the 
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Scheme 1.3. Synthesis of poly(benzyl ether) dendrimers by the convergent approach. The 
iterative synthesis involved: (i) a Williamson ether coupling between 3,5-dihydroxybenzyl 
alcohol and 2 eq. of benzylic bromide, and (ii) reaction of the 2° alcohol functionality at the 
focal point of the dendron with carbon tetrabromide and triphenylphosphine. 
 
accessibility and reactivity of the focal point is reduced as a result of steric inhibition, 
meaning that the synthesis of high generation dendrimers is difficult to achieve. 
1.3.2. Therapeutic Applications of Dendrimers 
Dendrimers have generated considerable interest in nanomedicine owing to their 
nano-metric size and monodispersity. More recently, however, a great deal of research 
has focussed on exploiting their extensive, multivalent surface functionality to yield 
nanomedicines with a high density of specific ligands capable of active targeting. Once 
again, the vast majority of this research is focused on applications in anticancer 
therapy.90–98 
Kesharwani et al investigated the active targeting potential of PPI dendrimers against 
various cancer-cell lines after functionalisation with folic acid, dextran, and galactose 
moieties; the MTT assay results using HeLa and SiHa cells found that the folate-PPI 
dendrimers exhibited the strongest anticancer activity.90 The synthesis of PEGylated 
PPI dendrimers bearing folate acid surface functionality has been described by  
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Sideratou et al; these materials showed low cytotoxicity and folate-receptor 
specificity.91 While Iyer and co-workers recently reported the functionalisation of 
fourth generation PAMAM dendrimers with hyaluronic acid (HA); a ligand capable 
of actively targeting CD44 receptors overexpressed on pancreatic tumours. 
Fluorescence studies showed a higher cellular uptake of HA-PAMAM dendrimers in 
MiaPaCa-2 cancer cells compared to the non-functionalised PAMAM dendrimers.92  
The ability of dendrimers to entrap guest molecules, either by physical 
encapsulation90–94,97,99–101 or chemical conjugation,96,102,103 has also made these 
materials promising drug-delivery vehicles.104 The physical encapsulation of guest 
molecules was first reported in 1994 by Meijer and coworkers, who described this 
concept as encapsulation within a ‘dendritic box’.105 This study involved the synthesis 
of generation 5 PPI dendrimers whose peripheral amine functionality was further 
functionalised with a dense shell consisting of tBOC-protected amino acids. Analysis 
of the encapsulation studies using various dye molecules confirmed their ability to 
host such guest molecules within the internal cavities, and also found that diffusion 
out of the box was immeasurably slow due to the close packing of the shell. Further 
development of this concept has led to the encapsulation of: (i) anticancer drugs 
(e.g. camptothecin, dimethoxycurcumin, doxorubicin, etoposide, 5-fluorouracil, 
methotrexate, and paclitaxel), (ii) anti-inflammatory drugs (e.g. diclofenac, diflunisal, 
ibuprofen, indomethacin, ketoprofen, mefenamic acid, methylprednisolone, naproxen, 
and nifedipine), and (iii) antimicrobial drugs (e.g. sulfamethoxazole, quinolones, 
artemether, niclosamide, and anti-chagasics). However, major issues remain regarding 
the potential of dendrimers as drug-delivery agents utilising such physical 
encapsulation methods. Firstly, high generation dendrimers are required to form 
globular structures with internal cavities capable of encapsulation; this involves 
expensive and difficult syntheses and purification procedures. Secondly, in order to 
prevent premature drug-leakage, the dendrimers must have a dense shell; this requires 
multiple reaction steps using small building blocks which consequently increases the 
risk of defect formation.  
The multivalent surface functionality associated with dendrimers theoretically 
provides the ideal platform for the chemical conjugation of guest molecules; however,  
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conjugation of hydrophobic drug molecules to the periphery of the dendrimer can 
significantly alter their physical behaviour (e.g. in vivo solubility), enhance 
opsonisation and recognition by the MPS, and limit their active targeting capabilities. 
As a consequence, there are currently no dendrimer-based nanomedicines that have 
been approved for drug-delivery applications. 
1.4. Hyperbranched Polymers 
Hyperbranched polymers (HBPs) are highly branched, polydisperse materials that 
share many properties with dendrimers; however, their defining feature is that they are 
dendritic materials that are structurally imperfect due to statistical branching of AB2 
monomers (Figure 1.7). Despite this, they are regarded as attractive, commercially 
viable alternatives to dendrimers primarily because they can be synthesised on a large 
scale through one-pot reactions without the need for laborious purification 
procedures.106–108  
This has led to the commercialisation of HBPs that include Boltorn® (hyperbranched 
aliphatic polyester), Hybrane® (hyperbranched polyesteramide), polyethyleneimine 
(hyperbranched polyamine) and polyglycerol (hyperbranched polyether). 
 
               
 
Figure 1.7. Graphical representation of a hyperbranched polymer, highlighting their 
imperfect branching and multivalent surface functionality. 
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Highly branched polymers were initially described by Flory in 1952 through the 
step-growth polycondensation of ABx monomers,109 however, the term 
‘hyperbranched polymers’ was later introduced by Kim and Webster who reported the 
synthesis of hyperbranched polyphenylene.110,111 Since then, the significant 
development of these materials, with particular emphasis on biocompatibility and 
biodegradability, has led to the synthesis of hyperbranched polyethers, hyperbranched 
polyesters, hyperbranched polyphosphates, hyperbranched polysaccharides, 
hyperbranched polypeptides, and hyperbranched polyamides; all have potential 
therapeutic applications in nanomedicine. The incorporation of targeting ligands onto 
the multivalent periphery of HBPs has highlighted the potential of these materials for 
the active targeting of disease. For example, the conjugation of folic acid onto the 
periphery of various amphiphilic HBPs has enabled the active targeting of folate 
receptors over-expressed on the surface of cancer cells.112–114  
1.5. Dendritic-Linear Polymer Hybrids 
Dendritic-linear polymer hybrids are complex macromolecules that combine key 
attributes of both individual structures: the extensive surface functionality associated 
with dendrimers, and the synthetic ease and versatility of linear polymers. Their 
architectures consist of linear polymers conjugated to at least one dendritic element, 
which can be combined in a number of ways to yield a range of functional structures. 
These can be grouped into three categories: (i) dendritic-linear block copolymers, 
(ii) dendronised polymer-hybrids, and (iii) star-like dendritic-linear polymer hybrids, 
(Figure 1.8). 
1.5.1. Dendritic-Linear Block Copolymers 
Dendritic-linear block copolymers are typically linear polymers with dendrons 
conjugated at one or both chain-ends, synthesis of which can be achieved using one of 
three general strategies: (i) coupling of a linear polymer with a preformed dendron, 
(ii) polymerisation of the linear block from the focal point of the dendron, and 
(iii) divergent growth of the dendron from the terminus of a linear polymer. 
These hybrids were first developed by Fréchet and coworkers in the early 1990s using 
a coupling route, which involved terminating the living anionic polymerisations of 
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Figure 1.8. Graphical representation of dendritic-linear polymer hybrids categorised into: (i) 
dendritic-linear block copolymers, (ii) dendronised polymer hybrids, and (iii) star-like 
dendritic-linear polymer hybrids. 
 
both polystyrene (PS) and PEG with Fréchet-type poly(benzyl ether) (PBE) dendrons 
bearing benzyl bromide focal functionality, yielding PBE-PS hybrids and amphiphilic 
PBE-PEG hybrids respectively.115,116 Investigations into the self-assembly of the PBE-
PEG hybrids in methanol/water mixtures enabled the formation of mono- and multi-
molecular micelles that were dependent on both the concentration and the dendron 
generation.117 Fréchet and coworkers later reported the synthesis of dendritic linear 
block copolymers using an alternative synthetic strategy that involved the anionic 
polymerisation of caprolactone from the focal point of a PBE dendron initiator.118 
Further syntheses of amphiphilic dendritic-linear block copolymers involved the 
divergent synthesis of poly(L-lysine) dendrons from a linear PEG chain,119 and the 
divergent synthesis of poly(propylene imine) dendrons (G1-G5) from 
amine-terminated PS,120 reported by Shaffer and coworkers, and Meijer and coworkers 
respectively. 
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Significant progress in the development of these hybrid materials, with particular 
emphasis on synthesis and their aqueous self-assemblies into micelles and vesicles, 
means they have potential application in drug-delivery and gene-therapy.121 Research 
has highlighted their ability to encapsulate and release hydrophobic payloads in a 
sustained 122–124 or stimuli-responsive manner,125–128 and to actively target specific 
tissues through the incorporation of targeting ligands, such as carbohydrates 
(e.g. galactose,129 mannose,129,130 and glucose131) and various peptide sequences.132,133 
With regards to the active targeting of these materials, one interesting study, carried 
out by Gillies and co-workers, compared the ability of dendritic-linear polymer 
vesicles bearing dendritic mannose functionality, with that of polymeric vesicles 
bearing non-dendritic mannose functionality, to bind to the mannose-binding lectin 
Concanavalin A (Con A) using a haemaglutination assay. Using the same overall 
mannose content on both vesicles, it was found that the dendritic vesicles exhibited a 
binding affinity over ten orders of magnitude higher than that of the non-dendritic 
vesicles. This was attributed to the density of the targeting ligands on the multivalent 
dendritic surface functionality. As a result, dendritic-linear polymer block copolymers 
and their self-assembled nanostructures present themselves as interesting candidates 
in the field of nanomedicine. 
1.5.2. Dendronised-Polymer Hybrids 
Dendronised-polymer hybrids consist of a linear polymer backbone with dendron 
moieties conjugated to a fraction of the repeat units (up to 100 %), therefore conveying 
architectures that closely resemble that of comb-polymers. These hybrids can be 
synthesised using one of two general approaches: the grafting-to approach, or the 
macromonomer approach. The former involves either the coupling (grafting-to) of a 
preformed dendron onto the repeat units of the polymer chain, or the divergent growth 
of a dendron from the polymer chain; whereas the latter approach involves the 
polymerisation of dendronised-monomers (macromonomers) using techniques such as 
controlled radical polymerisation, ring-opening metathesis polymerisation (ROMP), 
and Suzuki polycondensations.  
Although the synthesis of these hybrid materials remains challenging due to the 
high-chain density of the sterically-demanding dendrons, they have recently generated 
great interest owing to their molecular rigidity, morphological features, phase-
Chapter 1 
 
24 
 
transition properties, solvent-induced hierarchical self-assembly, and 
thermoresponsive behaviour, that has led to potential applications in photonics,134 
catalysis,135 biosensing,136 and photoresponsive drug-delivery.137 
1.5.3. Star-like dendritic-linear polymer hybrids 
Functionalisation at the periphery of dendritic compounds with linear polymers yields 
dendritic-linear polymer hybrids of a star-like nature. These hybrid materials can be 
synthesised by: (i) coupling of linear polymers to the periphery of a preformed 
dendron, or (ii) using the dendron as a macroinitiator to polymerise linear chains from 
its periphery. In either case, reactive functional groups at the periphery of the dendron 
are essential, and as such bis(methylol)propionic acid (bis-MPA) dendrons with 
multivalent hydroxyl functionality are a widely reported platform.138 
The synthesis of star-like dendritic-linear polymer hybrids via the coupling approach 
has been reported using various reactions. Nyström and coworkers reported the 
esterification of high molecular weight monofunctional PEG bearing carboxylic acid 
functionality with hyperbranched bis-MPA dendritic polymers (Boltorn H30 and 
H40).139 Studies involving the encapsulation of the anticancer drug doxorubicin were 
conducted and encapsulation efficiency, in vitro release, cellular uptake, cytotoxicity, 
and apoptosis induction were evaluated. In related studies, Grayson and coworkers 
utilised copper-catalysed azide-alkyne click (CuAAC) reactions to functionalise the 
periphery of first and second generation bis-MPA dendrimers with PEG and 
polystyrene (PS).140 
Synthesis of these hybrid materials via the macro-initiator approach can be achieved 
by either directly using hydroxyl functionalities for the ring-opening polymerisation 
(ROP) of monomers such as ɛ-caprolactone,141,142 or by decorating the periphery of 
the dendrons with functional groups capable of initiating controlled radical 
polymerisations such as atom transfer radical polymerisation (ATRP)143,144 and 
reversible addition-fragmentation chain-transfer (RAFT).145,146 
Qiao and coworkers reported an interesting approach to the synthesis of star-like 
dendritic-linear polymer hybrids, utilising bis-MPA dendrons (G1-G5) as 
macroinitiators for the ATRP of styrene: the polymerisation was initiated from the 
focal point of the dendrons, not the periphery, initially yielding hybrid materials whose 
architectures resemble that of dendritic-linear block copolymers. However, at high 
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vinyl conversion, divinylbenzene (DVB) was added to the polymerisation to form a 
cross-linked core. This yielded star-like hybrids whose final architecture differed from 
those obtained by conventional synthesis.147,148 
1.6. Hyperbranched Polydendrons 
Hyperbranched-polydendrons (hyp-polydendrons) are a new macromolecular 
architecture designed to combine aspects of reversible-deactivation radical 
polymerisation, branched vinyl polymerisation, and linear-dendritic hybrids, to yield 
high molecular weight macromolecules with ideally branched dendritic chain ends 
with the minimal number of reaction steps (Figure 1.9).149,150 
Synthesis involves a one-pot polymerisation of a mixture of monofunctional monomer 
and a low concentration of bifunctional branching monomer, initiated by a dendritic 
compound; less than one equivalent of branching monomer per primary chain is 
utilised to avoid gelation, as described by the Flory-Stockmayer theory.151–155  
Initially, dendritic initiators bearing benzyl ether functionality were utilised in the 
copper-catalysed ATRP of 2-hydroxypropyl methacrylate (HPMA) in the presence of 
the branching monomer ethylene glycol dimethacrylate (EGDMA); a degree of 
polymerisation (DPn) of 50 monomer units was targeted, and 0.8 equivalents of 
EGDMA per primary chain maintained.149 This yielded high molecular weight 
materials with Mw values as high as 1700 kg/mol, that were self-assembled via 
nanoprecipitation to form monodisperse, stable nanoparticles in aqueous media 
(Dz = 64 – 134 nm; PDI = 0.064 – 0.160). 
 
Figure 1.9. A) Schematic representation of a hyperbranched polydendron, showing the 
dendritic surface functionality and the branched polymer core. B) Examples of G2 dendritic 
ATRP initiators reported in the synthesis of the hyperbranched polydendrons. 
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Nanoparticle sizes could be controlled by varying the starting polymer concentration 
in THF, the final polymer concentration in water, and through manipulation of end-
group dendron generation. 
The complexity of these hyp-polydendrons was developed further by utilising mixed 
initiator systems to systematically control surface functionality.150 Here, a series of 
branched polymerisations were conducted via ATRP using varying ratios of a G2 
benzyl ether -functional dendritic initiator and a PEG-derived initiator (G2:PEG ratios; 
100:0, 90:10, 75:25, 50:50, 25:75, 10:90, 0:100). Nanoprecipitation of these materials 
into water yielded stable nanoparticles that were able to encapsulate hydrophobic 
molecules, such as Nile red and pyrene. This enabled preliminary in vitro 
pharmacological evaluation to assess the viability of these materials for drug-delivery 
applications. Low cytotoxicity was observed for each of the seven hyp-polydendron 
nanoprecipitates when assessed against the human epithelial colorectal 
adenocarcinoma (Caco-2) cell line. The transcellular permeation of the 
hyp-polydendron nanoprecipitates (encapsulating Nile red) was studied across 
differentiated Caco-2 monolayers as a model of absorption through the intestinal 
epithelium. Results show that: (i) all of the nanoprecipitates were able to permeate 
through the epithelium to a much greater extent than the aqueous Nile red solution, 
highlighting the potential of these materials as orally administered nanocarrier 
therapeutics, and (ii) a strong correlation was observed amongst the hyp-polydendron 
nanoprecipitates, where less transcellular permeability was achieved with decreasing 
dendron content.  
More recently, amphiphilicity has been introduced into the hyp-polydendron 
architecture through the use of tertiary-amine functional dendritic ATRP initiators in 
the branched copolymerisation of HPMA and EGDMA.156 Nanoprecipitation of these 
materials into water gave stable aqueous dispersions: the influence of polymer 
architecture, dendritic chain-end chemistry, and the pH of the precipitation medium, 
on the formation of nanoparticles was discussed. 
Essentially, hyp-polydendrons are regarded as an attractive, versatile alternative to 
dendrimers, particularly for therapeutic applications in nanomedicine. The reasons are, 
firstly, that hyp-polydendrons exhibit extensive surface functionality, yet can be easily 
obtained by combined dendron synthesis and one-pot branched polymerisation – this 
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is in stark contrast to the laborious, iterative synthesis widely associated with 
dendrimers. Secondly, the ability to tune the size of the hyp-polydendrons by either 
varying the degree of polymerisation, and/or modifying nanoprecipitation conditions 
means that these materials can easily be tailored for desired therapeutic application. 
Thirdly, mixed surface functionalities can be obtained by simply incorporating mixed 
initiating systems into a one-pot branched polymerisation. And finally, the branched 
core functionalities of hyp-polydendrons can be tailored for a variety of desired 
applications through the polymerisation of a wide range of vinyl monomers: the choice 
of monomer can enable the optimum encapsulation of a particular payload, and/or 
enable the materials to act in a stimuli-responsive manner (e.g. amine functionalised 
polymers in acidic environments). 
1.7. Research Objectives 
Ultimately, this research aims to synthesise amphiphilic hyp-polydendrons for 
potential drug-delivery applications, with a particular emphasis on developing the 
chemistry of both the hydrophilic surface functionalities and hydrophobic core 
functionalities to enable the active targeting of disease sites and the encapsulation of 
hydrophobic drugs (Figure 1.10). 
This will involve the convergent synthesis of dendritic ATRP initiators varying in 
generation number that will then be utilised in a branched vinyl copolymerisation 
following the Strathclyde approach to give the branched polymer core. Synthetic 
strategies will be developed to introduce saccharide functionalities to the multivalent 
periphery, whose hydrophilicity would enable nanoparticle formation in aqueous 
media, but more importantly facilitate potential interactions with specific lectin 
receptors. Various reports within the literature have demonstrated the ability of 
galactose and mannose bearing nanoparticles to target specific lectins that could 
potentially improve anticancer therapy157 and antiretroviral therapy,158 respectively; 
therefore, this research will aim to incorporate these monosaccharides onto the 
periphery of the hyp-polydendrons. Furthermore, the synthesis will aim to incorporate 
PEG functionalities - whose stealth properties that have been critical to the success of 
the majority of clinically-approved nanomedicines are described within this Chapter. 
The development of the hydrophobic branched polymer core will initially involve the 
optimisation of reaction conditions for the ATRP of hydrophobic monomers, n-butyl 
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methacrylate (nBuMA), methyl methacrylate (MMA) and t-butyl methacrylate 
(tBuMA) (Figure 1.11); it is hypothesised that these core functionalities will provide 
greater hydrophobicity than the p(HPMA) core functionalities previously reported, 
and thus enable a greater encapsulation efficiency of hydrophobic drug molecules. 
Finally, aqueous rapid nanoprecipitations of the hyp-polydendrons will be performed 
to study the effect of (i) the dendritic chain end functionality, (ii) the primary polymer 
chain length, and (iii) the molecular weight of the branched materials, on the formation 
of nanoparticles. 
 
Figure 1.10. Graphical representation of the aims of the project, showing varying dendron 
generation, hydrophilic surface functionalities and hydrophobic branched core functionalities. 
 
 
Figure 1.11. Graphical representation of the aims of the project, showing the varying primary 
polymer chain length of the hydrophobic branched polymer core. 
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Exploring the homogeneous controlled radical 
polymerisation of hydrophobic monomers in 
anti-solvents for their polymers 
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“Is methanol really a bad solvent for poly(n-butyl methacrylate)? Low dispersity and 
high molecular weight polymers of n-butyl methacrylate synthesised via ATRP in 
anhydrous methanol” 
A. B. Dwyer, P. Chambon, A. Town, T. He, A. Owen, and S. P. Rannard 
Polym. Chem., 2014, 5, 3608 
 
“Exploring the homogeneous controlled radical polymerisation of hydrophobic 
monomers in anti-solvents for their polymers: RAFT and ATRP of various alkyl 
methacrylates in anhydrous methanol to high conversion and low dispersity” 
A. B. Dwyer, P. Chambon, A. Town, F. L. Hatton, J. Ford and S. P. Rannard 
Polym. Chem., 2015, 6, 7286 
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2.1. Introduction 
2.1.1. Chain growth polymerisation 
The polymerisation of vinyl monomers via the ‘chain-growth’ mechanism is 
thermodynamically driven by the enthalpy change upon reaction of each monomer 
repeat unit: this overcomes the unfavourable entropy change as the more ordered 
polymer structure is progressively formed. Generally, these polymerisations consist of 
four steps that include (i) initiation, (ii) propagation, (iii) termination, and (iv) chain 
transfer; the rates of which are dependent on the technique that is employed. 
Free radical polymerisation is a simple, cost-effective synthetic technique that 
proceeds with a fast rate of propagation relative to a slow rate of initiation; termination 
and chain transfer reactions are inevitable due to the highly reactive nature of free 
radicals.1 As a consequence, the polymerisations proceed in an uncontrolled manner, 
yielding high molecular weight polymers with very broad distributions. 
The potential to tune polymer composition,2–4 architecture5–8 and chain-end9,10 
functionalities was later realised through the development of ‘living’ ionic 
polymerisations, whose success relies on a fast initiation relative to a slow 
propagation, and the omission of termination reactions that may arise through 
bimolecular coupling;11–13 the latter are not possible due to the repulsion of like 
charges. However, ionic polymerisation procedures are very difficult to perform due 
to the stringent reaction conditions that are required. 
Reversible-deactivation radical polymerisation (RDRP) - also known as controlled 
radical polymerisation - is a technique that aims to combine the synthetic control of a 
living ionic polymerisation, with the ease of a free radical polymerisation.14 Chain 
transfer and termination reactions cannot be avoided due to the highly reactive nature 
of radicals, but they can be minimised by maintaining a low concentration of the active 
radical species at any given moment. This concept is based on a dynamic equilibrium 
between dormant and active species, which can either be achieved by reversible 
capping of an active radical species or through a degenerative chain transfer 
mechanism. The most widely used RDRP techniques include atom transfer radical 
polymerisation (ATRP)15,16 and reversible addition-fragmentation chain transfer 
(RAFT).17,18 
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2.1.2. Atom transfer radical polymerisation (ATRP) 
During ATRP, the active radical species are generated through a reversible redox 
process catalysed by a transition metal complex Mtn/L (Scheme 2.1). The catalytic 
complex undergoes a one-electron oxidation whilst simultaneously abstracting a 
halogen atom from the dormant species R-X, forming the oxidised species X-Mtn+1/L, 
and the active radical species R•; this activation step proceeds with rate constant kact. 
The active radical R• can then propagate with vinyl monomer (rate constant kp) before 
being capped with the halide (rate constant kdeact) to form the dormant species once 
more. To reiterate, termination reactions can occur with rate constant kt, however this 
is minimised when the rate of deactivation is much greater than the rate of activation 
(kdeact >> kact): this means that the equilibrium is highly biased towards the dormant 
species so as to maintain a low concentration of active radicals at any given moment. 
These reactions are further minimised by the persistent radical effect: each termination 
involving bimolecular coupling results in the irreversible formation of two equivalents 
of the deactivator X-Mtn+1/L, which consequently increases the rate of deactivation 
(kdeact >>> kact) and shifts the equilibrium further towards the dormant species. Given 
the nature of the mechanism, it is important for the polymerisation to proceed in the 
absence of oxygen to prevent (i) scavenging of radicals and subsequent termination, 
and (ii) poisoning of the transition metal catalyst. 
The control of the polymerisation is based on two principles: (i) the rate of deactivation 
is much greater than the rate of activation (kdeact >> kact), thereby minimising 
termination reactions and maintaining a constant concentration of active species 
throughout, and (ii) the equilibrium rate constant (KATRP = kact/kdeact) is much greater 
than the rate of propagation (kp), enabling the near simultaneous growth of all polymer 
chains. 
 
Scheme 2.1. The mechanism of ATRP showing the reversible redox process catalysed by 
transition metal complex.  
 
Chapter 2 
 
42 
 
2.1.3. Reversible addition-fragmentation chain transfer (RAFT) 
In RAFT, the active radical species are generated after decomposition of an initiator, 
and are maintained through a degenerative chain transfer process involving a range of 
specialist chain transfer agents (CTA) known as a RAFT agents (Scheme 2.2); suitable 
RAFT agents include trithiocarbonates and dithioesters. The radicals I•, formed after 
the decomposition of a conventional free radical initiator (rate constant kd), react with 
a vinyl monomer (rate constant ki) to give P1•, which propagates with further monomer 
(rate constant kp) to give Pm•. This growing polymer chain (P m•) reacts with the 
thiocarbonyl group of the CTA (rate constant kadd) to form the radical intermediate, 
which subsequently fragments either towards (i) the initial growing chain (rate 
constant k-add), or (ii) to the free initiating group R• and the macro-CTA (rate constant 
kβ). However, for well-controlled RAFT, kβ > k-add to ensure the pre-equilibrium stage 
is rapidly completed; therefore fragmentation towards R• is favoured. The new active 
species can then re-initiate polymerisation (rate constant kre-i) and propagate with vinyl 
monomer (rate constant kp), before reacting with the thiocarbonyl of the macro-CTA 
to form the radical intermediate once more. At this stage, the polymerisation is in its 
main equilibrium where the original CTA has been fully consumed to leave only the 
macro-CTA present in the reaction medium. The ensuing rapid exchange between the 
active and dormant species ensures an equal probability for all polymer chains to grow, 
yielding polymers with controlled molecular weights and narrow dispersities. 
 
Scheme 2.2. RAFT mechanism showing the degenerative chain transfer process. 
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RAFT agents are often monomer-specific and correct choice is key to successfully 
performing RAFT: this requires appropriate selection of both the Z and R groups. The 
Z group strongly influences the stability of the radical intermediate; therefore, 
selection should enhance the reactivity of the thiocarbonyl group towards radical 
addition to enable the formation of the radical intermediate, but it needs to be finely 
tuned to also enable fragmentation towards the re-initiating group (R•). The R group 
also contributes to the stability of the radical intermediate, albeit to a lesser degree. 
More importantly, its selection requires it to be a good leaving group from the radical 
intermediate to enable an efficient re-initiation. 
2.1.4. Utilising alcohols as the reaction solvent 
RDRP techniques - including both ATRP and RAFT - have been instrumental in the 
design of sophisticated polymeric nanostructures for potential drug-delivery 
applications.19 Utilising such techniques has facilitated the synthesis of a diverse array 
of functional polymers with controlled molecular weights, narrow dispersities, 
specific compositions, defined architectures, and complex chain-end functionalities.20 
This has required the optimisation of reaction conditions that include initiator 
chemistry, catalyst selection, design of CTA, ratio of reagents, solvent environment, 
reaction temperature and concentration; each can vary significantly on a monomer-to-
monomer and polymerisation technique basis.13,20–24 Prior to application, the polymer 
obtained is usually purified by means of precipitation into an anti-solvent; the use of 
alcohols for the precipitation of hydrophobic polymers, particularly the use of 
methanol (MeOH), has been widely reported.25 
Utilising alcohols as reaction solvents has proven to aid control of some ATRP 
reactions involving the polymerisation of hydrophilic monomers such as 
oligo(ethylene glycol) methyl ether methacrylate,26 2-hydroxyethyl methacrylate,27 
2-(dimethylamino)-ethyl methacrylate28 and glycerol methacrylate;29 alcohols vary 
from MeOH to ethanol, propanol and isopropanol (IPA). 
The controlled polymerisation of hydrophobic monomers in alcoholic media is more 
challenging due to the difficulty of maintaining truly homogeneous reaction conditions 
if the final polymer is insoluble in the protic solvent environment at high monomer 
conversion. Rannard and coworkers reported the first homogeneous CuI catalysed 
ATRP of n-butyl methacrylate (nBuMA) in IPA and IPA/water mixtures under 
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ambient reaction conditions;30 IPA was selected due to its well-known behaviour as a 
theta solvent for p(nBuMA), and IPA solutions of the polymer could tolerate up to 
approximately 10 vol % water before precipitation occurred.31 Other homogeneous 
alcoholic polymerisations of hydrophobic monomers include methyl methacrylate 
(MMA) in ethanol,32 and 2-hydroxypropyl methacrylate (HPMA) in methanol.27 In 
the latter case, p(HPMA) is soluble in MeOH, and its polymerisation by CuI catalysed 
ATRP has yielded a range of polymers with complex architectures: these include 
14C-radiolabelled homopolymers,33,34 linear and branched copolymers,35,36 and 
hyperbranched polydendrons.37,38 However, polymerisations that undergo phase 
separation at high monomer conversions, leading to the formation of colloidal 
structures, is a phenomenon currently gaining significant interest. Through careful 
selection of the solvent, a polymerisation can be initiated within a solvent environment 
that is good for the growing polymer chains, but which progressively changes to a 
poor solvent environment as the chain lengths increase and the monomer is consumed, 
eventually leading to aggregation; such reactions have been termed polymerisation 
induced self-assembly, often referred to as the PISA approach. Alcoholic solvents, 
including MeOH, ethanol and IPA, have been widely used for the polymerisation of 
styrene and benzyl methacrylate following the PISA approach.39–46 
2.1.5. Chapter aims 
The aim of this chapter was to develop a method of obtaining well-defined 
hydrophobic homopolymers using RDRP techniques that could later be utilised to give 
the hydrophobic core functionality of amphiphilic polymeric nanoparticles. Given the 
success of the polymerisations of nBuMA and MMA in IPA and ethanol, respectively, 
one aim of the current research was to investigate their polymerisations in anhydrous 
MeOH – a well-known anti-solvent for both p(nBuMA) and p(MMA). Comparisons 
between ATRP and RAFT techniques were to be made, and the behaviour of the 
polymers in the methanolic environment were to be assessed by studying their cloud-
point temperatures (upper critical solution temperature). 
2.2.  Solubility of p(nBuMA) in MeOH and cloud point measurements 
As previously stated, MeOH is an anti-solvent for p(nBuMA), often used for 
purification by means of precipitation to remove residual monomer, initiator and 
catalytic residues. However, an interesting observation was noted when attempting to 
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dissolve p(nBuMA) (Mn = 13 570 g mol-1; 1wt %) in MeOH: complete dissolution was 
achieved when heated to temperatures approaching the boiling point of the solvent, 
producing a clear solution which became turbid when cooled to ambient temperature. 
Repeating the heating cycle in MeOH-d4 enabled the study of this behaviour using 
nuclear magnetic resonance (NMR) spectroscopy: 1H-NMR experiments were 
performed at 60 °C and 25 °C, and the obtained spectra were analysed and compared 
(Figure 2.1). The experiment performed at 60 °C produced a well-resolved NMR 
spectrum that integrated well and provided an excellent assignment of the polymer 
structure. Whereas, the experiment performed after cooling to 25 °C generated a very 
weak spectrum; an expansion of the regions between 0.50-2.00 ppm and 3.50-4.25 
ppm provided a clear indication of the presence of polymer resonances after cooling, 
suggesting residual solubility of the sample after the heating cycle (Figure A1, 
Appendix). As expected, a change in the chemical shift of the water resonance was 
observed due to the varying degree of hydrogen bonding: this is weaker at the higher 
temperature, meaning the protons are more shielded and therefore resonate with a 
lower chemical shift. 
 
Figure 2.1. Studies of p(nBuMA) solubility in MeOH-d4. (A) 1H-NMR spectra of 
(i) p(nBuMA) at 25 °C before heating, (ii) p(nBuMA) heated to 60 °C, (iii) p(nBuMA) after 
heating and cooling to 25 °C; (B) photographs of p(nBuMA) within the NMR tubes – (i) at 
25 °C prior to heating, (ii) 60 °C, and (iii) after cooling to 25 °C. 
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The solubility of the p(nBuMA) sample without heating cycle was also investigated, 
which simply involved mixing the polymer with MeOH-d4 at ambient temperature and 
performing a 1H-NMR experiment at 25 °C. The spectrum obtained showed no 
appreciable resonances attributed to the polymer, even after significant expansion. 
The behaviour of p(nBuMA) (Mn = 13 570 g mol-1) within the methanolic 
environment was also assessed by performing cloud point studies; cloud points were 
obtained by observing the temperatures at which precipitation occurred for various 
concentrations of the polymer in MeOH. This involved heating the samples within an 
oil bath until dissolution occurred below the boiling point of the solvent, after which 
the heating element was switched off to allow the samples to cool before noting the 
cloud point temperature as the onset of visible turbidity. Measurements were recorded 
in triplicate by repeating the heating cycle three times. Initially, anhydrous MeOH was 
utilised (stated <0.005 % H2O) and cloud points were observed for polymer solutions 
up to 5 wt% p(nBuMA) across a wide range of temperatures (47.5 – 64.7 °C) with 
excellent reproducibility (Figure 2.2; Table A1, Appendix); a clear trend can be seen 
whereby cloud point temperatures increased as the concentration of the polymer 
increased.  
 
Figure 2.2. Cloud point behaviour for p(nBuMA) in MeOH with varying water content within 
the organic solvent. Maximum p(nBuMA) solubility in MeOH-H2) (1 wt%) shown by red 
dashed line. Asymmetric error bars shown. 
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When analytical grade MeOH (stated <0.05 % H2O) was utilised, a maximum polymer 
concentration that achieved complete dissolution decreased to 4.5 wt % (cloud point 
= 64.1 °C) (Table A1 and Figure A2, Appendix), with a further decrease to 2 wt% 
(cloud point = 63.7 °C) when the water content was increased to 1 wt% through 
controlled water addition to anhydrous MeOH (Figure 2.2). Similar trends were 
observed for both studies, and when comparing data obtained in anhydrous MeOH and 
MeOH (+ 1 wt% H2O), an average increase of 5.5 °C was seen for the cloud point 
temperatures in the aqueous solvent (Figure 2.2). 
2.3. ATRP of nBuMA in anhydrous MeOH at elevated temperature 
Despite the low concentration of p(nBuMA) that was observed to undergo UCST 
behaviour in MeOH, the homopolymerisation of nBuMA was performed under 
conventional copper-catalysed (CuICl) ATRP conditions at 50 wt% in anhydrous 
MeOH at 60 °C, using the bidentate ligand 2,2-bipyridine (bpy), and the commercially 
available initiator ethyl α-bromoisobutyrate (Scheme 2.3). Initially, number average 
degrees of polymerisation (DPn) of 60, 80 and 100 monomer units were targeted 
(Table 2.1). The polymerisations appeared to progress homogeneously, with the 
characteristic dark brown opaque colour of the CuICl/bpy catalytic system evident 
throughout (Figure 2.3.i); no precipitate was observed, even when high monomer 
conversions were achieved. However, upon cooling the reactions precipitated as the 
polymer solution passed through the cloud point temperature. Initially, this was 
difficult to assess because of the strong, opaque colour of the reaction medium, but 
was more easily observed after deliberate poisoning of the catalytic system with air 
(Figure 2.3.ii). 
 
Scheme 2.3. Copper-catalysed ATRP of nBuMA in anhydrous MeOH at 60 °C. 
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Table 2.1. Cu-catalysed methanolic ATRP of nBuMA at 60 °C 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 99 % [59] 55 8 640 13 570 13 950 1.03 
80 96 % [77] 55 11 120 16 700 17 010 1.02 
100d 95 % [95] 79 13 700 19 690 21 310 1.03 
100d 93 % [93] 25 13 420 21 830 22 830 1.05 
150 94 % [141] 53 20 250 26 680 27 650 1.04 
200 87 % [174] 46 24 940 30 150 33 240 1.10 
300 90 % [270] 72 38 590 52 130 57 260 1.10 
400 74 % [296] 100 42 290 59 200 64 500 1.09 
500 66 % [330] 235 47 120 55 540 61 950 1.12 
1000 50 % [500] 648 71 300 75 880 85 500 1.13 
p(styrene) Std.e --- --- 9 200e 9 310 9 620 1.03 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue. c Triple-detection GPC utilising 
THF eluent and dn/dc = 0.0762 mL g-1 (averaged across 18 samples; Table A2, Appendix). 
d Repeat syntheses of p(nBuMA)100. e p(styrene) GPC calibration standard (Polymer 
Laboratories Ltd). 
 
 
 
Figure 2.3. Photographs of the methanolic polymerisation of nBuMA at 60 °C showing (i) 
the strong brown catalyst complex during polymerisation, (ii) the homogeneous 
polymerisation at 60 °C after careful exposure to oxygen, and (iii) precipitation of p(nBuMA) 
during cooling (57 °C). 
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Polymerisations were allowed to reach high conversions before the careful addition of 
air to the stirred reaction which led to oxidation of the CuI catalyst and the formation 
of a transparent green, homogenous solution at 60 °C (Figure 2.3.ii). Precipitation was 
readily observed upon cooling to 57 °C (Figure 2.3.iii); this is highly surprising given 
the concentration of the polymer (50 wt %) within the polymerisation and the observed 
inability to solvate the powdered polymer in anhydrous MeOH at concentrations 
above 5 wt%. Conveniently, the supernatant formed after the precipitation and 
sedimentation of the polymers was discarded to remove the vast majority of the 
catalytic system. After dissolving in THF, the polymers were purified further by 
passing through a neutral alumina column (using THF as eluent) to remove residual 
catalyst, and precipitated into cold methanol to give a white solid. In all cases, the 
polymerisations targeting a DPn of 60-100 monomer units reached high conversions 
(>95 %) and analysis by triple detection gel permeation chromatography (GPC) 
showed low dispersity polymers (Ð < 1.05) with number average molecular weight 
(Mn) values ranging from 13,570 - 21,830 g mol-1; 1.44-1.63 fold higher than 
theoretical values (Table 2.1., Figure 2.4.). 
 
Figure 2.4. GPC chromatograms (RI) showing p(nBuMA) molecular weight distributions 
across targeted DPn = 60-1000 monomer units – p(styrene) standard shown for comparison. 
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Due to the controlled nature of the polymerisations and the very low dispersities 
obtained, a series of polymerisations with escalating target DPn values - up to 
p(nBuMA)1000 - were conducted under the same reaction conditions by simply 
increasing the mass of monomer (Table 2.1). The time required to polymerise the 
increasingly longer targeted polymer chains increased considerably, with the target 
p(nBuMA)1000 achieving 50 % conversion (effectively a DPn = 500) in 27 days; again, 
the strong brown colour of the CuICl/bpy catalytic system was evident throughout, and 
no precipitation was observed. Despite the considerably reduced conversions and very 
long reaction times, the homogeneous polymerisations remained controlled, yielding 
polymers with Mn values up to 76,000 g mol-1 and low dispersities (Ð ≤ 1.13). GPC 
analysis of all recovered polymers gave monomodal and largely symmetrical 
chromatograms (Figure 2.4), showing no significant loss of propagating chains during 
the polymerisation. Furthermore, as the targeted polymer chain lengths increased, the 
deviation from the theoretical Mn values (corrected for actual conversions in Table 
2.1.) reduced considerably to a factor of 1.18 for p(nBuMA)500 and 1.06 for 
p(nBuMA)1000. 
The narrow molecular weight distributions observed for each of the polymerisations 
strongly indicate that they proceed in a controlled manner, but this was confirmed by 
performing kinetic studies targeting a DPn = 80 monomer units. The kinetic data was 
analysed by 1H-NMR spectroscopy and triple detection GPC, and can be seen as a 
semi-logarithmic plot of ln([M]0/[M]) vs. time (Figure 2.5.A), and as a plot of Mn vs. 
conversion (Figure 2.5.B).  
Linear correlations were observed in both plots, meaning that: (i) the rate of the 
polymerisation follows first order kinetics, where irreversible termination reactions 
are negligible and the concentration of active species remains constant throughout; 
and (ii) there is a constant number of chains throughout, all propagating at the same 
time, where the rate of activation/deactivation (KATRP = kact/kdeact) is much greater than 
the rate of propagation (kp). Furthermore, the evolution of Mn with conversion was 
close to the theoretical values, and low dispersities were also observed for each kinetic 
point (Ð < 1.10). 
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Figure 2.5. Kinetic studies of p(nBuMA)80 synthesis: (A) conversion and semi-logarithmic 
plots vs. time; and (B) evolution of Mn and dispersity with conversion. 
 
It is well known that ATRP polymerisations that reach very high conversion are likely 
to take part in termination reactions either by combination or disproportionation,47,48 
with the latter case more likely when polymerising methacrylate-based monomers. 
This is because the radicals continue to form by the activation/deactivation process 
even when the monomer has been fully consumed. Eventually, this will lead to radical-
radical coupling (combination) or β-hydrogen abstraction from an active chain 
(disproportionation); the latter generating a new double bond as well as terminating 
the radical. Therefore, either case will likely result in broadening of the molecular 
weight distribution. To determine if such termination reactions occur, a series of four  
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polymerisations, each with a target DPn of 60 monomer units, were performed over a 
period of 14 days in anhydrous MeOH at 60 °C. 
1H-NMR analyses of crude samples taken from each reaction flask during the progress 
of the polymerisations showed that near complete conversion was achieved within the 
first 24 hours. Each polymerisation was then stopped after different reaction times: the 
first after 2 days, and the rest after 7 days, 10 days and 14 days. However, GPC 
analyses showed no appreciable broadening of the molecular weight distribution, or 
movement of the distribution towards lower retention times (Figure 2.6; Table A3, 
Appendix); instead, the GPC (RI) traces overlaid almost perfectly. These results rule 
out termination by combination, but whether disproportionation has taken place 
without the new vinyl functionality then taking part within a chain growth reaction is 
difficult to ascertain without any degree of uncertainty. 
 
 
Figure 2.6. GPC (RI) chromatographic overlays of p(nBuMA)60 obtained after methanolic 
ATRP of nBuMA at 60 °C for extended periods of time: after 2 days (green solid line), 7 days 
(black solid line), 10 days (red solid line), and 14 days (blue solid line). 
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2.4. Contribution of monomer co-solvency within the methanolic ATRP  
The impact of co-solvency from unreacted monomer was studied by determining the 
cloud points of the purified products of the targeted p(nBuMA)60, p(nBuMA)200 and 
p(nBuMA)300 polymerisations in MeOH with varying concentrations of nBuMA 
monomer. MeOH-polymer mixtures (50 wt% p(nBuMA)x) were prepared and 
subjected to a heating cycle prior to the incremental addition of more nBuMA 
monomer and further heat cycling. Once dissolution was achieved below the boiling 
point of the solvent, the heating element was switched off and the cloud point 
temperatures were recorded upon cooling. The study can be considered from two 
perspectives: (i) the concentration of added monomer can be viewed as a single time 
point within a polymerisation, where the polymer present represents the conversion of 
the polymerisation within the monomer-methanol environment. As such, each cloud 
point measurement would represent a polymerisation with a subtly different, and 
systematically increasing, target DPn (Figure 2.7; Table A4, Appendix); or (ii) the 
cloud point data may be assessed as the number of polymer repeat units per monomer 
(unreacted) co-solvent molecule that generates a particular cloud point temperature 
(Figure 2.8). 
As expected, dissolution of the polymers within the methanolic environment (50 wt % 
composition) in the absence of monomer was not possible; but when introduced to the 
MeOH-polymer mixtures, the nBuMA monomer eventually solvated the polymers and 
had a considerable effect on the observed cloud point temperatures. The study was 
initially performed using the targeted p(nBuMA)60 which was subjected to continual 
heat cycles after the incremental (10µL) addition of monomer. As can be seen from 
Figure 2.7, 50 µL of monomer was required to solvate the polymer, forming a solution 
that gave a cloud point temperature of 53.6 °C upon cooling; this represents 11 
polymer repeat units per co-solvent monomer molecule or, alternatively a model 
polymerisation conversion of approximately 92 % for a targeted DPn = 65 nBuMA 
units (calculated as (1-[(60/11)/((60/11) + 60)] x 100%). A clear trend was observed, 
with each further addition of monomer reducing the temperature at which precipitation 
occurred, resulting in cloud points as low as 24.5 °C for the polymer within the 
monomer-rich environment. 
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Figure 2.7. Cloud point measurement of p(nBuMA)x (0.5 g) in anhydrous MeOH (0.5 g) with 
increasing concentrations of nBuMA monomer. 
 
     
Figure 2.8. Cloud point measurement of p(nBuMA)x (0.5 g) in anhydrous MeOH (0.5 g) with 
increasing concentrations of nBuMA monomer; presented as a function of the number of 
repeat unit per solvating monomer. 
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Interestingly, a noticeable effect was seen when repeating the study using the products 
of the targeted p(nBuMA)200 and p(nBuMA)300 polymerisations and comparing the 
data with that obtained from the targeted p(nBuMA)60: the cloud points dramatically 
increased as the polymer chain lengths increased, even though the mass of p(nBuMA)x 
and monomer concentration remained constant. This is highlighted in Figure 2.7, with 
the total addition of 100µL of monomer resulting in cloud point temperatures of 
43.0 °C, 54.5 °C and 56.9 °C, for the solutions of p(nBuMA)60, p(nBuMA)200 and 
p(nBuMA)300, respectively. This effect is perhaps more clearly observed in Figure 2.8, 
showing the significant difference in cloud point temperatures even though the number 
of repeat units per solvating monomer are the same. In addition, p(nBuMA)300 could 
only be induced to show measurable UCST behaviour in monomer rich environments, 
whilst p(nBuMA)200 and p(nBuMA)60 both exhibited cloud point behaviour across the 
range of monomer concentrations studied. 
The results of this study highlight the significant co-solvency effect of the nBuMA 
monomer, suggesting that it plays a crucial role in solvating the growing polymer 
chains in the methanolic environment as the polymerisation progresses; but they also 
suggest that precipitation will occur at a particular conversion that is dependent on the 
target DPn due to the poor solvent environment at high conversions as result of the 
monomer depletion. This does not explain the high conversions and low dispersities 
obtained for the homogeneous polymerisations seen in Table 2.1, nor does it explain 
why the p(nBuMA)60 polymerisation was successfully performed for 14 days without 
precipitation. Clearly, the presence of unreacted nBuMA monomer is not the only 
factor allowing the reaction to proceed with the observed success. 
2.5. Cu-catalysed ATRP of nBuMA in MeOH at low temperature 
The co-solvency studies showed that the nBuMA monomer plays a significant role in 
solvating the polymer within the methanolic environment enabling dissolution at much 
lower temperatures than our initial reactions, but do not explain how polymerisations 
progressed to high conversion (e.g. targeted p(nBuMA)60 conversion = 99%) without 
observed precipitation. To investigate this further, a series of polymerisations were 
performed at a temperature of 25 °C, targeting p(nBuMA)60, p(nBuMA)100 and  
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p(nBuMA)200. It was expected that the polymerisations initiated at low temperature 
would proceed homogeneously due to the monomer co-solvency effect, but reach a 
conversion where the monomer-polymer and MeOH-polymer interactions would be 
overcome by polymer-polymer interactions, leading to precipitation induced phase 
separation. Surprisingly, this was not the case; all polymerisations proceeded to high 
conversions (≥ 95%) without observed precipitation, yielding narrow dispersity 
products (Ð = 1.03) (Table 2.2). Furthermore, analysis by triple detection GPC 
indicated that the targeting of theoretical molecular weights were improved at this 
lower temperature compared those conducted at 60 °C: p(nBuMA)60 deviates from the 
Mn values by a factor of 1.43; p(nBuMA)100 by a factor of 1.19; and p(nBuMA)200 by 
a factor of only 1.08. Also, the GPC chromatograms showed monomodal and 
symmetrical molecular weight distributions (Figure 2.9). 
It is important to note, however, that sampling during a number of the polymerisations 
at 25 °C did induce precipitation as soon as the hypodermic needle was submerged 
into the solution; this was easily observed and quickly led to sedimentation of 
precipitate after stirring was ceased. Consequently, the polymerisations were repeated 
and left to stir for an extended period of time in order to reach high conversions without 
precipitation. This also meant that kinetic studies would be very difficult to perform, 
and were therefore avoided. 
Table 2.2. Cu-catalysed methanolic ATRP of nBuMA at 25°C 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 95 % [57] 24 8 300 11 810 12 100 1.03 
100 97 % [97] 74 13 990 16 660 17 150 1.03 
200 97 % [194] 122 27 780 29 960 30 830 1.03 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue. c Triple-detection GPC utilising 
THF eluent and dn/dc = 0.0762 mL g-1 (averaged across 18 samples; Table A2, Appendix). 
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Figure 2.9. GPC chromatograms (RI) showing p(nBuMA) molecular weight distributions 
across targeted DPn = 60 – 200 monomer units; polymerised in anhydrous MeOH at 25 °C. 
 
2.6. Comparative Cu-catalysed ATRP of nBuMA in IPA 
As already stated, Rannard and coworkers reported the ambient temperature ATRP of 
nBuMA in IPA and IPA/water mixtures, where IPA was selected because it is a theta 
solvent for the polymer. To compare against the methanolic syntheses described 
above, a series of polymerisations were, therefore, performed by Cu-catalysed ATRP 
in IPA at both 60 °C and 25 °C: p(nBuMA)60, p(nBuMA)100 and p(nBuMA)200 were 
targeted in IPA at 60 °C; and p(nBuMA)60 and p(nBuMA)200 were targeted in IPA at 
25°C (Table 2.3; Figures A3 and A4, Appendix). 
The polymerisations at both temperatures proceeded without precipitation, as 
expected, and achieved high conversions (≥ 97 %) to give low dispersity polymers 
(1.14 < Ð < 1.16). Dispersities were significantly higher than those seen for the 
products of the methanolic polymerisations (Tables 2.1 and 2.2), but still 
representative of a well-controlled ATRP. A direct comparison of p(nBuMA) 
synthesised at 60 °C within either IPA or MeOH can be seen by overlaying the GPC 
refractive index (RI) chromatograms (Figure 2.10); the samples of p(nBuMA)60, 
p(nBuMA)100 and p(nBuMA)200 synthesised in MeOH all displayed molecular weight 
distributions that were entirely encapsulated within the distributions of the equivalent 
samples synthesised in IPA, demonstrating the enhanced control in MeOH. 
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Table 2.3. Cu-catalysed ATRP of nBuMA in IPA 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 °C       
60 99 % [59] 47 8 640 11 850 13 500 1.14 
100 99 % [99] 68 14 270 17 900 20 740 1.16 
200 99 % [198] 68 28 350 33 770 38 900 1.15 
25 °C       
60 99 % [59] 68 8 640 14 190 16 400 1.16 
200 97 % [194] 100 27 780 32 830 37 980 1.16 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue. c Triple-detection GPC utilising 
THF eluent and dn/dc = 0.0762 mL g-1 (averaged across 18 samples; Table A2, Appendix). 
 
 
 
Figure 2.10. GPC (RI) chromatographic overlay comparing the syntheses in MeOH (blue 
solid line) and IPA (red solid line) for: (A) p(nBuMA)60, (B) p(nBuMA)100, and (C) 
p(nBuMA)200. 
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To determine if termination – either by combination or disproportionation – occurs 
towards the latter stages of the reaction in IPA, a polymerisation targeting a DPn = 60 
nBuMA monomer units was performed at 60 °C and left to stir for 7 days. 
Comparisons between the GPC data for p(nBuMA)60 obtained after 2 days 
(99 % conversion) and 7 days (> 99 % conversion) were made (Table A5; Appendix); 
analysis of the 7 day reaction showed a broadening of the molecular weight 
distribution towards lower retention times, revealing the presence of higher molecular 
weight materials (Figure 2.11). This is in direct contrast to the study performed in 
MeOH (Figure 2.6), where no change in the molecular weight distribution was 
observed. These results suggest that in comparison to the latter stages of the 
methanolic polymerisation, the active chain-end functionalities within IPA are more 
available to take part in termination reactions that lead to an increase in molecular 
weight. Considering that IPA is a theta solvent for the polymer and MeOH is regarded 
as an anti-solvent, this is not surprising, and it is reasonable to envisage more densely 
coiled polymer chains within the methanolic environment that sterically protect the 
active chain-end functionality as a consequence (Figure 2.12). 
 
 
Figure 2.11. GPC (RI) chromatographic overlay of p(nBuMA)60 polymerised by ATRP in 
IPA at 60 °C, over 2 days (blue solid line) and 7 days (red solid line). The extended heating 
in IPA at 60 °C led to a broadening of molecular weight distribution towards lower retention 
times. 
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Figure 2.12. Schematic representation of proposed nBuMA polymerisation in MeOH and 
IPA: (A) monomer-MeOH acts as a good solvent for growing oligomers, but larger polymer 
chains in monomer depleted environments adopt collapsed coils with hidden chain ends; (B) 
monomer-IPA mixtures act as a good solvent environment and monomer depletion does not 
generate a poor solvent system at high conversion, leading to more expanded coils and 
available chain-ends. Key: blue background = MeOH solvent, red background = IPA solvent, 
dark green spheres represent unreacted nBuMA, light green spheres represent reacted 
nBuMA, and red spheres represent active chain-ends. 
 
2.7.  Comparative Cu-catalysed ATRP in MeOH using different ligands 
As previously described, ATRP is performed via a reversible redox process catalysed 
by a transition metal complex, with those consisting of copper being the most 
successful. The selection of the ligand, however, is very important as it dictates the 
kinetics of the polymerisation and the dynamics of exchange between the dormant and 
active species, both of which are fundamental to its success; for Cu-mediated ATRP, 
nitrogen-based ligands are often utilised.49 To investigate the effect of the ligand on 
the success of the methanolic polymerisation of nBuMA, three syntheses of 
p(nBuMA)60 were conducted in MeOH at 60 °C using CuICl; selection of the ligand 
varied from two equivalents of bpy, to one equivalent of 
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tris[2-(dimethylamino)ethyl]amine (Me6TREN) and N,N,N’,N’,N’’-
pentamethyldiethylenetriamine (PMDETA).  
All polymerisations proceeded to relatively high conversions, but those utilising 
Me6TREN and PMDETA produced polymers with asymmetric molecular weight 
distributions (Figure 2.13) and much higher Mn and Mw values  when compared to the 
polymerisation utilising bpy (MnPMDETA = 20 360 g mol-1; MnME6TREN = 38 550 g mol-1) 
(Table A6, Appendix). This suggests an increased initiating efficiency for the Cu-bpy 
catalytic system under these reaction conditions. 
As a qualitative measure, a small study was performed to assess the solubility of each 
of the catalytic systems within bulk nBuMA an nBuMA-MeOH mixtures. Upon visual 
observation, the Cu-bpy complex was insoluble in the bulk monomer at ambient 
temperature, whereas the Cu-Me6TREN and Cu-PMDETA complexes existed in a 
swollen state and were thus sparingly soluble (Figure 2.14). The addition of MeOH 
enhanced the solubility of the bpy and PMDETA complexes, but decreased the 
solubility of the Me6TREN complex (Figure 2.15). Whether this difference in 
solubility plays a role in the monomer-depleted or monomer-rich stages of the 
polymerisation is unclear. 
 
Figure 2.13. Syntheses of p(nBuMA)60 in MeOH using different catalytic systems: bpy (blue 
solid line), PMDETA (red solid line) and Me6TREN (black solid line). 
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Figure 2.14. Photograph showing the solubility of the ligated CuICl catalytic systems in bulk 
nBuMA. 
 
 
Figure 2.15. Photograph showing the solubility of the ligated CuICl catalytic systems within 
the monomer-MeOH environment. 
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There have been many conflicting reports detailing the exact mechanism of ATRP in 
polar and protic solvents, where the choice of ligand is highly relevant; this ultimately 
dictates the rate of disproportionation and comproportionation between Cu0, CuI and 
CuII, which forms the basis of the debate over whether such polymerisations proceed 
by supplemental activator and reducing agent ATRP (SARA ATRP) or single-electron 
transfer living radical polymerisation (SET-LRP). In SARA ATRP, 
disproportionation of the CuI catalytic complex is negligible, thus CuI is the major 
activator and CuII the deactivator; Cu0 primarily acts as a supplemental activator and 
a reducing agent of excess CuII through comproportionation.50,51 Whereas in SET-
LRP, Cu0 is the exclusive activator and CuII is the major deactivator; CuI is unable to 
activate the polymerisation because it undergoes instant disproportionation to Cu0 and 
CuII, and comproportionation is negligible.52 The use of Me6TREN as a ligand has 
been widely reported for SET-LRP because it rapidly induces disproportionation of 
copper complexes in a variety of solvents,53–55 including MeOH.56–59 The studies of 
disproportionation of CuI halides under varying ligand and solvent conditions were 
recently published by Percec and coworkers, which included the formation of 
insoluble nascent Cu0 nanoparticles after disproportionation of CuIBr-bpy complexes 
in MeOH;60 however, it is important to note that this was observed using a 1:1 molar 
ratio of CuIBr:bpy, whereas classical ATRP utilises a 1:2 molar ratio. 
To address this, another study was performed to investigate the potential for Cu0 
formation within the successful CuICl:bpy conditions reported here; this involved a 
qualitative comparison of observed Cu0 formation between CuICl:bpy mixtures in 
MeOH at ambient temperature using either 1:1 or 1:2 molar ratios. The samples were 
prepared in anhydrous MeOH and compared after 90 minutes (Figure 2.16). 
Significantly less solid material was evident when utilising the 1:2 catalyst ratio, 
meaning that less disproportionation had taken place. This suggests that under the 
reaction conditions reported herein using a 1:2 catalyst ratio, the polymerisation 
proceeds by a mechanism that is analogous to SARA ATRP. Furthermore, the 
formation of solid material after the addition of MeOH to the CuICl:Me6TREN 
complex (Figure 2.15) may suggest the polymerisation conducted using this catalytic 
system proceeds by SET-LRP. However, no characterisation studies have been 
performed to confirm either mechanism, therefore the nature of the polymerisations 
reported throughout this thesis are referred to as conventional ATRP. 
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Figure 2.16. Photographic qualitative evaluation of CuICl:bpy catalytic systems in MeOH 
showing variation in Cu0 formation by disproportionation at a 1:1 ratio (left) and 1:2 ratio 
(right) after 90 minutes at ambient temperature. 
 
2.8.  Comparative RAFT polymerisation of nBuMA in MeOH at 60 °C 
The successful polymerisation of nBuMA in MeOH by ATRP seems to be 
significantly enhanced by the co-solvency effect of the unreacted monomer, allowing 
reactions to proceed to high conversion without observable precipitation to yield low 
dispersity polymers. However, it also seems that its success is heavily dependent on 
the ligand chemistry utilised to complex the CuICl; those ligated with bpy exhibited 
enhanced initiating efficiencies and control over the polymerisation. 
To investigate further, RAFT was utilised to polymerise nBuMA in anhydrous MeOH 
at 60 °C to provide comparative data to that obtained by ATRP. Polymerisations were 
conducted at 50 wt% with respect to monomer, utilising 4,4’-azobis(4-cyanopentanoic 
acid) (ACVA) as the free radical initiator, and 2-cyano-2-propyl benzodithioate 
(CPBD) as the chain transfer agent (CTA) (Scheme 2.4); both ACVA and CPBD were 
chosen based on their reported use in aqueous and alcoholic solvents to polymerise 
methacrylate-based monomers.61,62  
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Scheme 2.4. Reaction scheme for the RAFT polymerisation of nBuMA in anhydrous MeOH 
at 60 °C, utilising 4,4’-azobis(4-cyanopentanoic acid) (ACVA) and 2-cyano-2-propyl 
benzodithioate (CPBD). 
 
It’s important to note that due to the high temperature required to thermally decompose 
the ACVA initiator, polymerisations by RAFT at 25 °C were not possible. 
Surprisingly, the polymerisations by RAFT targeting a DPn = 60-1000 monomer units 
achieved high conversions (as high as 95 %) and yielded low dispersity polymers 
(Ð < 1.12). Analysis by triple detection GPC showed monomodal and symmetrical 
molecular weight distributions (Figure 2.17) with Mn values ranging between 
9,300 - 107,950 g mol-1, and also highlighted improved Mn control by RAFT 
compared to ATRP (Table 2.4).  
In all cases, the RAFT polymerisations proceeded to high conversions over much 
shorter reaction times than ‘equivalent’ ATRP conditions. This is most significant for 
the targeted p(nBuMA)1000, achieving 80 % conversion (i.e. p(nBuMA)800) in 44 
hours; in contrast, the equivalent polymerisation by ATRP achieved 50 % conversion 
(i.e. p(nBuMA)500) in 27 days. These results suggest that the ATRP mechanism is not 
critical to the methanolic polymerisation and, indeed, leads to a slower rate of 
propagation.  
The homogeneity of the RAFT polymerisations could be easily monitored due to the 
transparent pink solution that is characteristic of this technique. In doing so, this 
revealed that homogeneous conditions were maintained through to high conversion 
when targeting p(nBuMA)60. 
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Figure 2.17. GPC (RI) chromatographic overlay of p(nBuMA) syntheses in MeOH by RAFT. 
 
Table 2.4. Methanolic RAFT and Cu-catalysed ATRP of nBuMA at 60 °C 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conv. 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
RAFT       
60 95 % [57] 24 8 100 9 300 10 350 1.12 
100 91 % [91] 24 12 950 14 550 15 650 1.08 
500 93 % [465] 44 66 150 64 750 70 550 1.09 
1000 80 % [800] 44 113 750 107 950 113 950 1.06 
       ATRP       
60 99 % [59] 55 8 650 13 600 13 950 1.03 
100 95 % [95] 79 13 700 19 700 20 300 1.03 
500 66 % [330] 235 47 100 55 550 61 950 1.12 
1000 50 % [500] 648 71 300 75 900 85 500 1.13 
       p(styrene) Std.d --- --- 9 200 9 300 9 600 1.03 
a Target DPn calculated as [nBuMA]/[initiator or CTA]. b Theoretical Mn includes 
initiator/CTA residues and was calculated as [(target DPn x 142.2 g mol-1) x experimental 
monomer conversion]. c Triple-detection GPC utilising THF eluent and dn/dc = 0.0762 mL g-1 
(averaged across 18 samples; Table A2, Appendix). d p(styrene) GPC calibration standard 
(Malvern instruments Ltd.) 
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However, when targeting a DPn ≥ 100 monomer units, polymerisations proceeded 
homogeneously up to monomer conversions < 90 % (Figure 2.18.i), after which the 
reaction medium became turbid (Figure 2.18.ii). If stirring was ceased whilst 
maintaining reaction temperature at 60 °C, phase separation occurred resulting in a 
clear polymer-rich phase beneath a MeOH-rich turbid phase (Figure 2.18.iii): 
determined by 1H-NMR (Figure 2.19). Allowing the reaction medium to cool below 
its cloud point temperature resulted in the precipitation of the polymer from the 
polymer-rich phase (Figure 2.18.iv). And finally, complete phase separation was 
achieved after leaving the reaction medium to stand at ambient temperature overnight; 
evident by the clear MeOH phase (Figure 2.18.v). 
 
 
Figure 2.18. Photographs of a RAFT polymerisations showing: (i) homogeneous 
polymerisation at 60 °C at low conversion; (ii) onset of turbidity as high conversions; (iii) 
formation of layered phases when stirring is ceased, leaving a MeOH-rich phase (top) and a 
polymer-rich phase (bottom) above the cloud point temperature; (iv) precipitation of the 
polymer upon cooling below the cloud point temperature (image taken at 53 °C); and 
(v) complete phase separation and sedimentation at ambient temperature. 
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Figure 2.19. 1H-NMR (CDCl3) spectra of the biphasic system (normalised w.r.t. monomer 
residues) observed during the RAFT polymerisation of nBuMA in anhydrous MeOH at 60 °C: 
(i) MeOH-rich phase (top) showing resonances attributed to residual nBuMA monomer and 
weak signals attributed to p(nBuMA) (yellow dotted box); and (ii) polymer-rich phase 
(bottom) showing resonances attributed to residual nBuMA monomer, and strong signals 
attributed to p(nBuMA) (yellow dotted box). Inset: photograph of the biphasic system when 
stirring had ceased, from which samples were taken for analysis. 
 
A significant increase in the rate of polymerisation was expected with the onset of 
turbidity within the RAFT polymerisation, which would indicate that the reaction was 
proceeding under pseudo-dispersion conditions, as seen in polymerisation-induced 
self-assembly studies: this is attributed to compartmentalisation leading to a relatively 
high local concentration of monomer and thus rate enhancement. To determine this, 
kinetic studies were performed - targeting p(nBuMA)100 and p(nBuMA)1000 (Figures 
2.20 and 2.21 respectively) - through the simultaneous reaction of multiple vials 
containing monomer/CTA/initiator/MeOH stock solutions; this avoided perturbation 
of the reaction media when sampling that could potentially induce precipitation. 
Instead, each vial was used to represent a separate time-point within the overall 
polymerisation. 
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Figure 2.20. Kinetic studies of targeted p(nBuMA)100 by RAFT in anhydrous MeOH at 60 °C: 
(A) conversion and semi-logarithmic plots vs. time, and (B) evolution of Mn and dispersity 
(Ð) with conversion. 
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Figure 2.21. Kinetic studies of targeted p(nBuMA)1000 by RAFT in anhydrous MeOH at 
60 °C: (A) conversion and semi-logarithmic plots vs. time, and (B) evolution of Mn and 
dispersity (Ð) with conversion. 
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When targeting p(nBuMA)100, 1H-NMR and GPC analyses of the homogeneous 
samples terminated within 24 hours of initiation gave linear plots of both ln([M]0/[M]) 
vs. time, and Mn vs. conversion (Figure 2.20), indicating the polymerisation rate 
followed first order kinetics and termination reactions were negligible. However, after 
24 hours – equating to 88 % monomer conversion – the remaining 4 samples became 
turbid; analysis of these samples showed no deviation in the linear correlations already 
observed, indicating no change in the polymerisation rate. This suggests that even 
though the monomer co-solvency effect helps retain the polymer in solution, it is not 
critical to the controlled polymerisation by RAFT. 
The kinetic study targeting p(nBuMA)1000 maintained homogeneity up to the last data 
point, terminated at 72 % conversion, presumably due to the co-solvency effect of the 
unreacted monomer. Once more, linear correlations were observed when plotting 
ln([M]0/[M]) vs. time, and Mn vs. conversion (Figure 2.21), indicating the rate of 
polymerisation proceeded with first order kinetics, with minimal termination reactions 
having taken place. This is particularly surprising given the observed DPn = 720 
monomer units. 
2.9.  ATRP and RAFT polymerisations of MMA and tBuMA in MeOH 
Given the success of the methanolic nBuMA reactions, the monomer chemistry was 
extended to include other hydrophobic monomers to verify whether the respective 
polymerisations proceed with similar controlled behaviour: methyl methacrylate 
(MMA) and tert-butyl methacrylate (tBuMA) were selected. Therefore, Cu-catalysed 
ATRP and RAFT were performed in anhydrous MeOH under identical reaction 
conditions to the nBuMA polymerisations, and the resulting data were compared. 
The methanolic MMA polymerisations at 60 °C proceeded in a controlled manner that 
was analogous to the nBuMA reactions, achieving high conversions and yielding low 
dispersity homopolymers (1.07 < Ð < 1.19) by both RAFT (Figure A7, Appendix) and 
ATRP (Figure A8, Appendix) (Table 2.5). In addition, the onset of turbidity was once 
again observed towards the latter stages of the RAFT polymerisations when targeting 
a DPn ≥ 100 monomer units. 
The Cu-catalysed ATRP of tBuMA in MeOH at 60 °C proceeded homogeneously, but 
a significantly lower rate of polymerisation was observed, achieving only 41 % 
conversion within 25 hours of initiation (Table 2.5). Analysis by triple-detection GPC 
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showed much broader molecular weight distributions (Ð = 1.32) compared to the 
equivalent nBuMA polymerisation (Ð = 1.02; Table 2.1), highlighted in Figure 2.22. 
 
Table 2.5. RAFT and Cu-catalysed ATRP of MMA and tBuMA in MeOH at 60 °C 
    Triple-detection GPCc (THF) 
Targeta 
DPn 
Conv. 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn 
(g mol-1) 
Mw 
(g mol-1) 
Ð 
MMA       
RAFT       
60 95 % [57] 25 5 950 7 700 8 400 1.10 
100 93 % [93] 27 9 550 11 150 11 900 1.07 
200 89 % [178] 25 18 850 21 050 22 550 1.07 
       ATRP       
60 99 % [59] 26 6 150 8 350 9 950 1.19 
100 98 % [98] 23 10 000 12 050 13 400 1.11 
tBuMA       
ATRP       
80 41 % [33] 25 4 800 5 900 7 800 1.32 
a Target DPn calculated as [monomer]/[initiator or CTA]. b Theoretical Mn includes 
initiator/CTA residues and was calculated as [(target DPn x 100.12 or 142.2 g mol-1) x 
experimental monomer conversion]. c Triple-detection GPC utilising THF eluent and dn/dc = 
0.084 mL g-1 for p(MMA) (averaged across 6 samples; Table A7, Appendix). 
 
Figure 2.22. GPC (RI) chromatographic overlay of targeted p(tBuMA)80 and targeted 
p(nBuMA)80, synthesised by Cu-catalysed ATRP in anhydrous MeOH at 60 °C. 
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2.10. Conclusions 
In conclusion, well-defined p(nBuMA) homopolymers have been synthesised in 
anhydrous MeOH – a solvent widely regarded as an anti-solvent for the polymer, often 
used in purification procedures for precipitation purposes. Polymerisations performed 
by Cu-catalysed ATRP at 60 °C proceeded homogeneously to high monomer 
conversions, yielding polymers with narrow molecular weight distributions (Ð as low 
as 1.02); the observed dispersity values are comparable to those typically associated 
with ‘living’ ionic polymerisations, and the lack of broadening in the distribution at 
high monomer conversions offers a relatively easy route to the production of uniform 
linear polymers. However, the rates of the polymerisation were slow, particularly 
when targeting a DPn = 1000 monomer units which achieved 50 % conversion 
(i.e. p(nBuMA)500) in 27 days. Initially, it was assumed that the high reaction 
temperature was critical to the success of the homogeneous polymerisations, but cloud 
point studies revealed a significant co-solvency effect from the unreacted monomer 
which helps retain the polymer in solution as the reaction progresses. This enabled the 
successful methanolic polymerisation of nBuMA at 25 °C, achieving high conversions 
and yielding low dispersity polymers; the lower reaction temperature improved the Mn 
control compared to the polymerisations at 60 °C. The choice of ligand for the catalytic 
complex in Cu-catalysed ATRP had a significant effect on the success of the 
polymerisation, with those ligated with bpy exerting greater control and better Mn 
targeting. Comparative polymerisations by RAFT at 60 °C were also successful, 
yielding low dispersity polymers that were analogous to those obtained by ATRP, but 
more importantly, achieving high conversions in much shorter reaction times; a 
targeted p(nBuMA)1000 by RAFT achieved 80 % conversions in 2 days. The RAFT 
polymerisations enabled the monitoring of the reactions as they progressed and 
revealed the onset of turbidity at high conversions under these conditions, indicating 
a possible pseudo-dispersion towards the latter stages of the polymerisation; however, 
kinetic analysis revealed no change in the polymerisation rate, suggesting that the 
monomer co-solvency is not critical to its success. And finally, the monomer 
chemistry was extended to include the hydrophobic monomers MMA and tBuMA, 
with both polymerisations proceeding homogeneously; however, in the latter case, 
much broader dispersities were observed and the polymerisation rate was significantly 
lower when compared to the nBuMA polymerisations. 
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A potential rationale for the success of the methanolic polymerisations is that they are 
initiated within a good solvent environment, enhanced by the unreacted monomer, 
which progressively changes to a poor solvent environment as the monomer is 
depleted. As the monomer concentration decreases, the polymer chains are likely to 
adopt more densely coiled structures than an equivalent polymerisation within a good 
solvent, thereby avoiding bimolecular termination of the active chain-end 
functionalities. The fact that the polymers remain solvated after full consumption of 
the monomer means that the polymer-MeOH interactions are sufficient enough to 
prevent the polymer-polymer interactions inducing aggregation and subsequent 
precipitation. 
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3.1. Introduction 
3.1.1. Poly(ethylene glycol) (PEG) functionalisation 
Liposomes and polymer-protein conjugates utilising the EPR effect have significantly 
improved the treatment of various forms of cancer, as described in Chapter 1. 
Functionalisation with PEG has been pivotal to their clinical success, helping to evade 
the RES and MPS by reducing adsorption of opsonins (a process known as 
opsonisation); thus, systemic circulation is prolonged and biodistribution enhanced.1,2 
PEG functionalisation continues to be heavily studied in the design of new drug 
delivery systems as a result of the stealth properties that are imparted to the 
nanoparticles and the success already achieved. 
An interesting study, reported by Borsali and coworkers, involved the synthesis of 
double hydrophilic PEG-b-poly(glycerol monomethacrylate) (PEG-b-p(GMA)) block 
copolymers (Ð < 1.2) by methanolic ATRP using PEG macro-initiators. The pendant 
hydroxyl groups present in the p(GMA) block enabled post-polymerisation 
conjugation of the hydrophobic nonsteroidal anti-inflammatory drug, 
indomethacin (IND), yielding PEG-b-(p(GMA)-IND) drug conjugates.3 
Self-assembly studies revealed the formation of micelles and vesicles within aqueous 
media, whose morphology was dependent on the p(GMA) block length and the degree 
of IND-conjugation; encapsulation of free IND drug molecules within the 
hydrophobic internal phases was also achieved. Similar studies performed by Yang 
and coworkers involved the synthesis of amphiphilic PEG-b-poly(tert-butyl acrylate)-
b-poly(2-hydroxyethyl methacylate) (PEG-b-p(tBA)-b-p(HEMA)) triblock 
copolymers by ATRP - also using PEG macro-initiators - whose p(HEMA) block was 
further functionalised through conjugation of doxorubicin (DOX) via an acid-sensitive 
cis-aconityl linkage to yield the corresponding polymer-drug conjugate; self-assembly 
into micelles in aqueous media enabled the encapsulation of free DOX drug 
molecules.4 Additionally, Davis and coworkers used PEG macro-initiators to 
polymerise N-isopropylacrylamide (NIPAM) by ATRP, yielding thermoresponsive, 
double hydrophilic PEG-b-p(NIPAM) block copolymers that were sensitive to the 
biological messenger molecule, nitric oxide (NO); the amide functionalised 
o-phenylenediamine moieties present at the chain junction point between the two 
blocks react with NO, resulting in scission of the diblock copolymer into the 
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corresponding homopolymers.5 It was concluded that these materials may have the 
potential for NO-mediated drug release. 
3.1.2. Synthesis of branched polymers via the chain-growth mechanism 
Branched polymerisations via the chain-growth mechanism were first reported by 
Fréchet and coworkers in 1995,6 who described the self-condensing vinyl 
polymerisation (SCVP) of inimers (vinyl monomers that also bear an initiating group) 
(Figure 3.1.A); this involved the polymerisation of 3-(1-chloroethyl)ethenyl benzene 
in the presence of tin tetrachloride to yield hyperbranched poly(styrene). Since this 
initial report, the SCVP method was developed to utilise RDRP techniques that 
include ATRP7–9 and RAFT.10–12  
An alternative approach to branched polymer synthesis involves the statistical 
copolymerisation of vinyl and divinyl monomers, with the incorporation of the latter 
essentially joining two or more primary polymer chains together to give the branched 
architecture. It is important to note that less than one equivalent of divinyl monomer 
per primary polymer chain must be maintained to avoid gelation, as described by the 
Flory-Stockmayer theory;13–17 however, this is dependent on the polymerisation 
technique, monomer concentration, initiator efficiency and the selection of divinyl 
monomer.18–20 
Free radical polymerisation in the presence of divinyl monomers rapidly leads to 
gelation at low conversions - even when maintaining very low concentrations of the 
bifunctional monomer - due to the uncontrolled nature of the technique and the 
constant initiation of new polymer chains throughout the polymerisation. To overcome 
this, Sherrington and coworkers introduced chain transfer agents (typically thiols) into 
the branched polymerisations to suppress gelation by limiting the primary polymer 
chain length and thus the average number of branch points per chain, yielding soluble, 
branched polymers at high conversions (Figure 3.1.B); this is often referred to as the 
Strathclyde route as a result of its development at the University of Strathclyde.21,22 
Branched polymerisations following the Strathclyde approach can also be achieved 
using ATRP23–26 and RAFT27,28 (Figure 3.1.C). An interesting study performed by Li 
and Armes describes the methanolic ATRP of 2-hydroxypropyl methacrylate (HPMA) 
in the presence of a dimethacrylate branching monomer containing a disulfide bond, 
yielding branched p(HPMA) copolymers.29 Cleavage of the disulphide bonds using 
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dithiothreitol or benzoyl peroxide gave the corresponding linear polymers; this 
confirms that the branched architecture is obtained through the statistical linking of 
primary chains rather than chain transfer reactions associated with free radical 
polymerisations. Similar studies were performed by Bannister et al, describing the 
synthesis of branched p(HPMA) using either ethylene glycol dimethacrylate 
(EGDMA) or bisphenol A dimethacrylate (BPDMA); the results highlight that 
branching is negligible at low conversion, occurring only towards that later stages of 
the polymerisation, and that the observed branching behaviour concurs almost 
perfectly with the classic Flory-Stockmayer theory.30 Another interesting example, 
recently published by Rannard and coworkers, involved the branched polymerisation 
of HPMA by ATRP using EGDMA as the branching monomer and mixed initiating 
systems consisting of PEG macroinitiators and generation 2 (G2) benzyl ether-
functional dendritic initiators.31 The branched polymers obtained enabled 
encapsulation of hydrophobic guest molecules and showed promise as nanocarriers in 
drug delivery systems. 
The advantages of utilising RDRP techniques for branched polymerisations following 
the Strathclyde approach include: (i) the primary polymer chain length can be 
controlled by simply adjusting the monomer/initiator molar ratio without the need for 
chain transfer agents; (ii) the primary polymer chains that are synthesised have narrow 
dispersities, thereby minimising the probability of chains containing on average 
greater than one equivalent of branching monomer; and (iii) the greater control of 
chain end functionalities. 
 
Figure 3.1. Illustration of branched polymers prepared by: (A) self-condensing vinyl 
polymerisation (SCVP) of inimers, (B) free radical polymerisation in the presence of divinyl 
monomer following the Strathclyde route, and (C) reversible-deactivation radical 
polymerisation (RDRP) in the presence of divinyl monomer following the Strathclyde route. 
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3.1.3. Nanoprecipitation of polymers 
Nanoprecipitation is a solvent displacement method that forms nanoparticles via a 
proposed nucleation/growth mechanism - the rates of which dictate the final particle 
size and the size distribution.32,33 It is a technique that can be performed using small 
organic molecules, inorganic molecules and polymeric materials; in the context of this 
thesis, only the nanoprecipitation of polymers will be discussed herein. Initially a 
polymer is solvated within a good, volatile organic solvent (usually acetone, THF or 
ethanol) which is then added to a miscible anti-solvent (usually water) (Figure 3.2). 
Upon addition, the mixed binary solvent solution becomes an anti-solvent for the 
polymer, causing the collapse and subsequent association/aggregation of the solvated 
chains. Evaporation of the organic solvent can lead to further aggregation of the 
polymers, forming colloidally stable nanoparticles within the anti-solvent. 
An interesting study, performed by Priestley and coworkers, involved the flash 
nanoprecipitation of high molecular weight poly(styrene) (PS), described so because 
of the rapid solvent displacement achieved as a result of high intensity mixing regimes 
of THF solutions and water.34 Nanoparticle size could be controlled by varying the 
polymer and electrolyte (NaCl) concentrations, with an increase in either case leading 
to an increase in particle size. The rationale behind the mechanism of particle 
formation and stabilisation was described through the competitive London Van Der 
Waals attraction and electrostatic repulsion interactions, highlighting that the size-
dependent electrostatic repulsions between nanoparticles and unimers control the 
aggregation behaviour. A similar study performed by Rannard and coworkers, 
 
Figure 3.2. Illustration of rapid nanoprecipitation, following the nucleation/growth 
mechanism to form colloidally stable nanoparticles within the anti-solvent. 
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involved the rapid nanoprecipitation of acetone solutions of both linear and branched 
p(HPMA)  (prepared by methanolic ATRP in the absence/presence of divinyl 
monomer EGDMA)  into water.35 Particle sizes (ranging from 60-800 nm) could be 
controlled by varying the primary polymer chain length and the precipitation 
parameters (e.g. polymer concentration, temperature, rate of addition); however, only 
the branched polymers remained stable within the aqueous environment, revealing that 
the polymer architecture has a significant effect on the stabilisation of the 
nanoparticles. Further studies revealed that the aqueous dispersions were stable to 
dilution, solvent addition, sonication and temperature, with destabilisation occurring 
only upon addition of NaCl – indicating the presence of charge stabilisation. This 
study was developed further to include the nanoprecipitation of branched amphiphilic 
copolymers,31,36 with one particular study showing the co-nanoprecipitation of 
branched hydrophobic copolymers with amphiphilic AB block copolymers leading to 
aggregation behaviour that was different to the individually nanoprecipitated 
copolymers (branched or diblock).37 
3.1.4. Chapter aims 
The aim of this chapter was to synthesise hydrophilic PEG macro-initiators of various 
molecular weight, for use in the methanolic ATRP of nBuMA to yield amphiphilic 
materials. Linear PEG-b-p(nBuMA) diblock copolymers were to be synthesised, 
targeting various degrees of polymerisation, which would then be analysed by 
1H-NMR and triple detection GPC; the control of the polymerisations were to be 
assessed by performing kinetic studies. Various concentrations of the divinyl 
monomer EGDMA were to be introduced to the polymerisations to obtain amphiphilic 
branched architectures in a one-pot reaction; their ability to form stable nanoparticle 
dispersions in aqueous media were to be assessed by performing rapid 
nanoprecipitation studies. 
3.2. Synthesis of PEG macro-initiators 
The monofunctional PEG macro-initiators (DPn = 17, 45, 112 ethylene oxide repeat 
units) were synthesised via an esterification that has been well-reported within the 
literature;38–40 this involved reacting PEG monomethyl ether with α-bromo isobutyryl 
bromide in anhydrous toluene under an inert nitrogen atmosphere (Scheme 3.1).  
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Scheme 3.1. Reaction scheme detailing the PEG macro-initiator syntheses via esterifications. 
 
An excess of triethylamine (TEA) was used to scavenge the hydrogen bromide (HBr) 
side product, forming a triethylammonium bromide salt that precipitated from solution 
as the reaction progressed. After reaction completion, the salt was filtered off, the 
solvent removed on the rotary evaporator, and the crude products dissolved in acetone 
prior to multiple precipitations into petroleum ether (40-60). The purified products 
were then characterised by 1H-NMR, 13C-NMR and triple detection GPC 
(Figures 3.3-3.5; Figures A9-A12, Appendix). 
1H-NMR analysis of the macro-initiators enabled the full assignment of their structure, 
with the integrations of each environment in relative agreement with the theoretical 
values (Figure 3.3; Figures A9 and A11, Appendix); this was determined by 
normalising the integration of the methoxy group (δ = 3.38 ppm) to three protons. The 
assignment of the isobutyryl group at 1.94 ppm confirmed the structure of the desired 
compounds. Furthermore, 13C-NMR analyses for each of the macro-initiators enabled 
the full assignment of their structure, with the peak at 172 ppm attributed to the ester 
group of the desired compound (Figure 3.4; Figures A10 and A12, Appendix). 
Analyses by triple detection GPC revealed narrow molecular weight distributions with 
Mn and Mw values that closely matched theoretical values (Figure 3.5, Table 3.1). 
An α,ω-bifunctional macro-initiator with DPn = 91 ethylene oxide units was also 
synthesised under the same reaction conditions (Scheme 3.2), and characterised by 
1H-NMR, 13C-NMR and triple detection GPC (Figure A13 and A14, Appendix). 
 
Scheme 3.2. Reaction scheme detailing the PEG macro-initiator syntheses via esterifications. 
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Figure 3.3. 1H-NMR (CDCl3) spectrum of PEG45-Br macro-initiator. 
 
 
Figure 3.4. 13C-NMR (CDCl3) spectrum of PEG45-Br macro-initiator 
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Figure 3.5. GPC chromatograms (RI) showing the molecular weight distributions for each of 
the PEG macro-initiators. 
 
3.3. Synthesis of PEG-b-p(nBuMA) diblock and triblock copolymers 
Initially, methanolic ATRP of nBuMA at 60 °C was performed using the 
monofunctional PEG macro-initiators, targeting a DPn = 60, 80, 100 monomer units 
(Scheme 3.3). As expected, the PEG macro-initiators were readily solvated within the 
MeOH after gentle heating, with the addition of nBuMA monomer having no effect 
on their solubility. The polymerisations proceeded homogeneously to high conversion 
(≥ 92 %) to yield low dispersity (Ð ≤ 1.05) amphiphilic AB block copolymers across 
the different block lengths; determined by 1H-NMR and triple detection GPC (DMF) 
respectively (Table 3.1). Furthermore, the GPC (RI) chromatograms for each of the 
AB block copolymers showed monomodal and symmetrical molecular weight 
distributions (Figure 3.6). Although the low dispersities obtained were characteristic 
of well-controlled ATRP, the experimental Mn values observed after GPC analysis 
were significantly higher than theoretical values, indicating poor initiator efficiencies 
for PEGx-Br. Estimations for the initiator efficiencies were calculated as 
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((Theoretical Mn)/(Observed Mn (GPC)) x 100 %), which gave consistent values 
across the polymer series: PEG17-Br = 55 %, PEG45-Br = 60 %, PEG113-Br = 73 %, 
with a maximum standard deviation (σ) = 3 % observed for PEG113-Br.  
Amphiphilic ABA triblock copolymers were obtained using the bifunctional 
Br-PEG91-Br macro-initiator, targeting a DPn = 40 and 80 monomer units on either 
side (i.e. total target DPn = 80, 160) of the PEG central block. Once again, 
polymerisations proceeded homogeneously to high conversions (≥ 98 %) to yield 
narrow dispersity polymers; however, the observed dispersities were significantly 
higher than those seen for the AB diblock copolymers (Table 3.1; Figure A15, 
Appendix). 
This can be explained by the following two reasons: (i) poor initiation efficiencies will 
have double the impact on the final molecular weight distributions due to the 
propagation of monomer on either side of the polymer chain; and (ii) early termination 
reactions on one side of the bifunctional initiator would essentially lead to a mono-
initiated polymer with a considerably lower molecular weight. Either case would lead 
to a significant impact on the molecular weight distribution. 
The methanolic syntheses of PEG113-b-p(MMA)60-100 diblock copolymers were also 
attempted, but will not be discussed within the context of this thesis; the results are, 
however, presented in the Appendix (Table A9, Figures A16 and A17). 
 
 
Scheme 3.3. Reaction scheme detailing the AB diblock and ABA triblock copolymer 
syntheses via methanolic ATRP of nBuMA using PEG macro-initiators.
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Table 3.1. Methanolic Cu-catalysed ATRP of nBuMA at 60 °C using PEG-derived macro-initiators 
 Triple-detection GPC (DMF) 
Targeta  DPn Conversion [actual DPn] Time (h) Mn theoryb Mn 1H-NMR Mn  (g mol-1) Mw  (g mol-1) Ð 
PEG macro-initiators        
PEG17 --- --- 900 950 --- --- --- 
PEG45 --- --- 2 150 2 300 2 300 2 500 1.09 
PEG91 --- --- 4 300 4 650 5 150 5 400 1.05 
PEG113 --- --- 5 150 5 800 6 000 6 150 1.02 
PEG17-Br        
60 99 % [59] 24 9 350 15 550 17 850 18 250 1.02 
80 96 % [77] 24 11 850 19 100 21 300 21 700 1.02 
100 92 % [92] 24 14 000 23 200 24 900 25 400 1.02 
PEG45-Br        
60 99 % [59] 24 10 600 15 950 17 250 17 900 1.04 
80 98 % [78] 25 13 250 18 800 23 000 24 050 1.05 
100 97 % [97] 27 15 900 29 600 26 800 27 800 1.04 
PEG113-Br        
60 97 % [58] 5 13 420 12 400 17 650 18 050 1.02 
80 93 % [74] 17 15 800 12 400 21 850 22 500 1.03 
100 94 % [94] 17 18 600 16 100 26 600 27 700 1.04 
Br-PEG91-Br        
40 (x 2) 99 % [79] 26 15 600 --- 22 050 26 000 1.18 
80 (x 2) 98 % [157] 26 26 600 --- 38 300 38 300 1.13 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn includes initiator residue and was calculated as [(Target DPn x 142.2 g mol-1) x monomer conversion]. 
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Figure 3.6. GPC (RI) chromatograms showing the molecular weight distributions of 
PEG-b-p(nBuMA) diblock copolymers using: (A) PEG17-Br, (B) PEG45-Br, (C) PEG113-Br. 
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3.4. Kinetic studies for the PEG-b-p(nBuMA) diblock copolymer syntheses 
The narrow molecular weight distributions observed for each of the polymerisations 
strongly indicate that they proceed in a controlled manner, but this was confirmed by 
performing kinetic studies targeting a DPn = 80 monomer units, using each of the 
monofunctional PEG macro-initiators. The kinetic data - obtained after analysis by 1H 
NMR and triple detection GPC - is presented as semi-logarithmic plots of ln([M]0/[M]) 
vs. time, and as Mn vs. conversion (Figure 3.7). 
With regards to the plots of Mn vs. conversion, it is important to note that the value of 
the refractive index increment (dn/dc) of the individual copolymer samples (taken 
during the kinetic studies) are expected to vary systematically due to the progressively 
increasing p(nBuMA) chain length at the end of each PEG block. Therefore, two plots 
of Mn vs. conversion were analysed and compared for each experiment using: (i) Mn 
values for each kinetic point determined by employing the calculated dn/dc value from 
the final recovered polymer, and (ii) Mn values for each kinetic point determined by 
employing theoretical copolymer dn/dc values calculated using Eqn. 3.1, as discussed 
by Hadjichristidis et al,41 
(d݊/dܿ)େ୭୮୭୪୷୫ୣ୰ = ( ୔ܹ୉ୋ  ×  (d݊/dܿ)୔୉ୋ) + ቀ(1 −  ୔ܹ୉ୋ )  × (d݊/dܿ)௣(௡୆୳୑୅)ቁ (3.1) 
where WPEG is the weight fraction of the PEGx block, and (dn/dc)PEG and 
(dn/dc)p(nBuMA) are average values determined by triple detection GPC(DMF) analysis 
for three linear homopolymer samples of each polymer: (dn/dc)PEG = 0.0566 mL g-1 
(σ = 0.0010); (dn/dc)p(nBuMA) = 0.0624 mL g-1 (σ = 0.0007), (Table A8, Appendix). 
Linear correlations were observed in all plots, meaning that: (i) the rate of the 
polymerisations follow first order kinetics, where irreversible termination reactions 
are negligible and the concentration of active species remains constant throughout; 
and (ii) there is a constant number of chains throughout, all propagating at the same 
rate, where the rate of activation/deactivation (KATRP = kact/kdeact) is much greater than 
the rate of propagation (kp). And finally, the comparative Mn vs. conversion graphs for 
the targeted copolymers showed a decreasing discrepancy with increasing PEG 
macro-initiator chain length, as may be expected due to the increasing weight fraction 
dominance of the PEG blocks.  
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Figure 3.7. Kinetic studies of anhydrous methanolic ATRP at 60 °C showing the conversion 
and semi-logarithmic plots vs time, and the evolution of Mn and dispersity with conversion for 
PEGx-p(nBuMA)80 block copolymers. (A) Polymerisation initiated with PEG17-Br 
macro-initiator, (B) polymerisation initiated with PEG45-Br macro-initiator, and (C) 
polymerisation initiated with PEG113-Br macro-initiator. Mn vs. conversion plotted using both 
the dn/dc value of the final purified polymer (solid black triangles), and the calculated dn/dc 
values using Eqn. 3.1. (open red triangles); dispersities shown as open green squares. 
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3.5. Synthesis of PEG-b-p(nBuMA) diblock copolymers via ATRP at 25 °C 
The successful homopolymerisation of nBuMA via methanolic ATRP at 25 °C was 
demonstrated in Chapter 2; therefore, a study to establish the potential for AB block 
copolymer synthesis using ATRP at reduced temperature was conducted using the 
three monofunctional PEG macro-initiators, targeting a DPn of 80 nBuMA units. 
Each of the polymerisations were allowed to react for approximately 25 hours to 
enable direct comparisons of the data (Figure 3.8, Table 3.2); it was evident that higher 
monomer conversions and better Mn targeting were achieved when using the larger 
macro-initiators, with initiator efficiencies estimated as PEG17-Br = 64 %, PEG45-Br 
= 86 %, and PEG113-Br = 92 %. In comparison to the equivalent polymerisations 
conducted at the higher temperature (Table 3.1), the initiation efficiencies of all 
macro-initiators were greater within the polymerisations conducted at 25 °C, which 
may indicate fewer termination reactions having taken place; however, the dispersities 
 
 
Figure 3.8. GPC (RI) chromatograms for PEGx-b-p(nBuMA80) obtained via ATRP at 25 °C. 
 
Table 3.2. Synthesis of PEG-b-p(nBuMA) block copolymers via methanolic ATRP at 25 °C: 
hydrophobic block target DPn = 80 nBuMA units 
     Triple-detection GPC (DMF) 
Initiator 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theorya 
Mn  
1H-NMR 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
PEG17-Br 68 25 8 600 7 900 13 550 16 300 1.20 
PEG45-Br 89 25 12 300 13 100 14 250 18 800 1.32 
PEG113-Br 85 26 14 850 14 950 16 200 19 500 1.21 
a Theoretical Mn includes initiator residue and was calculated as [(Target DPn x 142.2 g mol-1) 
x experimental monomer conversion]. 
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observed for all block copolymer samples were significantly higher (Ð ≥ 1.2). 
3.6. Synthesis of branched PEG-b-p(nBuMA-co-EGDMA) via ATRP 
Amphiphilic copolymers consisting of a branched architecture were obtained by 
polymerisation following the Strathclyde approach. This involved the methanolic 
ATRP of nBuMA in the presence of the divinyl monomer EGDMA, whose statistical 
incorporation enabled the inter-chain branching of the primary polymer chains; a low 
concentration of the branching monomer was maintained (less than one equivalent per 
initiator) so as to avoid gelation, and initiator selection was confined to PEG113-Br 
(Scheme 3.4). 
It is important to note that a reaction temperature of 60 °C was selected for the 
following reasons: (i) greater control was demonstrated when polymerising at the 
elevated temperature during the AB diblock copolymer syntheses, which would help 
to limit the average number of branch points per chain during the branched 
polymerisations and thus avoid gelation, and (ii) the nBuMA homopolymerisation 
study (Chapter 2) was concluded by hypothesising that the methanolic polymerisations 
are initiated within a good solvent environment, enhanced by the unreacted monomer, 
which progressively changes to a poor solvent environment as the monomer is 
depleted, resulting in densely coiled polymer structures. Therefore, branched 
polymerisations performed at elevated temperatures will provide a greater entropic 
effect that will be more likely to promote inter-chain – rather than intra-chain – 
branching. 
 
Scheme 3.4. Reaction scheme detailing the methanolic ATRP of nBuMA in the presence of 
EGDMA using a monofunctional PEG113-Br macro-initiator to yield amphiphilic branched 
AB block copolymers; targeting a DPn = 60 monomer units per primary chain and using less 
than one equivalent of the divinyl monomer with respect to the initiator. 
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A series of branched polymerisations were performed using the PEG113-Br 
macro-initiator, each targeting a DPn = 60 monomer units, with only the concentration 
of EGDMA varying from 0.75 to 0.95 equivalents with respect to the initiator. All 
polymerisations were allowed to progress to 99 % conversion over approximately 2 
days to achieve maximum branching and to enable direct comparisons between the 
data (Table 3.3). 
GPC (DMF) analysis of each of the branched copolymers calculated Mn and Mw values 
that were greater than those calculated for the linear analogue. Generally, an increase 
in EGDMA concentration resulted in an increase in the observed Mn and Mw values, 
with the polymerisation proceeding with 0.9 equivalents of the divinyl monomer 
yielding branched polymers with Mn = 1.62 x 105 g mol-1 and Mw = 2.33 x 106 g mol-1 
(Figure A18, Appendix); these values correspond to number average structures with 
approximately 9 conjoined primary amphiphilic AB block copolymer chains and 
weight average structures containing approximately 129 chains. Anomalously, 
however, the polymerisation proceeding with 0.95 equivalents of EGDMA yielded 
branched polymers with lower Mn and Mw values than those obtained after 
polymerisation with 0.9 equivalents, suggesting the formation of microgel and its 
subsequent removal during either the filtration step of the GPC sample preparation or 
when removing the catalytic system from the crude polymer sample; the dn/dc values 
obtained for each polymer were consistent, indicating that the GPC sample 
concentration was not affected during sample preparation.  
 
Table 3.3. Methanolic ATRP of nBuMA and EGDMA at 60 °C using PEG113-Br 
    Triple-detection GPC (DMF) 
Targeta DPn 
Conversion 
[actual DPn] 
Time 
(h) 
EGDMA: PEG113-Br 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
PEG113-Br       
60 99 % [59] 53 0.95 : 1 36 400 439 550 12.08 
60 99 % [59] 51 0.9 : 1 161 500 2 327 000 14.41 
60 99 % [59] 51 0.85 : 1 36 600 419 500 11.46 
60 99 % [59] 51 0.8 : 1 27 800 184 750 6.62 
60 99 % [59] 48 0.75 : 1 34 100 186 200 5.46 
a Target DPn calculated as [nBuMA]/[initiator]. 
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This, therefore, implies removal of the microgel during purification (alumina column) 
of the crude polymer. 
Furthermore, the observed dispersities for each of the branched copolymer samples 
were significantly higher than those seen in the linear polymerisations (Ð = 1.02; 
Table 3.1), due to the statistical nature of the branching; an increase in EGDMA 
concentration from 0.75 to 0.9 equivalents resulted in an increase in dispersity 
(Ð = 5.46 - 14.41). This is also reflected in the GPC chromatograms, displaying an 
increasingly complex molecular weight distribution as the EGDMA concentration 
increased (Figure 3.9). Overlaying these chromatograms with the linear 
PEG-b-p(nBuMA60) showed the expected presence of linear chains that have not been 
incorporated into the branched architecture; this also confirmed the formation of 
primary AB block copolymer chains equivalent in dispersity and molecular weight to 
the linear polymer analogues.  
 
 
Figure 3.9. Overlaid GPC (RI) chromatograms of linear and branched AB block copolymers 
produced using methanolic ATRP of nBuMA at 60 °C (targeting DPn = 60 monomer units 
within the hydrophobic block) using PEG113-Br macro-initiator and varying equivalents of 
(0.75-0.9 wrt. Initiator) of divinyl monomer, EGDMA. 
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3.7. Nanoprecipitation of PEG-b-p(nBuMA60-co-EGDMA0.75-0.95) 
As previously described, nanoprecipitation is a solvent displacement method that 
involves the addition of a polymer solution – with the polymer usually solvated within 
acetone, THF or ethanol - into a miscible antisolvent (e.g. H2O). However, solvating 
the PEG-b-p(nBuMA60-co-EGDMA0.75-0.95) branched copolymers within volatile 
organic solvents that were also miscible with water, such as those listed above, proved 
to be difficult; rather than clear transparent solutions, those obtained were turbid, 
suggesting assembly/aggregation had already taken place before its addition to the 
anti-solvent. 
Clear, transparent polymer solutions were achieved, however, when using binary 
mixtures of THF and H2O (1:1 ratio by volume). Therefore, nanoprecipitations of the 
amphiphilic branched copolymers were performed through the rapid addition of 1 mL 
of these polymer solutions (5 mg mL-1) into 4.5 mL of H2O, after which the volatile 
organic solvent was allowed to evaporate under ambient conditions to yield 
nanoparticles within the antisolvent (Figure 3.10). These aqueous dispersions were 
analysed by dynamic light scattering (DLS) (Table 3.4, Figure 3.11). 
 
Figure 3.10. Pictures displaying the aqueous dispersions of the amphiphilic branched 
copolymers after rapid nanoprecipitation and subsequent evaporation of the organic solvent: 
(A) PEG-b-p(nBuMA60-co-EGDMA0.95), (B) PEG-b-p(nBuMA60-co-EGDMA0.9), (C) PEG-
b-p(nBuMA60-co-EGDMA0.85), (D) PEG-b-p(nBuMA60-co-EGDMA0.80), and (E) PEG-b-
p(nBuMA60-co-EGDMA0.75). 
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Table 3.4. DLS data of nanoprecipitations using binary THF-H2O solutions of PEG-b-p(nBuMA60-co-EGDMAx) (1 mL) into H2O (4.5 mL) 
   DLS a 
   Unfiltered Filtered b 
Sample 
Initial Conc. 
in THF/H2O 
Final Conc. 
in H2O 
Dz c 
(d.nm) 
PdI d 
DNn e 
(d.nm) 
Derived count 
rate (kcps) 
[attenuator] 
Dz c 
(d.nm) 
PdI d 
Dn e 
(d.nm) 
Derived count 
rate (kcps) 
[attenuator] 
PEG-b-p(nBuMA60-co-EGDMA0.95) 5 mg mL-1 1 mg mL-1 54 0.330 26 12 000 [7] 66 0.403 25 15 000 [7] 
PEG-b-p(nBuMA60-co-EGDMA0.9) 5 mg mL-1 1 mg mL-1 80 0.275 17 19 000 [7] 78 0.296 23 17 000 [7] 
PEG-b-p(nBuMA60-co-EGDMA0.85) 5 mg mL-1 1 mg mL-1 98 0.508 27 23 000 [7] 105 0.266 24 31 000 [7] 
PEG-b-p(nBuMA60-co-EGDMA0.8) 5 mg mL-1 1 mg mL-1 67 0.376 24 12 000 [7] 52 0.325 24 11 000 [7] 
PEG-b-p(nBuMA60-co-EGDMA0.75) 5 mg mL-1 1 mg mL-1 65 0.495 25 11 000 [7] 59 0.392 24 11 000 [8] 
a DLS measurements recorded at 25 °C after an equilibration period of 2 minutes. b Samples filtered using a 1 µm PTFE filter. c Size distribution using z-average 
values. d Polydispersity index. e Size distribution using number average values. 
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Figure 3.11. DLS traces showing the rapid nanoprecipitations (unfiltered) of: (A) PEG113-b-
p(nBuMA60-co-EGDMA0.95), (B) PEG113-b-p(nBuMA60-co-EGDMA0.9), (C) PEG113-b-
p(nBuMA60-co-EGDMA0.85), (D) PEG113-b-p(nBuMA60-co-EGDMA0.8), (E) PEG113-b-
p(nBuMA60-co-EGDMA0.75). Intensity weighted distribution displayed on the left (red traces); 
Number weighted distributions displayed on the right (blue traces). 
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DLS analysis of the unfiltered samples revealed that the amphiphilic branched 
copolymer nanoparticles had z-average diameter values (Dz) ranging from 54 to 98 nm 
with high polydispersity index (PdI) values ranging from 0.275 to 0.508; however, the 
intensity weighted distributions were multimodal (Figure 3.11), which consequently 
discredits these values as they do not truly reflect the particle size of the majority of 
the sample. 
Although an indirect measurement, number weighted particle size distributions (Dn) 
can be derived from the intensity distributions using Mie theory42 to give results that 
are more representative of the whole sample (Table 3.4).  Analysis of these 
distributions for each of the branched copolymers gave monomodal traces (Figure 
3.11) with similar Dn values ranging from 17 to 27 nm; the small particle sizes 
observed suggest the nanoparticles are formed by a solvent-switch rather than 
conventional nanoprecipitation, leading to very small structures without subsequent 
aggregation. 
In all cases, a small peak at approximately 5000 nm was observed in the intensity 
weighted distributions which may be due to multiple scattering, aggregates or dust. 
Attempts were made to remove this small population by passing the samples through 
1 µm PTFE filters; however, DLS measurements of the filtered samples retained this 
small population. To investigate further, the samples were passed through 0.22 µm 
PTFE filters, fully aware that the filtration may also remove the population at 
approximately 200-300 nm. Once again, this small population at 5000 nm was 
observed (Figure 3.12), suggesting a loosely self-assembled structure that is broken 
during filtration, but quickly re-assembles afterwards. These populations at 200 nm 
and 5000 nm could potentially be attributed to the linear polymers present within the 
sample that did not form part of the branched architecture (Figure 3.9), which self-
assemble into large structures upon rapid addition to the aqueous media. 
 
Figure 3.12. DLS traces of the aqueous dispersion of PEG-b-p(nBuMA60-co-EGDMA0.95), 
before and after filtration. 
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It was believed that these small populations were loose associations rather than 
aggregations, which would break upon dilution to give a monomodal, intensity 
weighted particle size distribution. Therefore, a small study was performed to 
determine if this was the case; this involved taking aliquots of the unfiltered 
PEG-b-p(nBuMA60-co-EGDMA0.95) sample, and diluting with H2O to give various 
concentrations of the nanoparticles within the aqueous media, which were then left to 
roll overnight. DLS measurements were recorded at 25 °C after having set the 
attenuator and measurement position constant: attenuator = 7, and measurement 
position = 4.65 mm.  
Analysis of the results show no change in either the Dz or the Dn values upon dilution, 
with only the derived count rate decreasing approximately by a factor of 2 with each 
dilution (Table 3.5). Furthermore, very little change can be observed in both the 
intensity weighted and number weighted particle size distributions (Figure 3.13). 
 
Table 3.5. Dynamic light scattering data of the PEG-b-p(nBuMA60-co-EGDMA0.95) branched 
copolymer after various dilutions in H2O 
 DLS a 
Concentration Dz  (d. nm) b Dn  (d. nm) c Derived count rate (kcps) 
1 mg mL-1 54 26 12 000 
0.5 mg mL-1 54 26 6 500 
0.25 mg mL-1 54 27 3 250 
0.125 mg mL-1 53 28 1750 
a DLS measurements recorded at 25 °C after an equilibration period of 2 minutes, with the 
attenuator set equal to 7 and the measurement position set at 4.65 mm. b Size distribution using 
z-average values. c Size distribution using number average values. 
 
 
Figure 3.13. DLS traces of PEG-b-p(nBuMA60-co-EGDMA0.95) after dilution to various 
concentrations in H2O: (A) intensity weighted particle size distribution, and (B) number 
weighted particle size distribution. 
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3.8. Conclusion 
In conclusion, monofunctional and bifunctional PEG macroinitiators - synthesised via 
esterifications with α-bromo isobutyryl bromide - were used to initiate the methanolic 
ATRP of nBuMA at 60 °C, targeting various degrees of polymerisation, yielding 
well-defined AB diblock (Ð = 1.02-1.05) and ABA triblock (Ð = 1.13, 1.18) 
amphiphilic copolymers; however, analysis by triple detection GPC calculated Mn 
values greater than the theoretical values, indicating poor initiation efficiencies.  
Kinetic studies were performed under the same reaction conditions using each of the 
monofunctional PEG-Br macroinitiators, targeting a DPn = 80 monomer units; linear 
correlations were observed in semi-logarithmic plots of ln([M]0/[M]) vs. time, and in 
plots of Mn vs. conversion, indicating a well-controlled ATRP where the consumption 
of monomer follows first order kinetics and termination reactions are negligible. 
 The synthesis of PEGx-b-p(nBuMA) diblock copolymers were also achieved at a 
lower temperature of 25 °C, with GPC analysis indicating higher initiation efficiencies 
but showing broader molecular weight distributions (Ð = 1.20-1.32) compared to those 
obtained at 60 °C. 
 Branched polymerisations were performed at 60 °C using the PEG113-Br 
macro-initiator and EGDMA as the branching monomer, yielding amphiphilic 
branched copolymers with Mw values as high as 2.33 x 106 g mol-1.  
Nanoprecipitations of these branched copolymers into H2O gave stable nanoparticles 
in aqueous media, sterically stabilised by the PEG functionalities; although DLS 
studies showed multimodal intensity weighted particle size distributions, the number 
weighted distributions showed monomodal traces with Dn = 17-27 nm. 
Although encapsulation and pharmacological studies were not performed, it is thought 
that the synthesised amphiphilic branched copolymers bearing PEG surface 
functionalities are interesting materials with potential drug-delivery applications that 
have high relevance to nanomedicine with regards to passively targeting tumours. 
Furthermore, the establishment of reaction conditions to form amphiphilic materials 
can be regarded as a key tool that will enable the future development of more complex 
branched structures. 
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4.1. Introduction 
4.1.1. Hepatocellular carcinoma and the asialoglycoprotein receptor 
Hepatocellular carcinoma accounts for approximately 85-90 % of primary liver 
cancers – one of the most common causes of cancer mortality worldwide despite its 
early diagnosis, with an estimated 745,000 deaths in 2012 alone.1,2,3 It can be treated 
by anti-cancer therapy, but serious issues remain; in most cases, a strong resistance to 
anti-cancer drugs are shown, and patients generally have a poor tolerance to 
chemotherapy due to liver dysfunction.4 To address these issues, research is directed 
towards developing drug delivery systems that actively target hepatocytes to improve 
the efficacy of the treatment and avoid undesirable side-effects. 
An interesting target is the asialoglycoprotein receptor (ASGPR) - a C-type lectin 
abundantly expressed on hepatocytes that has a high affinity for D-galactose (Gal) and 
N-acetylgalactosamine (GalNAc) residues.5  Cellular internalisation by clathrin 
enabled receptor-mediated endocytosis is rapidly induced through polyvalent and 
calcium-dependent interactions between these residues and the carbohydrate 
recognition domains present on ASGPR. 
4.1.2. Galactose-functionalised polymers targeting ASGPR on hepatocytes 
Biessen and coworkers reported the synthesis of a series of amphiphilic glycolipids 
containing a multivalent dendritic galactosylated head-group, whose incorporation 
into liposomes (5 wt% loading) resulted in efficient recognition and cellular uptake by 
the liver.6 A small study was performed that involved monitoring the rate of 
internalisation of the galactosylated liposomes in the presence of free asialofetuin – an 
established competitor for ASGPR-mediated uptake;7,8 the results showed almost 
complete inhibition by the asialofetuin, thereby confirming that cellular internalisation 
of the liposomes proceeded via interactions between the galactose moieties and the 
hepatic ASGPR receptors. 
Zhuo and coworkers reported the synthesis of galactosylated and fluorescein 
isothiocyanate labelled polycaprolactone-g-dextran graft copolymers that could 
self-assemble into spherical micelles (approx. 120 nm) in aqueous media and in serum. 
Both in vivo and in vitro studies showed that the galactosylated micelles could be 
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selectively internalised into HepG2 cells - a human hepatocellular liver carcinoma cell 
line – through interactions with ASGPR receptors.9 
More recently, Narain and coworkers reported the synthesis of galactosylated block 
and statistical cationic copolymers of varying compositions and molecular weights via 
RAFT polymerisation of 2-lactobionamidoethyl methacrylamide (LAEMA) and 
2-aminoethyl methacrylamide hydrochloride (AEMA).10 Evaluation of their 
transfection efficiencies in HepG2 and Huh7.5 cells found that the block copolymer 
with composition p(AEMA58-b-LAEMA56) showed the highest transfection 
efficiency, driven by the interactions of the galactose functionalities with the 
overexpressed ASGPR of hepatocytes. In a similar study to that performed by Biessen 
and coworkers described above, a competitive assay of transfection and cellular uptake 
of the copolymers in the presence of free asialofetuin was performed on HepG2 cells; 
this resulted in significant reduction in transfection efficiency of the copolymers. 
Additionally, transfection efficiencies of the copolymers in ASGPR deficient cells 
(HeLa and SK hep1 cells) was negligible, emphasising the specificity of these 
polymers towards ASGPR receptors. 
Other interesting studies detailing the syntheses of galactosylated polymers that have 
the potential to target ASGPR receptors on hepatocytes have been reported by Pan11 
and coworkers, Gillies12 and coworkers, Huang13 and coworkers, and Akaike14 and 
coworkers. 
4.1.3. The Michael addition reaction 
The Michael addition (named after the organic chemist, Arthur Michael) is an example 
of a conjugate addition that involves the reaction between nucleophiles (Michael 
donors) and olefins/alkynes (Michael acceptors), where the nucleophile adds across a 
carbon-carbon multiple bond.15 Generally, the Michael addition is considered as the 
base-catalysed addition of an enolate nucleophile to an activated olefin; described so 
due to the requirement of an electron-withdrawing and resonance-stabilising 
activating group that can stabilise the anionic intermediate. However, amines,16–18 
thiols19,20 and phosphines21,22 have also shown the ability to act as efficient 
nucleophiles, meaning that nucleophile selection is not limited to enolates; these 
reactions are typically referred to as Michael-type additions. 
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The reactions using nitrogen-based nucleophiles (often described as aza-Michael-type 
additions) do not require additional base due to the nucleophilicity and basicity of the 
amine functionality. In fact, primary amines are nucleophilic enough to react with two 
equivalents of a Michael acceptor to form tertiary amines; this is, however, highly 
dependent on the electronic and steric environment of the intermediate secondary 
amine formed after reaction with one equivalent of the acceptor. A well-known 
example of this type of reaction is the synthesis of PAMAM dendrimers, described in 
Chapter 1 (Section 1.3.1.1).23 
4.1.4. Chapter aims 
The aims of this Chapter were to synthesise galactose functionalised dendritic 
initiators (G0, G1 and G2) using exhaustive aza-Michael-type additions and 
esterification reactions, which would be utilised in the methanolic Cu-catalysed ATRP 
of nBuMA (Figure 4.1B). Linear polymerisations, targeting chain lengths of various 
chain DPn values, were selected to assess the control of the polymerisations. 
Progression to branched copolymerisation in the presence of a low concentration of 
divinyl monomer, EGDMA, would yield galactosylated hyp-glycopolydendrons 
(Figure 4.1A). Deprotection strategies will be developed to yield amphiphilic 
materials that are capable of targeting hepatic ASGPR receptors; their ability to form 
stable nanoparticle dispersions in aqueous media will be assessed by performing rapid 
nanoprecipitation studies. 
 
Figure 4.1. Schematic representation of: (A) a hyperbranched polydendron, showing the 
dendritic surface functionality and the branched polymer core, and (B) galactose 
functionalised dendritic initiators (G0, G1 and G2) prepared by a sequence of exhaustive 
aza-Michael-type additions and bromo-esterifications. 
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4.2. Synthesis of galactose functionalised dendritic initiators 
Synthesis of the dendritic initiators (G0, G1 and G2) began using the commercially 
available 1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose (proGal-OH [1]). 
4.2.1 Synthesis of G0 galactose initiator 
Synthesis of the G0 galactose initiator (G0-proGal-Br [2]) began by reacting 
proGal-OH [1] with α-bromo isobutyryl bromide in anhydrous dichloromethane 
(DCM) under an inert nitrogen atmosphere (Scheme 4.1). The reaction was catalysed 
by 4-dimethylaminopyridine (DMAP), and an excess of triethylamine (TEA) was used 
to scavenge the hydrogen bromide (HBr) side product. After reaction completion, the 
DCM was removed on the rotary evaporator to give a viscous brown coloured oily 
residue; the product was extracted from this residue using diethyl ether, with each 
extract passed through filter paper to remove the triethylammonium bromide 
(Et3N+Br−) salt. After removal of the solvent on the rotary evaporator, the product was 
purified further by normal phase flash chromatography to give the G0-proGal-Br [2] 
initiator in 60 % yield. In comparison to the proGal-OH starting material, 1H-NMR 
analysis of the purified product showed the disappearance of the broad resonance at 
2.72 ppm attributed to the hydroxyl group, and the appearance of a resonance at 
1.95 ppm attributed to the isobutyryl group introduced as a result of the 
bromo-esterification (Figures 4.2 and 4.3). Furthermore, 13C-NMR analysis revealed 
resonances at 31 ppm, 57 ppm and 173 ppm that are attributed to the C(=O)C(CH3)2Br, 
C(=O)C(CH3)2Br and C(=O)C(CH3)2Br carbon environments, respectively 
(Figure 4.4), and electrospray ionisation (ESI) mass spectrometry showed a molecular 
ion [M+Na]+ peak at 433 Da (Figure 4.5). Further NMR studies were also performed 
that included one-dimensional APT experiments and two-dimensional COSY and 
HSQC experiments, all of which enabled the assignment of each proton and carbon 
environment within the compound; the spectra are presented in the Appendix 
(Figures A19-A21). 
 
Scheme 4.1. Reaction scheme detailing the synthesis of the G0-proGal-Br ATRP initiator. 
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Figure 4.2. 1H-NMR (CDCl3) of: (A) proGal-OH [1], and (B) G0-proGal-Br [2]. The observed 
disappearance of the resonance attributed to the hydroxyl group and the appearance of a 
resonance attributed to the isobutyryl group are highlighted by the yellow boxes. 
 
 
 
Figure 4.3. 1H-NMR (CDCl3) of G0-proGal-Br [2], showing the multiplicity and integrations 
of each environment after normalising the integration of the anomeric proton (1) at 5.54 ppm 
to 1H. 
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Figure 4.4. 13C-NMR (CDCl3) of G0-proGal-Br [2], showing a total of 16 carbon 
environments that matches the theoretical number. 
 
 
 
Figure 4.5. ESI mass spectrometry of G0-proGal-Br [2] showing the [M+H]+, [M+Na]+ and 
[M+K]+ molecular ion peaks. 
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4.2.2 Synthesis of G1 galactose initiator 
4.2.2.1. Synthesis of proGal-acrylate 
Synthesis began by reacting proGal-OH [1] with acryloyl chloride in anhydrous DCM 
under an inert nitrogen atmosphere (Scheme 4.2); the reaction was catalysed by 
DMAP, and an excess of TEA was used to scavenge the HCl by-product, forming a 
Et3N+Cl- salt that precipitated from solution as the reaction progressed. After reaction 
completion, the salt was filtered off and washed with cold DCM before removing the 
solvent on the rotary evaporator (at 35 °C to avoid self-polymerisation) to give a brown 
coloured residue. The product was extracted from this residue using diethyl ether, with 
each extract filtered to remove residual Et3N+Cl- salt, before being concentrated and 
purified further by normal phase flash chromatography to give the proGal-acrylate [3] 
as a yellow coloured oil in 81 % yield. In comparison to the proGal-OH starting 
material, 1H-NMR analysis of the purified product showed the disappearance of the 
broad resonance at 2.72 ppm attributed to the hydroxyl group, and the appearance of 
a further three resonances between 5.80-6.50 ppm attributed to the vinyl protons 
introduced as a result of the esterification (Figure 4.6; Figure A22, Appendix). 
 
Scheme 4.2. Reaction scheme detailing the synthesis of proGal-acrylate. 
 
Figure 4.6. 1H-NMR (CDCl3) of: (A) proGal-OH, and (B) proGal-acrylate. The observed 
disappearance of the resonance attributed to the hydroxyl group and the appearance of 
resonances attributed to the vinyl group are highlighted by the yellow boxes. 
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Analysis by 13C-NMR revealed the appearance of a peak at 166 ppm attributed to the 
ester carbonyl functionality, and a further two peaks between 127-132 ppm that can 
be assigned to each carbon of the vinyl functionality introduced by the esterification 
(Figure A23, Appendix).  
4.2.2.2. Synthesis of G1-proGal-OH 
The next step in the synthesis involved the reaction of ethanolamine with a 4-fold 
excess of proGal-acrylate [3] via aza-Michael-type additions; initially, a 35 % yield of 
the purified product was obtained when performing the reaction in DCM over 4 days, 
but this was increased to 74 % yield after repeating the reaction in IPA (Scheme 4.3); 
clearly, the protic solvent has a catalytic effect on the reaction. In comparison to the 
proGal-acrylate starting material, 1H-NMR analysis showed the disappearance of the 
vinyl resonances between 5.80-6.50 ppm, and the appearance of two resonances at 
2.58 ppm and 3.57 ppm - each integrating to 2H - that are attributed to the CH2 
environments of the ethanolamine moiety (Figure 4.7; Figure A24, Appendix). The 
appearance of a further two resonances at 2.51 ppm and 2.82 ppm - each integrating 
to 4H - can be assigned to the CH2 environments introduced as a result of the 
aza-Michael-type addition. Additionally, 13C-NMR (CDCl3) analysis showed the 
disappearance of two peaks between 127-132 ppm attributed to each carbon of the 
vinyl functionality of proGal-acrylate [3], and the appearance of peaks at 49 ppm and 
63 ppm attributed to the CH2 environments introduced as a result of the aza-Michael-
type addition (Figure A25, Appendix); ESI mass spectrometry analysis showed a 
[M+H]+ molecular ion peak at 690 Da (Figure 4.8).  
 
Scheme 4.3. Reaction scheme detailing the synthesis of G1-proGal-OH [4] via aza-Michael-
type additions between ethanolamine and an excess of proGal-acrylate [3]. 
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Figure 4.7. 1H-NMR (CDCl3) of: (A) proGal-acrylate [3], and (B) G1-proGal-OH [4]. The 
observed disappearance of the resonances attributed to the vinyl group and the appearance of 
resonances attributed to the ethanolamine group are highlighted by the yellow boxes. 
 
 
Figure 4.8. ESI mass spectrometry analysis of G1-proGal-OH [4] showing the [M+H]+ 
molecular ion peak. 
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4.2.2.3. Synthesis of G1-proGal-Br initiator 
The final synthetic step involved the reaction between G1-proGal-OH [4] with 
α-bromo isobutyryl bromide in anhydrous DCM under an inert nitrogen atmosphere 
(Scheme 4.4). The reaction was catalysed by DMAP, and an excess of TEA was used 
to scavenge the HBr side product. After reaction completion, the DCM was removed 
on the rotary evaporator to give a viscous brown coloured oily residue; the product 
was extracted from this residue using diethyl ether, with each extract passed through 
filter paper to remove the triethylammonium bromide (Et3N+Br−) salt. After removal 
of the solvent on the rotary evaporator, the product was purified further by normal 
phase flash chromatography to give G1-proGal-Br [5] initiator in 82 % yield. In 
comparison to the G1-proGal-OH [4] starting material, 1H-NMR (CDCl3) analysis of 
the purified product showed the disappearance of the broad resonance at 2.90 ppm 
attributed to the hydroxyl group, the appearance of a resonance at 1.95 ppm 
(integrating to approximately 6H) attributed to the isobutyryl group introduced as a 
result of the bromo-esterification, and a down-field shift for the resonances attributed 
to the CH2 environments of the ethanolamine moiety (Figures 4.9 and 4.10). 
Furthermore, 13C-NMR analysis revealed resonances at 31 ppm, 57 ppm and 173 ppm 
that are attributed to the C(=O)C(CH3)2Br, C(=O)C(CH3)2Br and C(=O)C(CH3)2Br 
carbon environments, respectively (Figure 4.11), and ESI mass spectrometry showed 
a molecular ion [M+H]+ peak at 838 Da (Figure 4.12). 
 
 
Scheme 4.4. Reaction scheme detailing the synthesis of the G1-proGal-Br [5] initiator. 
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Figure 4.9. 1H-NMR (CDCl3) of: (A) G1-proGal-OH [4], and (B) G1-proGal-Br [5]. The 
observed disappearance of the resonance attributed to the hydroxyl group and the appearance 
of the resonance attributed to the isobutyryl group are highlighted by the yellow boxes. 
 
 
 
Figure 4.10. 1H-NMR (CDCl3) analysis of the G1-proGal-Br [5] initiator showing the 
assignment and integration of each proton environment. 
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Figure 4.11. 13C-NMR (CDCl3) analysis of the G1-proGal-Br [5] initiator showing the 
assignment of each carbon environment. 
 
 
 
Figure 4.12. ESI mass spectrometry analysis of the G1-proGal-Br [5] initiator showing the 
[M+H]+ molecular ion peak. 
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4.2.3. Synthesis of G2 galactose initiator 
4.2.3.1. Synthesis of APAP branching unit 
The synthesis of higher generation (G2) dendritic initiators bearing galactose 
functionalities via aza-Michael-type additions required an alternative organic 
compound with a greater degree of amine functionality; thus, the three-step synthesis 
of 1-[N, N-bis(2-aminopropyl)-amino]-2-propanol (APAP; [8]) was developed and 
this was used as an AB2 branching unit. 
Synthesis began by reacting a 2-fold excess of tertiary-butanol (tert-BuOH) with 
1,1’-carbonyldiimidazole (CDI) in anhydrous toluene for 6 hours at 60 °C under an 
inert nitrogen atmosphere (Scheme 4.5), forming an imidazole carboxylic ester 
intermediate; an excess of tert-BuOH was used to ensure that the CDI coupling agent 
had been fully consumed, thereby preventing undesirable side-reactions in the next 
stage of the synthesis. After the dropwise addition of bis(3-aminopropyl)amine 
(BAPA), the reaction was stirred for a further 18 hours whilst maintaining the 
temperature at 60 °C; the reaction mixture was then cooled to ambient temperature, 
causing the imidazole by-product to precipitate from solution. This was subsequently 
filtered off and washed with toluene. The reaction solvent was removed on the rotary 
evaporator prior to further purification by repeated solvent-solvent extraction to give 
the intermediate product [6] as a white solid in 84 % yield. 1H-NMR (CDCl3) analysis 
showed resonances at 1.63 ppm, 2.65 ppm and 3.22 ppm - each integrating to 
approximately 4H - that are attributed to the CH2 environments of the BAPA  
 
Scheme 4.5. Reaction scheme detailing the 3-step synthesis of the AB2 branching moiety, 
APAP. 
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moiety, and a resonance at 1.44 ppm - integrating to approximately 18H - attributed 
to the tert-butoxycarbonyl functional group (Figure A26, Appendix). 
The second synthetic step involved the ring-opening of propylene oxide (PO) after 
nucleophilic attack from the secondary amine functionality of the intermediate [6]; 
excess PO was removed under high vacuum, and further purification by normal phase 
flash chromatography afforded the second intermediate [7] in 85 % yield. 1H-NMR 
(CDCl3) analysis revealed resonances at 1.13 ppm, 2.32 ppm and 3.79 ppm that are 
attributed to the CH3, CH2 and CH environments introduced as result of the reaction 
(Figure A27, Appendix); furthermore, chemical ionisation mass spectrometry showed 
a [M+H]+ molecular ion peak at 390 Da (Figure A28, Appendix). 
The third synthetic step involved the cleavage of the tBOC protecting groups using 
concentrated hydrochloric acid (HCl) in ethyl acetate in an open-necked reaction flask, 
causing a significant evolution of CO2 gas in the process. 1H-NMR (CDCl3) analysis 
allowed the reaction to be monitored by observing the disappearance of the resonance 
at 1.44 ppm attributed to the protecting groups, with complete deprotection achieved 
after stirring at ambient temperature for 4 hours followed by further stirring at 50 °C 
for 3 hours. Treatment with 4M sodium hydroxide (NaOHaq) followed by solvent-
solvent extractions gave the desired product [8] as a yellow coloured oil in 82 % yield. 
Characterisation by 1H-NMR (CDCl3), 13C-NMR (CDCl3) and ESI mass spectrometry 
confirmed the structure of the compound (Figures 4.13–4.15). 
 
Figure 4.13. 1H-NMR (CDCl3) of APAP [8], showing the integration of each environment 
after normalising the peak at 3.78 ppm to 1H. 
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Figure 4.14. 13C-NMR (CDCl3) of APAP [8], showing 6 carbon environments that matches 
the theoretical number. 
 
 
 
Figure 4.15. Chemical ionisation mass spectrometry analysis of APAP [8], showing the 
[M+H]+ molecular ion peak. 
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4.2.3.2. Synthesis of G2-proGal-OH 
The next step in the synthesis involved the 7-day reaction of APAP [8] with an 8-fold 
excess of proGal-acrylate [3] via aza-Michael-type additions in IPA at ambient 
temperature (Scheme 4.6). After reaction completion, the solvent was removed on the 
rotary evaporator, and the crude product was purified by normal phase flash 
chromatography to give the G2-proGal-OH [9] dendritic compound as pale-yellow 
coloured syrup in 76 % yield. In comparison to the proGal-acrylate [3] starting 
material, 1H-NMR (CDCl3) analysis showed the disappearance of the vinyl resonances 
between 5.80-6.50 ppm, and the appearance of resonances at approximately 2.20 ppm, 
2.40 ppm and 3.70 ppm that are attributed to the CH3, CH2 and CH environments of 
the APAP branching unit, and the appearance of a further two resonances at 
approximately 2.50 ppm and 2.75 ppm that can be assigned to the CH2 environments 
introduced as a result of the exhaustive aza-Michael-type addition (Figure 4.16). The 
integrations of each environment confirmed that a total of four protected galactose 
functionalities were present on the periphery of the dendritic compound (Figure A29, 
Appendix). Additionally, 13C-NMR (CDCl3) analysis showed the disappearance of 
two peaks between 127-132 ppm attributed to each carbon of the vinyl functionality 
of proGal-acrylate, and the appearance of peaks at 49 ppm and 63 ppm attributed to 
the CH2 environments introduced as a result of the aza-Michael-type addition (Figure 
A30, Appendix); ESI mass spectrometry analysis showed a [M+H]+ molecular ion 
peak at 1,447 Da (Figure 4.17).  
 
Scheme 4.6. Reaction scheme detailing the synthesis of G2-proGal-OH [9] by aza-Michael-
type additions between proGal-acrylate [3] and APAP [8]. 
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Figure 4.16. 1H-NMR (CDCl3) of: (A) proGal-acrylate [3], and (B) G2-proGal-OH [9]. The 
observed disappearance of the vinyl resonances and the appearance of resonances attributed 
to the CH2 environments introduced as a result of the aza-Michael-type additions are 
highlighted by the yellow boxes. 
 
 
 
Figure 4.17. ESI mass spectrometry analysis of G2-proGal-OH [9] showing the [M+H]+ 
molecular ion peak. 
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4.2.3.3. Synthesis of G2-proGal-Br initiator 
The final step in the synthesis involved the reaction between G2-proGal-OH [9] and 
α-bromo isobutyryl bromide in anhydrous DCM under an inert nitrogen atmosphere 
(Scheme 4.7). The reaction was catalysed by DMAP, and a three-fold excess of TEA 
was used to scavenge the HBr side product. After reaction completion, the DCM was 
removed on the rotary evaporator to give a viscous brown coloured oily residue that 
was then purified by normal phase flash chromatography to give the 
G2-proGal-Br [10] initiator in 68 % yield. 1H-NMR (CDCl3) analysis showed a shift 
in resonance attributed to the CH environment of the APAP moiety from 3.70 ppm to 
approximately 5.20 ppm, thereby suggesting that the esterification had indeed taken 
place (Figure 4.18). However, an unusual group of resonances between 1.85-2.00 ppm 
were observed rather than the expected singlet attributed to the isobutyryl functionality 
(Figure 4.18(B)). Initially, it was thought that this could potentially be due to different 
orientations of the isobutyryl functional group over the saccharide ring structure that 
have different chemical shifts as a consequence of various through-space 
intramolecular interactions, but it was later realised that the tertiary amines of the 
dendritic compound were scavenging the HBr by-product rather than the excess TEA, 
with the resulting protonated amines causing unexpected shifts for various resonances. 
 
Scheme 4.7. Reaction scheme detailing the synthesis of G2-proGal-Br. 
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Figure 4.18. 1H-NMR (CDCl3) of: (A) G2-proGal-OH [9], and (B) G2-proGal-Br [10]. The 
observed shift of the CH resonance of the APAP moiety from 3.70 ppm to 5.20 ppm is 
highlighted by the yellow box. However, an unexpected shift in CH2 resonances, and the 
appearance of a group of unusual resonances attributed to the isobutyryl group were also 
observed; they, too, are highlighted by yellow boxes. 
 
In an attempt to deprotonate these amines, 4M NaOHaq was added to 
G2-proGal-Br [10] in THF, and the solution was then stirred for 30 minutes at ambient 
temperature. After removing the solvent on the rotary evaporator, the crude product 
was re-purified by normal phase flash chromatography and dried in vacuo. 1H-NMR 
(CDCl3) analysis showed an up-field shift for the CH resonance of the APAP moiety 
from 5.20 ppm to 5.00 ppm, and an up-field shift for the CH2 resonances (introduced 
as a result of the aza-Michael-type additions earlier on in the synthesis) from 
2.50-3.10 ppm to 2.30-2.85 ppm, with the resonances also becoming less broad and 
more defined (Figure 4.19). Additionally, the unexpected group of resonances 
between 1.85-2.00 ppm had disappeared, and the expected singlet attributed to the 
isobutyryl group – integrating to approximately 6H – was now observed at 1.91 ppm 
(Figure 4.20). Each of these changes in the 1H-NMR spectra confirm that the tertiary 
amines have been deprotonated to the neutral species once more, and consequently 
exhibit a reduced electron-withdrawing effect on their neighbouring environments. 
Furthermore, 13C-NMR (CDCl3) analysis revealed resonances at 31 ppm, 56 ppm and 
171 ppm that are attributed to the C(=O)C(CH3)2Br, C(=O)C(CH3)2Br and 
C(=O)C(CH3)2Br carbon environments of the isobutyryl group, respectively 
(Figure 4.21), and ESI mass spectrometry showed a molecular ion [M+Na]+ peak at 
1,597 Da (Figure 4.22). 
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Figure 4.19. 1H-NMR (CDCl3) of G2-proGal-Br [10]: (A) prior to treatment with 4M NaOHaq, 
and (B) after treatment with 4M NaOHaq. The observed shift in resonances are highlighted by 
the yellow boxes. 
 
 
 
Figure 4.20. 1H-NMR (CDCl3) analysis of G2-proGal-Br [10], showing the integrations of 
each environment after normalising the integration of the anomeric protons to 4H. 
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Figure 4.21. 13C-NMR (CDCl3) analysis of G2-proGal-Br [10] showing the assignment of 
each environment. 
 
 
Figure 4.22. ESI mass spectrometry analysis of G2-proGal-Br [10] showing the [M+H]+ 
molecular ion peak. 
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4.3. Methanolic ATRP of nBuMA using galactosylated dendritic initiators 
A series of polymerisations that involved the methanolic Cu-catalysed ATRP of 
nBuMA were performed at 60 °C using each of the galactose-functionalised dendritic 
initiators (G0, G1 and G2), with each series targeting a DPn = 60, 80, 100 monomer 
units; the polymerisations were allowed to progress to high conversion over similar 
reaction times to enable direct comparisons between the data. After reaction 
completion, crude samples were taken for 1H-NMR analysis to determine the 
conversion before exposing the polymerisations to air to poison the catalytic system; 
the polymers were then diluted with THF and purified by passing through an alumina 
column to remove the CuII catalyst before being concentrated and precipitated into 
cold hexane to give white solids. 
All polymerisations proceeded homogeneously to high conversions (≥ 98%), with 
those initiated by G0-proGal-Br [2] yielding low dispersity polymers (1.13 ≤ Ð ≤ 1.17) 
with number average molecular weight (Mn) values ranging from 
13,950 – 18,500 g mol-1; these values were 1.28-1.58 fold higher than theoretical 
values, with the deviation decreasing as the targeted DPn increased (Table 4.1). 
Whereas, those initiated by G1-proGal-Br [5] yielded low dispersity polymers 
(1.12 ≤ Ð ≤ 1.30) with Mn values ranging from 14,450 – 18 200 g mol-1 (1.22 – 1.57 
fold higher than theoretical values), and those initiated by G2-proGal-Br [10] yielded 
low dispersity polymers (1.15 ≤ Ð ≤ 1.19) with Mn values ranging from 14,450 – 
26 000 g mol-1 (1.37 – 1.64 fold higher than theoretical values). In comparison to the 
linear polymerisations described in Chapters 2 and 3 (using ethyl α-bromoisobutyrate 
and PEG macro-initiators, respectively), triple-detection GPC(DMF) analysis of the 
polymers initiated by the galactosylated dendritic compounds revealed higher 
dispersities than was expected; however, these values are still highly indicative of 
well-controlled ATRP, with the increase likely due to poorer initiation efficiencies. 
Furthermore, the GPC (RI) chromatograms showed narrow, monomodal and 
symmetrical molecular weight distributions (Figure 4.23 - 4.25). 
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Table 4.1. Cu-catalysed methanolic ATRP of nBuMA at 60 °C using the galactosylated 
dendritic initiators (G0, G1 and G2). 
    Triple-detection GPC (DMF) 
Target a 
 DPn 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theory b 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
G0-proGal-Br       
60 99 % [59] 25 8 850 13 950 16 100 1.16 
80 99 % [79] 48 11 650 17 300 19 600 1.13 
100 99 % [99] 72 14 500 18 500 21 600 1.17 
G1-proGal-Br       
60 98 % [59] 19 9 200 14 450 16 250 1.12 
80 99 % [79] 48 12 100 15 400 18 900 1.23 
100 99 % [99] 74 14 900 18 200 23 600 1.30 
G2-proGal-Br       
60 99 % [59] 22 10 050 14 450 16 600 1.15 
80 99 % [79] 50 12 850 17 650 20 950 1.19 
100 99 % [99] 72 15 800 26 000 29 850 1.15 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue). 
 
 
 
Figure 4.23. GPC chromatograms (RI) showing G0-proGal-p(nBuMA)x molecular weight 
distributions across targeted DPn = 60-100 monomer units. 
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Figure 4.24. GPC chromatograms (RI) showing G1-proGal-p(nBuMA)x molecular weight 
distributions across targeted DPn = 60-100 monomer units. 
 
 
 
 
Figure 4.25. GPC chromatograms (RI) showing G2-proGal-p(nBuMA)x molecular weight 
distributions across targeted DPn = 60-100 monomer units. 
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It is important to note that Tomalia et al highlighted the potential for deleterious 
retro-Michael additions when synthesising PAMAM dendrimers at temperatures 
greater than 80 °C;23 these reactions are the reverse reaction of the Michael addition, 
which caused the dendrimers to fragment. To determine whether such reactions had 
taken place during the polymerisations conducted at 60 °C, 1H-NMR analysis of the 
purified G2-proGal-p(nBuMA)60 polymer was performed (Figure 4.26). As can be 
seen from Figure 4.26, the resonances at 2.45 ppm and 2.75 ppm attributed to the 
dendritic CH2 environments (introduced as a result of the Michael-type additions) can 
be easily observed, and the resonances at 4.10-4.40 ppm, 4.60 ppm and 5.50 ppm 
confirm that the protected galactose units are still present on the dendritic chain end 
functionality; this suggests that retro-Michael additions have not taken place. 
However, the integrations of the protons attributed to the protected galactose 
functionalities were marginally lower than expected, with the resonances at 4.60 ppm 
and 5.50 ppm integrating to 3.64H and 3.67H, respectively, rather than the theoretical 
value of 4H; these figures were determined by normalising the integration of the 
resonance at 2.75 ppm to 8H. Furthermore, the analysis revealed an unexpected 
resonance at 3.65 ppm, integrating to 4.33H. This analysis suggests that the MeOH 
solvent may have trans-esterified with the dendritic chain end functionality and/or the 
repeat units of the polymer backbone; however, this was not conclusive at this stage. 
 
Figure 4.26. 1H-NMR (CDCl3) analysis of G2-proGal-p(nBuMA)60 after purification; the 
resonance potentially due to transesterification reactions is highlighted by the yellow box.                    
Chapter 4 
 
132 
 
4.4. Synthesis of galactosylated hyp-glycopolydendrons 
As described in Chapter 1 (section 1.6), hyperbranched polydendrons 
(hyp-polydendrons) - a new macromolecular architecture designed to combine aspects 
of RDRP, branched vinyl polymerisation, and linear-dendritic hybrids - can be 
synthesised using dendritic initiators in a one-pot branched polymerisation following 
the Strathclyde approach. Therefore, the Cu-catalysed methanolic ATRP of nBuMA, 
targeting a DPn = 30 monomer units, was performed at 60 °C using the galactosylated 
dendritic initiators. Once again, a low concentration of EGDMA (0.8 eqv. per initiator) 
was utilised to promote the statistical inter-chain branching of primary polymer chains, 
with each polymerisation allowed to progress to high conversion over 12 hours to 
enable direct comparisons between the data (Table 4.2; Figure 4.27). 
All polymerisations proceeded homogeneously to high conversion (99 %) to yield 
high molecular weight polymers with weight average molecular weight (Mw) values 
ranging from 102,650 g mol-1 to 159,450 g mol-1. Although linear polymerisations 
targeting a DPn = 30 nBuMA using the galactose functionalised initiators were not 
performed, Mw values for such linear polymers can be estimated as half those values 
observed for the linear polymers with targeted DPn = 60 monomer units (Table 4.1). 
Therefore, the Mw values can be estimated as: 8,050 g mol-1 for G0-proGal-
p(nBuMA)30, 8,150 for G1-proGal-p(nBuMA)30, and 8,300 g mol-1 for G2-proGal-
p(nBuMA)30. Using these values, the number of conjoined primary polymer chains 
within the weight average structures of the branched polymers can be estimated as: 
15 chains for G0-proGal-p(nBuMA30-co-EGDMA0.8), 13 chains for G1-proGal-
p(nBuMA30-co-EGDMA0.8), and 19 chains for G2-proGal-p(nBuMA30-co-
EGDMA0.8). Furthermore, the observed dispersities for each of the branched polymer 
samples (4.09 ≤ Ð ≤ 6.69) were significantly higher than those seen in the linear 
polymerisations (Table 4.1) due to the statistical nature of the branching. 
As used for the linear polymerisations performed at 60 °C, 1H-NMR analysis of the 
purified G2-proGal-p(nBuMA30-co-EGDMA0.8) showed that the integrations of the 
protons attributed to the protected galactose functionalities were slightly lower than 
expected, with the resonances at 4.60 ppm and 5.50 ppm integrating to 3.57H and 
3.59H, respectively, rather than the theoretical value of 4H (Figure A31, Appendix). 
Additionally, the resonance at 3.65 ppm (integrating to 3.27H) was also observed. 
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Table 4.2. Branched Cu-catalysed methanolic ATRP of nBuMA at 60 °C using the 
galactosylated dendritic initiators (G0, G1 and G2) and EGDMA as branching monomer.  
    Triple-detection GPC (DMF) 
Targeta DPn 
Conversion 
[actual DPn] 
Time (h) EGDMA: Initiator 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
G0-proGal-Br       
30 99 % [30] 12 0.8 : 1 17 900 119 600 6.69 
G1-proGal-Br       
30 99 % [30] 12 0.8 : 1 25 100 102 650 4.09 
G2-proGal-Br       
30 99 % [30] 12 0.8 : 1 24 350 159 450 6.55 
a Target DPn calculated as [nBuMA]/[initiator]. 
 
 
 
Figure 4.27. GPC chromatograms (RI) showing the molecular weight distributions of 
Gx-proGal-p(nBuMA30-co-EGDMA0.8) obtained via Cu-catalysed methanolic ATRP at 60 °C: 
G0-proGal-p(nBuMA30-co-EGDMA0.8) shown by the black solid line, G1-proGal-
p(nBuMA30-co-EGDMA0.8) shown by the red solid line, and G2-proGal-p(nBuMA30-co-
EGDMA0.8) shown by the blue solid line. 
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4.5. Deprotection of the galactosylated hyp-glycopolydendrons 
The synthesis of hyp-glycopolydendrons capable of actively targeting hepatic ASGPR 
receptors required the removal of the isopropylidene protecting groups from the 
dendritic chain end functionality. Many reports have demonstrated this deprotection 
under harsh acidic conditions, often using trifluoroacetic acid (TFA)24–27 or formic 
acid11,28,29 in polar protic solvents. Therefore, numerous attempts were made to 
deprotect the hyp-glycopolydendrons using TFA, DOWEX-H+ and DOWEX-Na+ ion 
exchange resins in THF, THF-H2O (90/10) binary solutions and IPA reaction solvents, 
but all proved unsuccessful; one possible explanation for this may be that the chain 
end functionalities are not easily accessible within the branched architecture. 
However, successful deprotection was achieved when using para-toluene sulfonic 
acid monohydrate (PTSA). 
4.5.1. Deprotection of proGal-OH using PTSA 
Initially, the isopropylidene protecting groups of the proGal-OH [1] starting material 
were deprotected as a proof of concept; this involved the reaction between 
proGal-OH [1] and a catalytic amount (0.1 eqv.) of PTSA, which was performed in 
MeOH at 50 °C for 6 hours (Scheme 4.8). 1H-NMR (MeOD) analysis of the crude 
product showed the near-complete absence of resonances attributed to the 
isopropylidene protecting groups, and an up-field shift for all resonances attributed to 
the galactose (Gal [11]) protons (Figure 4.28). Furthermore, IR spectroscopy revealed 
a significant increase in transmittance at approximately 3,400 cm-1 attributed to the 
hydroxyl (O-H) stretch (Figure 4.29). The results therefore confirm that the 
isopropylidene protecting groups can be successfully removed using PTSA in the 
protic solvent MeOH at elevated temperature. 
 
Scheme 4.8. Reaction scheme detailing the deprotection of isopropylidene groups of 
proGal-OH [1] using para-toluene sulfonic acid monohydrate (PTSA) in MeOH at 50 °C. 
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Figure 4.28. 1H-NMR (MeOD) analysis of: (A) proGal-OH [1], and (B) Gal [11]. The 
disappearance of the isopropylidene resonances is highlighted by the yellow box. 
 
 
Figure 4.29. IR spectroscopy analysis of: (A) proGal-OH [1], and (B) deprotected Gal [11], 
showing the greater transmittance at approximately 3,400 cm-1 (attributed to the O-H stretch) 
after deprotection. 
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4.5.2. Deprotection of hyp-glycopolydendrons using PTSA 
Deprotection of the hyp-glycopolydendrons using PTSA was then performed using 
similar reaction conditions to that described in section 4.5.1; however, dissolution of 
the p(nBuMA-co-EGDMA) copolymers within the methanolic environment required 
the co-solvency effect of nBuMA monomer, and the complete removal of the 
isopropylidene protecting groups required an excess of PTSA with respect to the 
protected chain end functionality. After stirring at the elevated temperature for 24 
hours, the MeOH reaction solvent was removed on the rotary evaporator and the crude 
product was dissolved in THF before being treated with 4M NaOHaq; this formed a 
PTSA-Na+ salt that precipitated from solution. The salt was filtered off, and the 
polymer-THF solution was dialysed against THF for 48 hours using a regenerated 
cellulose dialysis tubing with a molecular weight cut-off of 2000 g mol-1. 1H-NMR 
(CDCl3) analysis of the purified polymers showed the disappearance of resonances at 
4.60 ppm and 5.50 ppm attributed to the protons of the protected galactose 
functionalities, and the disappearance of resonances at approximately 1.35 ppm and 
1.50 ppm attributed to the isopropylidene protecting groups, therefore indicating that 
deprotection had been achieved (Figure 4.30). Furthermore, resonances attributed to 
the CH2 environments of the dendritic chain end (introduced as a result of the 
aza-Michael-type additions during the initiator synthesis) could be easily observed at 
approximately 2.40 ppm and 2.75 ppm, thereby confirming that the dendritic chain 
end functionality remains present and has not been cleaved during the reaction, nor 
has it undergone deleterious retro-Michael additions. However, resonances attributed 
to the deprotected galactose functionalities were not easily observed. The proof of 
concept study involving the deprotection of proGal-OH [1] (described in section 4.5.1) 
showed 1H-NMR (MeOD) resonances attributed to the deprotected compound in the 
region of 3.40 - 4.20 ppm; unfortunately, this region in the 1H-NMR spectrum of the 
deprotected hyp-glycopolydendrons is masked by the large, broad resonance attributed 
to the pendant CH2 environment of the nBuMA polymer repeat units. Expansion of 
this region certainly revealed resonances around the baselines of the polymer CH2 
resonance, but whether these can be attributed to the deprotected galactose chain end 
functionalities is difficult to say without any degree of uncertainty. To investigate 
further, IR spectroscopy was performed; the analysis revealed a small transmittance at 
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approximately 4,500 cm-1, which suggests that the deprotected galactose 
functionalities are present on the chain ends (Figure A32, Appendix). 
Once again, resonance at approximately 3.65 ppm was observed in the 1H-NMR 
(CDCl3) spectrum, this time resonating with a higher integration (11H) compared to 
those observed in the 1H-NMR spectra of the protected polymers (sections 4.3 and 
4.4). As described earlier, this is likely due to transesterification reactions between the 
MeOH solvent and either the galactose chain end functionalities or the p(nBuMA) 
pendant groups, in this case catalysed under the acidic conditions. 
Triple detection GPC analysis of the hyp-glycopolydendrons before and after the 
deprotection experiments were performed once more to determine whether their 
branched architecture had been affected by the proposed transesterification reactions 
(Figure 4.31). The G0 and G1 series were both analysed in DMF eluent; however, 
dissolution of the deprotected G2 hyp-glycopolydendron was difficult to achieve in 
the DMF solvent, and so the G2 series were analysed in THF eluent. The analysis of 
each series revealed high Mw values for both the protected and deprotected polymers, 
indicating that the hyp-glycopolydendrons retained their branched architecture despite 
transesterifications having taken place.   
 
Figure 4.30. 1H-NMR (CDCl3) analysis of the deprotected G2-proGal-p(nBuMA30-co-
EGDMA0.8) hyp-glycopolydendron, showing resonances attributed to the CH2 environments 
of the dendritic chain end functionality, and possible resonances attributed to the deprotected 
galactose moieties. 
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Figure 4.31. Triple-detection GPC (DMF) analysis of the protected and deprotected hyp-
glycopolydendrons: (A) G0 series, and (B) G1 series. (C) GPC (THF) analysis of the protected 
and deprotected of the G2 hyp-glycopolydendrons. 
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4.6. Nanoprecipitations of protected and deprotected hyp-glycopolydendrons 
Nanoprecipitations of each of the hyp-glycopolydendrons were performed through the 
rapid addition of 1 mL of polymer-THF solutions (5 mg mL-1) into 5 mL of H2O, after 
which the volatile organic solvent was allowed to evaporate under ambient conditions 
to yield nanoparticles within the aqueous antisolvent. These aqueous dispersions were 
analysed by dynamic light scattering (DLS) (Table 4.3, Figure 4.32). 
DLS analysis of each of the protected hyp-glycopolydendrons revealed monomodal 
intensity-weighted distributions, with z-average values (Dz) ranging from 123 nm to 
197 nm and low polydispersity index (PdI) values ranging from 0.015 to 0.109; 
monomodal number-weighted distributions, with number-average values (Dn) ranging 
from 93 to 178 nm (Figures 4.32A-C) were also observed. The large sizes observed 
indicate that the nanoparticles are formed via the proposed nucleation/growth 
mechanism that is described in Chapter 3 (Section 3.1.3). Additionally, negative zeta 
potentials (ranging from -10.8 to -34.6 mV) were observed for each sample, indicating 
the presence of charge stabilisation. Analysis of the data shows that an increase in 
generation number of the dendritic chain end functionality from G0 to G1 results in a 
decrease in Dz values from 197 to 123 nm, and an increase in negative zeta potential 
from -26.4 to -34.6 mV; however, the data obtained for the protected G2 hyp-
glycopolydendron revealed a higher Dz value (143 nm) and zeta potential (-10.8 mV) 
when compared to its G1 analogue. This out-of-trend result can be explained by the 
proposed transesterification side-reactions occurring during polymer synthesis, 
whereby the MeOH solvent has displaced protected galactose functionalities. 
Scanning electron microscopy (SEM) images taken of the protected G0 and G1 hyp-
glycopolydendrons showed spherical particles with sizes that correlate well with the 
data obtained by DLS (Figure 4.33); however, the SEM images taken of the protected 
G2 hyp-glycopolydendron showed spherical particles that seem to have aggregated to 
form a film-like structure. This is likely due to a drying effect as the water evaporated 
during sample preparation. 
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Table 4.3. DLS data of nanoprecipitations of protected and deprotected hyp-glycopolydendron – THF solutions (1 mL) into H2O (5 mL) 
   DLS a  
Hyp-glycopolydendron 
Initial 
concentration 
in THF  
Final 
concentration 
in H2O  
Dz (d.nm) b PdI c Dn (d.nm) d 
DCR e (kcps) 
[attenuator] 
Zeta potential 
(mV) 
Protected        
G0-proGal-p(nBuMA30-co-EGDMA0.8)  5 mg mL-1 1 mg mL-1 197 0.015 178 292 481 [5] -26.4 
G1-proGal-p(nBuMA30-co-EGDMA0.8) 5 mg mL-1 1 mg mL-1 123 0.079 93 54 296 [6] -34.6 
G2-proGal-p(nBuMA30-co-EGDMA0.8) 5 mg mL-1 1 mg mL-1 143 0.109 111 35 877 [6]     -10.8 
Deprotected        
G0-Gal-p(nBuMA30-co-EGDMA0.8) 5 mg mL-1 1 mg mL-1 46 0.185 25 25 725 [7]     -42.3 
G1-Gal-p(nBuMA30-co-EGDMA0.8) 5 mg mL-1 1 mg mL-1 43 0.140 25 30 784 [7]     -47.6 
G2-Gal-p(nBuMA30-co-EGDMA0.8) f 5 mg mL-1 1 mg mL-1 22 0.435 8 2 170 [9]     -34.3 
a DLS measurements recorded at 25 °C after an equilibration period of 2 minutes. b Size distribution using z-average values. c Polydispersity index. d Size 
distribution using number average values. e Derived count rate. f Sample filtered using 0.45 µm PTFE filter. 
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Figure 4.32. DLS traces showing the rapid nanoprecipitations of: (A) protected 
G0 hyp-glycopolydendron, (B) protected G1 hyp-glycopolydendron, (C) protected 
G2 hyp-glycopolydendron, (D) deprotected G0 hyp-glycopolydendron, (E) deprotected 
G1 hyp-glycopolydendron, and (F) deprotected G2 hyp-glycopolydendron. 
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Figure 4.33. Scanning electron microscopy (SEM) images of nanoparticles formed after 
nanoprecipitation of: (A) protected G0 hyp-glycopolydendron, (B) protected G1 
hyp-glycopolydendron, and (C) protected G2 hyp-glycopolydendron. Scale bars of 5 µm are 
observed in all images. 
Chapter 4 
 
143 
 
 
DLS analysis of the deprotected G0 and G1 hyp-glycopolydendrons revealed 
monomodal intensity-weighted distributions (Figures 4.32D and 4.32E) with 
significantly smaller Dz values (46 and 43 nm, respectively), and greater zeta 
potentials (-42.3 mV and -47.6 mV, respectively) compared to their protected 
equivalents; these results confirm that the deprotected galactose functionalities are 
present on the surface of the nanoparticle, with the liberated hydroxyl groups 
providing a greater degree of charge stabilisation that has resulted in colloidally stable 
nanoparticles with much smaller hydrodynamic diameters. It was also apparent that 
the deprotection of the hyp-glycopolydendrons yielded nanoparticles with broader PdI 
values of 0.185 and 0.140 for the G0 and G1 deprotected materials, respectively. 
Analysis of the G2 hyp-glycopolydendron required filtration of the sample using a 
0.45 µm PTFE filter due to the presence of precipitate; it is important to note that 
nanoprecipitations of branched p(nBuMA30-co-EGDMA0.8) obtained by the 
methanolic Cu-catalysed ATRP of nBuMA using ethyl α-bromoisobutyrate as the 
initiator resulted in macro-phase separation and precipitation of the polymer upon 
addition of the polymer-THF solution to H2O. Therefore, the precipitate observed after 
the nanoprecipitation of the deprotected G2 hyp-glycopolydendron is likely attributed 
to the branched material that had taken part in the acid-catalysed transesterification 
reactions between the dendritic chain ends and the MeOH solvent during the 
deprotection step. DLS analysis of the filtered sample also showed a significantly 
smaller Dz value (22 nm) and greater zeta potential (-34.3 mV) compared to its 
protected equivalent, suggesting that deprotected galactose functionalities are present 
on the dendritic chain ends of the branched polymer. However, the analysis also 
revealed a bimodal intensity-weighted distribution (Figure 4.32F), meaning that the 
Dz values are not reliable and therefore have to be discredited; instead, a Dn value of 
8 nm was calculated using Mie theory. This small nanoparticle size is analogous to 
that observed for dendrimers, but the high attenuator and low derived count rate 
observed during the measurement indicate that the concentration of the filtered sample 
is too low to provide a reliable result. 
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4.7. Conclusions 
In conclusion, G0, G1 and G2 dendritic ATRP initiators bearing protected galactose 
functionalities were successfully synthesised via aza-Michael-type additions and 
esterifications, with each synthesis beginning with the commercially available 
1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose (proGal-OH [1]); the structure of 
each compound was confirmed by 1H-NMR, 13C-NMR spectroscopy and ESI mass 
spectrometry. The synthesis of the G2 dendritic initiator (G2-proGal-Br [10]) initially 
encountered a small problem, with the tertiary amines scavenging the HBr by-product 
of the bromo-esterification despite a 3-fold excess of TEA present within the reaction 
medium. Treatment with 4M NaOHaq followed by normal phase flash chromatography 
resolved this issue, with 1H-NMR analysis of the purified product showing down-field 
shifts for resonances attributed to the APAP moiety of the compound; it is believed 
that this could be avoided in future syntheses by simply increasing the moles of TEA 
(e.g. 12-fold excess) used within the reaction. 
Each of the dendritic initiators were utilised in the methanolic Cu-catalysed ATRP of 
nBuMA at 60 °C, targeting DPn = 60, 80, 100 monomer units, with all polymerisations 
proceeding homogeneously to high conversion (≥ 98 %) to yield low dispersity 
polymers (1.12 ≤ Ð ≤ 1.30); the observed dispersities were higher than those seen in 
Chapters 2 and 3, but still highly indicative of a well-controlled polymerisation. 
1H-NMR analysis of the purified G2-proGal-p(nBuMA)60 polymer clearly showed the 
presence of the dendritic chain end functionality despite conducting the 
polymerisation at high temperature; this confirmed that the deleterious retro-Michael 
additions had not taken place during the reaction. However, the analysis did show a 
small unexpected peak at 3.65 ppm, suggesting that the MeOH solvent may have 
trans-esterified the dendritic chain end functionality and/or the repeat units of the 
polymer backbone. 
Hyp-glycopolydendrons bearing protected galactose functionalities were synthesised 
by utilising the galactosylated dendritic initiators in branched polymerisations 
following the Strathclyde approach, using EGDMA as the divinyl branching 
monomer; DPn = 30 monomer units were targeted and the reaction temperature was 
maintained at 60 °C. Each of the branched polymerisations proceeded homogeneously 
to high conversion (99 %) to yield high molecular weight polymers with weight 
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average molecular weight (Mw) values ranging from 102,650 g mol-1 to 
159,450 g mol-1. 
Deprotection of the hyp-glycopolydendrons was achieved using para-toluene sulfonic 
acid monohydrate (PTSA) in MeOH, utilising the co-solvency effect of the nBuMA 
monomer to solvate the branched polymers. 1H-NMR analysis of the deprotected 
polymers showed the absence of resonances attributed to the isopropylidene protecting 
groups and protected galactose functionalities, and showed resonances attributed to 
the APAP moiety of the dendritic chain end functionality; however, resonances 
attributed to the deprotected galactose functionalities were not easily observed, with a 
proof-of-concept study involving the deprotection of the proGal [1] starting material 
showing that the resonances are likely to reside beneath the large broad peak attributed 
to the CH2 environment of the p(nBuMA) pendant groups. IR spectrometry analysis 
did show a small transmittance at 3,400 cm-1 attributed to the O-H stretch, indicating 
that deprotected galactose functionalities are present within the polymer. 
Unfortunately, the 1H-NMR analysis revealed a significantly greater intensity for the 
unexpected peak at 3.65 ppm, which suggests a greater degree of transesterification 
reactions having occurred during the deprotection step, catalysed under the acidic 
reaction conditions. 
Finally, nanoprecipitations of the protected and deprotected hyp-glycopolydendrons 
were performed by the rapid addition of polymer-THF solutions into H2O; DLS 
analysis of the aqueous dispersions revealed smaller Dz values and greater negative 
zeta potentials for the deprotected G0 and G1 hyp-glycopolydendrons when compared 
to their protected equivalents, therefore suggesting that the isopropylidene protecting 
groups were successfully removed to leave the deprotected galactose functionalities 
on the surface of the nanoparticles. However, the analysis of the protected G2 
hyp-glycopolydendron revealed data that did not follow the trend of decreasing size 
with increasing generation number of the dendritic chain end functionality, indicating 
that the galactose functionalities may have been displaced by the MeOH solvent 
during the deprotection step. The analysis of the deprotected G2 
hyp-glycopolydendron required sample filtration due to the presence of precipitate; 
the results did show a greater negative zeta potential than its protected equivalent, but 
the high attenuator and low derived count rate suggest that the sample concentration 
is too low to provide a credible result. 
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Although the analysis suggests that the deprotection of the G0 and G1 
hyp-glycopolydendrons using PTSA successfully yielded galactosylated nanoparticles 
capable of actively targeting ASGPR receptors expressed on hepatic cells, it is 
believed that the deprotection step requires optimisation so that transesterification 
reactions can be completely avoided; future attempts would involve deprotection using 
PTSA in THF-H2O mixtures at low temperature. 
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5.1. Introduction 
5.1.1. HIV/AIDS  
The human immunodeficiency virus (HIV) is a lentivirus - a sub-group of the 
retrovirus family - that infects and progressively diminishes vital cells of the immune 
system;1,2 its main targets are CD4+ T lymphocytes, with the infection cycle beginning 
with fusion of the viral envelope to the host cell after interactions between the virion 
glycoprotein gp120 and the CD4 receptor.3 This induces a conformational change that 
enables the interaction of gp120 with the chemokine CCR5 and CXCR4 co-receptors, 
resulting in the exposure of a fusogenic peptide that then anchors into the host cell 
membrane.4,5 After cellular internalisation, the viral RNA is released into the host 
cell’s cytoplasm, transcribed to viral double-stranded DNA by the viral enzyme, 
reverse transcriptase, and incorporated into the host cell genome by the viral enzyme, 
integrase.6 Through transcription and translation processes, viral proteins are formed 
that then self-assemble to form the replicated virion, encapsulating two copies of 
single stranded RNA, and the viral enzymes integrase, reverse transcriptase and 
protease. The final stage involves the enveloping of the virus by a lipid bilayer derived 
from the membrane of the host cell as it buds out into the extracellular fluid. This viral 
replication results in the depletion of the CD4+ T lymphocytes, which consequently 
weakens immune function and eventually leads to acquired immunodeficiency 
syndrome (AIDS) if untreated. 
5.1.2. Antiretroviral therapy (ART) 
At present, there is no cure for HIV/AIDS, but antiretroviral therapy (ART) has been 
hugely successful in suppressing viral replication by significantly reducing the plasma 
viral load and increasing the CD4+ T cell count; as a result, this has changed the 
prognosis from that of high mortality to a chronic, yet manageable, disease.1 Currently, 
there are 38 antiretroviral drugs that have gained FDA approval for clinical use, each 
categorised into 1 of 6 mechanistic classes that target different stages of the viral 
replication cycle; these classes include nucleoside reverse transcriptase inhibitors, 
non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase 
inhibitors, fusion inhibitors and entry inhibitors.7 ART involves a strict regimen 
whereby patients are administered a combination of three or more of these drugs 
(selected from at least two mechanistic classes) on a daily basis. 
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As a result, ART improves the quality of life for infected individuals and delays the 
progression to AIDS, but it is not sufficient enough to eradicate the virus. This is 
because the virus is able to establish latent cellular reservoirs (e.g. CD4+ memory T 
cells, macrophages and follicular dendritic cells)8–14 and anatomical reservoirs 
(e.g. central nervous system, lymphatic system, lungs and genital organs)15, in which 
the viral genome persists in a DNA form as an integrated pro-virus that is not actively 
transcribed; for as long as these latently infected reservoirs remain dormant, they will 
evade recognition by the immune system, enabling the replication cycle to be 
re-activated at any time. Furthermore, the presence of numerous biological barriers 
(e.g. blood-brain barrier, blood-cerebrospinal fluid barrier, blood-testes barrier) make 
it very difficult to attain therapeutically relevant antiretroviral drug concentrations 
within these reservoirs.  
To address these problems, research is directed towards actively targeting the viral 
reservoirs to achieve therapeutically relevant concentrations of the antiretroviral 
drugs, or alternatively, to force the activation of latently infected cells; in the latter 
case, activation of the viral replication cycle enables recognition and elimination of 
the infected cells by the immune system.16 
5.1.3. Actively targeting DC-SIGN receptors and mannose receptors 
Dendritic cell-specific intercellular adhesion-molecule-3-grabbing non-integrin 
(DC-SIGN) and the mannose receptor are C-type lectins abundantly present on the 
surface of dendritic cells and macrophages.17,18 Through multi-valent and 
calcium-dependent interactions, they are able to bind to highly glycosylated proteins 
presented on the surface of pathogens, including the gp120 high mannose glycan of 
HIV, rendering them viable targets for anti-HIV drug delivery systems and 
vaccines.19–21 
Two interesting studies, reported by Haddleton and coworkers, involved the synthesis 
of a library of glycopolymers - consisting of mannose, galactose, glucose and fucose 
functionalities - via a combination of Cu-mediated SET-LRP and Cu-catalysed 
azide-alkyne click (CuAAC) reactions; the binding behaviour of the glycopolymers to 
DC-SIGN was assessed, with the results showing a greater affinity for the polymers 
with higher mannose content.22,23 Another interesting study, reported by Dutta and 
Jain, investigated the targeting potential and anti-HIV activity of mannosylated 5th 
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generation PPI dendrimers encapsulating the antiretroviral drug, lamivudine (43 % 
entrapment efficiency). The results showed the extent of cellular internalisation of the 
mannosylated PPI dendrimers was significantly greater than that seen for the free-drug 
and the non-functionalised PPI dendrimer (by a factor of 21 and 8.3 respectively); 
consequently, a significantly higher anti-HIV activity was observed for the mannose 
functionalised dendrimer.24 
5.1.4. Chapter aims 
The aim of this Chapter was to synthesise mannose-functionalised dendritic initiators 
(G0 and G2) using similar chemistry to that demonstrated in Chapter 4; these initiators 
will then be utilised in the methanolic Cu-catalysed ATRP of nBuMA to yield 
amphiphilic materials capable of actively targeting DC-SIGN and mannose receptors. 
Linear polymerisations will be performed, targeting various degrees of 
polymerisation, to assess the control of the polymerisations before being repeated in 
the presence of a low concentration of the divinyl monomer, EGDMA, to yield 
mannosylated hyp-glycopolydendrons. Their ability to form stable nanoparticle 
dispersions in aqueous media will be assessed by performing rapid nanoprecipitation 
studies. 
5.2. Synthesis of G0 mannose initiator 
The synthesis of the mannose functionalised G0 ATRP initiator was performed in 3 
steps that involved the protection of all hydroxyl groups, followed by the selective 
deprotection of the anomeric centre and, finally, a bromo-esterification to introduce 
the tertiary bromide functionality required to initiate the polymerisation (Scheme 5.1). 
The hydroxyl groups of D-mannose were protected via an acetylation procedure  
 
Scheme 5.1. Reaction scheme detailing the 3-step synthesis of the mannose functionalised G0 
ATRP initiator. 
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reported by Kartha and Field, which involved reacting the monosaccharide with acetic 
anhydride, using iodine as a lewis acid catalyst;25 the exothermic reaction was 
complete within 30 minutes. The crude product was purified by solvent-solvent 
extractions that involved an aqueous sodium thiosulfate wash to remove the iodine, 
and saturated sodium bicarbonate washes to remove the acetic acid by-product. 
Further purification by normal phase flash-chromatography afforded the 
Mann-(OAc)5 [12] acetylated product in a 98 % yield. The structure of the desired 
compound was confirmed by resonances between 2.0-2.25 ppm in the 1H-NMR 
spectrum attributed to the COCH3 acetyl protons (Figure 5.1A; Figure A33, 
Appendix), and resonances between 168-172 ppm in the 13C-NMR spectrum attributed 
to the OC=OCH3 ester groups introduced as a result of the acetylation (Figure A24, 
Appendix). The purified product was also characterised by ESI-mass spectrometry 
showing a molecular ion peak [M+Na]+ at 413 Da (Figure A35, Appendix). 
Deprotection of the anomeric centre was achieved by reacting Mann-(OAc)5 [12] with 
ethylene diamine and acetic acid in THF under ambient reaction conditions, a method 
that is widely reported in the literature.26–28 The crude product was purified by solvent-
solvent extraction and normal phase flash chromatography to afford 
Mann-(OAc)4 [13] (2:98 α:β ratio) in 56 % yield. In comparison to the 
Mann-(OAc)5 [12] starting material, 1H-NMR analysis of the purified product showed 
the disappearance of resonances between 6.0-6.3 ppm and the appearance of 
resonances between 3.25-3.60 ppm; each of these environments are attributed to the 
anomeric protons, with the observed shift confirming the selective deacetylation at the 
anomeric centre (Figure 5.1; Figure A36, Appendix).  
 
Figure 5.1. 1H-NMR (CDCl3) spectra of: (A) Mann-(OAc)5 [12], and (B) Mann-(OAc)4 [13]. 
The observed shift in resonance of the anomeric protons after selective deacetylation is 
highlighted by the yellow boxes. 
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This is also confirmed by the disappearance of a peak at 2.18 ppm attributed to the 
COCH3 acetyl protons. Furthermore, 13C-NMR analysis showed 4 peaks between 
169-171 ppm attributed to the remaining acetyl groups, and ESI-mass spectrometry 
analysis showed a molecular ion [M+Na]+ peak at 371.1 Da (Figures A37 and A38, 
Appendix). 
Finally, Mann-(OAc)4 [13] was reacted with α-bromo isobutyryl bromide in 
anhydrous dichloromethane (DCM) under an inert nitrogen atmosphere. The reaction 
was catalysed by 4-dimethylaminopyridine (DMAP), and an excess of triethylamine 
(TEA) was used to scavenge the hydrogen bromide (HBr) side product. After reaction 
completion, the DCM was removed on the rotary evaporator to give a viscous brown 
coloured oily residue; the product was extracted from this residue using diethyl ether, 
with each extract passed through filter paper to remove the triethylammonium bromide 
(Et3N+Br−) salt. After removal of the solvent on the rotary evaporator, the product was 
purified further by normal phase flash chromatography to give G0-Mann-Br [14] 
initiator in 95 % yield. Although assignment of each resonance was difficult to 
achieve, the total integration of the peaks within the 1H-NMR spectrum matched 
theoretical values when normalising the multiple resonances between 1.70-2.40 ppm 
to 18H (Figure 5.2). Furthermore, 13C-NMR analysis revealed a resonance at 30 ppm 
attributed to the isobutyl group introduced by the esterification (Figure 5.3), and ESI 
mass spectrometry showed a molecular ion [M+Na]+ peak at 519 Da (Figure 5.4). 
 
Figure 5.2. 1H-NMR (CDCl3) of G0-Mann-Br [14] initiator. 
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Figure 5.3. 13C-NMR (CDCl3) of G0-Mann-Br [14] initiator. 
 
 
 
Figure 5.4. ESI mass spectrometry analysis of G0-Mann-Br [14], showing the [M+Na]+ and 
[M+K]+ molecular ion peaks. 
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5.3. Synthesis of G2 mannose functionalised dendritic initiator 
Synthesis began by reacting Mann-(OAc)4 [13] with acryloyl chloride in anhydrous 
DCM under an inert nitrogen atmosphere (Scheme 5.2); the reaction was catalysed by 
DMAP, and an excess of TEA was used to scavenge the HCl by-product, forming a 
Et3N+Cl- salt that precipitated from solution as the reaction progressed. After reaction 
completion, the salt was filtered off and washed with cold DCM before removing the 
solvent on the rotary evaporator (at 35 °C to avoid self-polymerisation) to give a brown 
coloured residue. The product was extracted from this residue using diethyl ether, with 
each extract filtered to remove residual Et3N+Cl- salt, before being concentrated and 
purified further by normal phase flash chromatography to give the Mann-(OAc)4-
acrylate [15] as a yellow coloured oil in 66 % yield. In comparison to the Mann-(OAc)4 
starting material, 1H-NMR analysis of the purified product showed a shift for anomeric 
resonances from 3.25-3.60 ppm to approximately 6.20 ppm, and the appearance of a 
further three resonances attributed to vinyl protons of the acrylate functional group 
(Figure 5.5; Figure A39, Appendix). Analysis by 13C-NMR revealed the appearance 
of two peaks between 129-137 ppm that can be assigned to each carbon of the vinyl 
functionality introduced by the esterification, and ESI-mass spectrometry gave a 
[M+Na]+ molecular ion peak at 425.1 Da (Figures A40 and A41, Appendix). 
 
Scheme 5.2. Reaction scheme detailing the synthesis of Mann-(OAc)4-acrylate [15]. 
 
Figure 5.5. 1H-NMR (CDCl3) of: (A) Mann-(OAc)4 [13], and (B) Mann-(OAc)4-acrylate [15]. 
The observed disappearance of the anomeric protons and the appearance of the vinyl protons 
are highlighted by the yellow boxes. 
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The next step in the synthesis involved the reaction of Mann-(OAc)4-acrylate [15] with 
the AB2 branching unit, APAP [8], via exhaustive aza-Michael-type addition; it was 
demonstrated in Chapter 4 that aza-Michael-type addition in protic solvents resulted 
in significantly higher yields, therefore this reaction was performed in IPA at ambient 
temperature for 7 days, using an 8:1 excess of the acrylate relative to APAP [8] 
(Scheme 5.3). Analysis of the crude product by thin layer chromatography (TLC) on 
silica plates revealed 5 spots with Rf values ranging from 0.03 to 0.8. Thus, utilising 
normal phase flash chromatography, the first four compounds were collected and 
analysed by 1H-NMR and 13C-NMR spectroscopy (Figures 5.6). The compound 
attributed to the fifth spot on the TLC plate (Rf = 0.03) was retained by the column 
and could not be analysed; this is likely to be unreacted APAP [8] that did not elute 
from the column due to the strong acid-base interactions between the silica and the 
compound. 
Analysis of the first eluted compound showed resonances between 5.70-6.50 ppm in 
the 1H-NMR spectrum (Figure 5.6A(i)) and resonances between 129-137 ppm in the 
13C-NMR spectrum (Figure 5.6B(i)), both of which are attributed to the vinyl 
functionality of Mann-(OAc)4-acrylate [15]; this is to be expected given that it was in 
excess to drive the reaction to completion. Analysis of the second eluted compound 
showed an identical 13C-NMR spectrum (Figure 5.6B(ii)) to that observed for the 
Mann-(OAc)4 [13]; however, the 1H-NMR spectrum showed identical resonances with 
only one exception - no resonance between 3.20-3.60 ppm that would be attributed to 
the anomeric proton (Figure 5.6A(ii)). Instead, a small, broad resonance at  
 
Scheme 5.3. Reaction scheme detailing the attempted synthesis of dendritic 
G2-Mann-OH [16] via aza-Michael-type additions. 
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Figure 5.6.  1H-NMR spectra (A), and 13C-NMR spectra (B) of the compounds formed during 
the attempted synthesis of the G2-Mann-OH [16] dendritic compound; the compounds are 
shown in order of their elution from the silica column, with (i) being the first compound to 
elute, and (iv) the last compound to elute. 
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approximately 3.90 ppm was observed which may be attributed to the anomeric proton 
that has shifted down-field as a consequence of running the NMR sample at high 
concentration; a concentrated sample could induce hydrogen-bonding between 
hydroxyl groups on the anomeric carbons and subsequently reduce electron-density, 
resulting in a de-shielding effect with respect to the external magnetic field of the 
spectrometer. Therefore, even though a significant shift in resonance attributed to the 
anomeric proton was observed, both the 1H-NMR and 13C-NMR spectra strongly 
suggest that the eluted compound is indeed Mann-(OAc)4 [13], formed as a result of a 
transesterification side-reaction between Mann-(OAc)4-acrylate [15] and the IPA 
solvent. 1H-NMR analysis of both the third and fourth eluted compounds showed 
resonances attributed to APAP [8] (δ = 1.10 ppm, 2.40-3.00 ppm), and weak 
resonances attributed to the acetyl groups of the protected mannose functionalities 
(δ = 1.90-2.20 ppm) (Figure 5.6A(iii-iv)). Furthermore, two strong resonances at 
approximately 2.40 and 2.70 ppm are likely to be attributed to CH2 environments 
introduced as a result of aza-Michael-type addition, therefore, suggesting that the 
desired reaction has indeed taken place to some degree. However, a large doublet at 
approximately 1.20 ppm was also observed, which could be attributed to methyl 
environments introduced via aza-Michael-type addition between the proposed 
isopropyl-acrylate side-product and APAP [8]. The high intensity of this peak in both 
compounds indicates a greater degree of the isopropyl functionality compared to the 
protected mannose functionality; it’s important to note that due to overlapping of 
resonances and poor baselines observed in each spectrum, it was difficult to determine 
the exact ratios of each functionality reacted onto the APAP [8] unit. 
Therefore, after analysis of each of the compounds formed during the reaction, it is 
clearly evident that the desired G2-Mann-OH dendritic compound was not formed and 
that the reaction was unsuccessful. It has been proposed that a series of side-reactions 
have taken place that were instigated by the protic IPA solvent (Scheme 5.4); such 
reactions were not observed during the synthesis of the G2-Gal-OH dendritic 
compound in Chapter 4, suggesting that the position of the acrylate functionality on 
the ring structure of the saccharide is an important parameter to consider when utilising 
such chemistry. Additionally, it is not clear if APAP [8] plays a negative role but, its 
structural similarity to ethylene diamine (used in the selective deprotection step to 
yield Mann-(OAc)4 [13]) may go some way to explain the observed issues. 
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Scheme 5.4. Reaction scheme detailing the proposed side-reactions during the attempted 
synthesis of G2-Mann-OH [16]: (I) transesterification between Mann-(OAc)4-acrylate [15] 
and the IPA solvent, and (II) the subsequent aza-Michael-type additions between the isopropyl 
acrylate/ Mann-(OAc)4-acrylate [15] and APAP [8]. 
 
5.4. Methanolic ATRP of nBuMA using G0-Mann-Br initiator 
The methanolic Cu-catalysed ATRP of nBuMA was performed using the 
G0-Mann-Br [14] initiator, targeting a DPn = 60, 80, 100 monomer units (Scheme 5.5); 
the effect of temperature was assessed by performing the series of polymerisations at 
both 60 °C and 25 °C. Each polymerisation was allowed to progress to high conversion 
before exposing the reaction flask to air to poison the catalytic system. The polymers 
were purified by passing through an alumina column to remove the CuII catalyst before 
being concentrated in THF and precipitated into cold hexane to give white solids. 
 
Scheme 5.5. Cu-catalysed ATRP of nBuMA in anhydrous MeOH at 50 wt%. 
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The polymerisations performed at 60 °C progressed homogeneously to high 
conversion (99 %) to yield low dispersity (Ð ≤ 1.08) homopolymers with number 
average molecular weight (Mn) values ranging from 15,530 – 23,000 g mol-1; 
1.58-1.72 fold higher than theoretical values, with the deviation decreasing as the 
targeted DPn increased (Table 5.1). Furthermore, the GPC (RI) chromatograms for 
each of the polymers showed monomodal and symmetrical molecular weight 
distributions, indicating no significant loss of propagating chains during the 
polymerisation (Figure 5.7). 
The polymerisations performed at 25 °C, targeting DPn = 60, 80 nBuMA units, 
progressed homogeneously to high conversions (91 % and 92 % respectively); 
however, the polymerisation targeting DPn = 100 monomer units phase separated at 
towards the end of the polymerisation to give a viscous, polymer-rich phase clumped 
around the magnetic stirrer bar. This was not obvious at first, but could be more easily 
observed when manipulating the stirrer bar with a magnet. This phase separation 
behaviour could be due to one of two reasons: (i) the anhydrous MeOH solvent had 
been contaminated with moisture, which would have a significant effect on the cloud 
point temperature of the polymer in the methanolic environment – as demonstrated in 
the cloud point studies of Chapter 2, or (ii) the protected mannose chain-end 
functionality may have a significant effect on the ability of the polymer to remain in 
Table 5.1. Cu-catalysed methanolic ATRP of nBuMA at 60 °C and 25 °C using G0-Mann-Br 
    Triple-detection GPC (DMF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(h) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 °C       
60 99 % [59] 24 8 950 15 350 16 600 1.08 
80 99 % [79] 48 11 750 19 150 20 300 1.06 
100 99 % [99] 72 14 600 23 000 24 950 1.08 
25 °C       
60 91 % [55] 24 8 250 12 850 13 500 1.05 
80 92 % [74] 48 10 950 16 400 17 400 1.06 
100 98 % [98] 72 14 450 21 550 22 500 1.05 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue). 
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solution. Rannard and coworkers have previously demonstrated how the LCST 
behaviour for p(DMAEMA) is affected by very subtle (single methylene group) 
changes in the structure of the initiating chain-end functionalities;29 it is, therefore, 
reasonable to assume that the changes in the structure of the initiating groups presented 
within this thesis may have a significant effect of the UCST behaviour of p(nBuMA). 
For the targeted DPn = 100 polymer, it is important to note that before taking a crude 
sample for 1H-NMR analysis, chloroform was added to the reaction flask to give a 
single phase that enabled the monomer conversion to be determined accurately as 
98 %. In all cases, the polymerisations proceeded to lower monomer conversions when 
compared to those performed at 60 °C over similar reaction times, indicating a slower 
rate of polymerisation at this reduced temperature. Additionally, triple detection GPC 
(DMF) analysis revealed low dispersity polymers (Ð < 1.06) with Mn values ranging 
from 12,850 – 21,550 g mol-1; 1.49-1.56 fold higher than theoretical values, with the 
deviation, once again, decreasing as the targeted DPn increased. In all cases, narrower 
molecular weight distributions and improved Mn targeting were observed for the 
polymers obtained at 25 °C compared to those obtained at 60 °C. Interestingly, the 
best results were observed for the G0-Mann-p(nBuMA)100 polymer despite having 
phase-separated during the reaction, indicating no negative effect on the control of the 
polymerisation. Furthermore, the GPC (RI) chromatograms for each of the polymers 
showed monomodal and symmetrical molecular weight distributions (Figure 5.7). 
 
Figure 5.7. GPC (RI) chromatograms showing the molecular weight distributions of 
p(nBuMA)60-100, obtained via ATRP using the G0-Mann-Br initiator [14] at 60 °C (solid lines) 
and 25 °C (dashed lines). 
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5.5. Branched methanolic ATRP of nBuMA using G0-Mann-Br initiator 
Polymers consisting of a branched architecture with protected mannose surface 
functionalities were obtained by polymerisation following the Strathclyde approach; 
this involved the Cu-catalysed methanolic ATRP of nBuMA, targeting a DPn = 30 
monomer units, in the presence of the divinyl monomer, EGDMA, to promote the 
statistical inter-chain branching of primary polymer chains (Scheme 5.6). A low 
concentration of EGDMA was maintained (0.8 equivalents per initiator) so as to avoid 
gelation, and the reaction temperature was varied from 60 °C to 25 °C to study its 
effect on the degree of branching. 
Each polymerisation was allowed to progress to high conversion over 21 hours to 
enable direct comparisons between the data (Table 5.2), after which the reaction flask 
was exposed to air to poison the catalytic system. The polymers were purified by 
passing through an alumina column to remove the CuII catalyst before being 
concentrated in THF and precipitated into cold hexane to give white solids. 
 
Scheme 5.6. Cu-catalysed methanolic ATRP of nBuMA in the presence of a low concentration 
of EGDMA at both 60 °C and 25 °C. 
 
Table 5.2. Branched Cu-catalysed methanolic ATRP of nBuMA at 60 °C and 25 °C using 
EGDMA as branching monomer and G0-Mann-Br [14] as initiator. 
    Triple-detection GPC (DMF) 
Targeta DPn 
Conversion 
[actual DPn] 
Time 
(h) 
EGDMA: G0-Mann-Br 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 °C       
30 99 % [30] 21 0.8 : 1 19 750 89 800 4.54 
25 °C       
30 94 % [28] 21 0.8 : 1 17 300 66 400 3.84 
a Target DPn calculated as [nBuMA]/[initiator]. 
Chapter 5 
 
164 
 
As seen with, linear polymerisations performed in the absence of EGDMA 
(Section 5.4), the reaction at the elevated temperature proceeded homogeneously to 
high conversion; however, the reaction at 25 °C phase separated towards the later 
stages of the polymerisation, which is surprising given that the linear polymers with 
target DPn = 60, 80 monomer units remained in solution to high conversion (≥ 91%; 
Table 5.1). This suggests that the polymer architecture also influences the UCST 
behaviour of the polymer. In this case, chloroform was added to the reaction flask to 
give a single phase before sampling for 1H-NMR analysis. 
1H-NMR (CDCl3) analysis of crude samples taken at the end of each polymerisation 
showed that higher monomer conversions were achieved when polymerising at 60 °C, 
indicating a greater rate of polymerisation at the elevated temperature. Furthermore, 
GPC (DMF) analysis calculated higher weight average molecular weight values 
(Mw = 89,800 g mol-1) for the polymers obtained at 60 °C compared to those obtained 
at 25 °C (Mw = 66,400 g mol-1), which is to be expected given that that the statistical 
branching mainly occurs towards the latter stages of the polymerisation,30 and that 
lower monomer conversions were achieved at the reduced temperature. This is also 
reflected in the GPC chromatograms, showing the elution of higher molecular weight 
materials at lower retention times for the polymer obtained at 60 °C (Figure 5.8). 
 
 
Figure 5.8. GPC (RI) chromatograms showing the molecular weight distributions of 
G0-Mann-p(nBuMA30-co-EGDMA0.8) obtained via Cu-catalysed methanolic ATRP at both 
60 °C (red solid line) and 25 °C (blue solid line). 
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5.6. Nanoprecipitation of G0-Mann-p(nBuMA30-co-EGDMA0.8) 
Nanoprecipitations of each of the branched copolymers were performed through the 
rapid addition of 1 mL of polymer-THF solutions (5 mg mL-1) into 5 mL of H2O, after 
which the volatile organic solvent was allowed to evaporate under ambient conditions 
to yield nanoparticles within the aqueous antisolvent (Figure 5.9). These aqueous 
dispersions were analysed by dynamic light scattering (DLS) (Table 5.3, Figure 5.10). 
DLS analysis of the unfiltered samples revealed monomodal intensity-weighted 
distributions (Figure 5.10A) for each of the branched copolymer nanoparticles, with 
z-average values (Dz) ranging from 120 to 140 nm and low polydispersity index (PdI) 
values ranging from 0.046 to 0.074. The number-weighted particle size distributions 
(Dn), derived from the intensity distributions using Mie theory, were also monomodal 
(Figure 5.10B) and gave Dn values ranging from 96 to 113 nm. Additionally, negative 
zeta potentials were observed for each sample (≥ -18.4 mV) indicating the presence of 
charge stabilisation. The large sizes of the nanoparticles observed in both the intensity-
weighted and number-weighted distributions indicate that the nanoparticles are 
formed via the proposed nucleation/growth mechanism that is described in Chapter 3 
(Section 3.1.3). Scanning electron microscopy (SEM) images were taken of each 
sample, both of which showed spherical particles with sizes that correlate well with 
the data obtained by DLS (Figure 5.11); however, fewer nanoparticles were observed 
for the branched copolymer obtained at 25 °C (Figure 5.11B). This is also reflected in 
lower derived count rate that was calculated by the DLS instrument. 
 
Figure 5.9. Pictures displaying the aqueous dispersions of the amphiphilic branched 
copolymers after rapid nanoprecipitation and subsequent evaporation of the organic solvent: 
(A) G0-Mann-p(nBuMA30-co-EGDMA0.8) obtained at 60 °C, and (B) G0-Mann-p(nBuMA30-
co-EGDMA0.8) obtained at 25 °C. 
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Table 5.3. Dynamic light scattering data of nanoprecipitations using THF solutions of G0-Mann-p(nBuMA30-co-EGDMA0.8) (1 mL) into H2O (5 mL) 
   DLS a  
Sample 
Initial 
concentration 
in THF  
Final 
concentration in 
H2O  
Dz (d.nm) b PdI c Dn (d.nm) d 
DCR e (kcps) 
[attenuator] 
Zeta potential 
(mV) 
G0-Mann-p(nBuMA30-co-
EGDMA0.8) (60 °C) 
5 mg mL-1 1 mg mL-1 144 0.074 113 301 250 [5] -26.2 
        
G0-Mann-p(nBuMA30-co-
EGDMA0.8) (25 °C) 
5 mg mL-1 1 mg mL-1 120 0.046 96       29 700 [7]     -18.4 
a DLS measurements recorded at 25 °C after an equilibration period of 2 minutes. b Size distribution using z-average values. c Polydispersity index. d Size 
distribution using number average values. e Derived count rate. 
 
 
Figure 5.10. DLS traces showing: (A) intensity-weighted distributions, and (B) number-weighted distributions of the G0-Mann-p(nBuMA30-co-EGDMA0.8) 
branched copolymers obtained at 60 °C (solid lines) and 25 °C (dashed lines). 
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Figure 5.11. Scanning electron microscopy (SEM) images of nanoparticles formed after 
nanoprecipitation of: (A) G0-Mann-p(nBuMA30-co-EGDMA0.8) obtained at 60 °C, and 
(B) G0-Mann-p(nBuMA30-co-EGDMA0.8) obtained at 25 °C. Scale bars of 4 µm are observed 
in both images. 
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5.7. Conclusions 
In conclusion, a generation zero (G0), mannose functionalised ATRP initiator was 
successfully synthesised by a 3 step reaction procedure that involved protection and 
selective deprotection strategies, followed by a bromo-esterification to introduce the 
required tertiary bromide functionality at the anomeric centre of the saccharide; the 
structure of the compound was confirmed by 1H-NMR and 13C-NMR spectroscopy, 
and ESI mass spectrometry. 
The methanolic Cu-catalysed ATRP of nBuMA was performed using the 
G0-Mann-Br [14] initiator, under the same reaction conditions that have been utilised 
throughout this thesis. Linear G0-Mann-p(nBuMA) polymers were synthesised at both 
60 °C and 25 °C, targeting a DPn = 60, 80, 100 monomer units, with all 
polymerisations achieving high conversions (≥ 91 %) to yield low dispersity polymers 
(Ð ≤ 1.08); narrower molecular weight distributions and improved Mn targeting were 
observed when polymerising at the reduced temperature. However, phase separation 
did occur when polymerising at 25 °C, targeting a DPn = 100 nBuMA units; this could 
either be due to contamination of the reaction solvent with H2O, or the presence of the 
protected mannose chain-end functionalities having a significant effect on the UCST 
behaviour of the polymer within the methanolic environment. It is important to note 
that no effect was observed on the molecular weight distribution of the obtained 
G0-Mann-p(nBuMA)100, despite phase separation having taken place. 
Branched polymerisations were performed following the Strathclyde approach, using 
EGDMA as the divinyl branching monomer; a DPn = 30 monomer units was targeted, 
and the reaction temperature was varied to study its effect on the degree of branching. 
Once again, phase separation occurred when polymerising at 25 °C, suggesting that 
the polymer architecture also has an effect on the UCST behaviour of the polymer 
within the methanolic environment. Analysis by 1H-NMR and triple detection GPC 
(DMF) revealed that higher conversions were achieved and higher Mw values 
(Mw = 89 800 g mol-1) obtained when polymerising at 60 °C. Nanoprecipitations were 
performed using each of the branched materials to yield nanoparticles that, once 
deprotected, have the potential to actively target DC-SIGN and mannose receptors that 
abundantly present on latent cellular reservoirs of HIV. DLS analysis of the formed 
nanoparticles showed monomodal and symmetrical distributions with Dz values 
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ranging from 120-140 nm, very low PdI values (≤ 0.074) and negative zeta potentials 
(≥ -18.4 mV); the latter indicating the presence of charge stabilisation. Furthermore, 
SEM images confirmed the presence of spherical nanoparticles with sizes that 
correlate well with the DLS data. Unfortunately, deprotection of the mannose chain-
end functionalities of the branched polymers were not attempted due to lack of time, 
but future attempts would involve similar deprotection strategies to that described in 
Chapter 4, employed to remove isopropylidene protecting groups present on the 
galactose functionalities; this would involve treating the protected G0-Mann-
p(nBuMA30-co-EGDMA0.8) branched copolymers with para-toluene sulfonic acid 
monohydrate within a protic solvent. 
Attempts were made to synthesise generation 2 (G2) dendritic initiators that involved 
protection and selective deprotection strategies, followed by an esterification with 
acryloyl chloride to introduce an activated acrylate functionality at the anomeric centre 
of the saccharide. The Mann-(OAc)4-acrylate [15] obtained was then used in the 
attempted aza-Michael-type addition with APAP [8] within the protic solvent IPA; 
unfortunately, however, the reaction proved unsuccessful. 1H-NMR and 13C-NMR 
analysis strongly suggested that a series of side-reactions had taken place that initially 
involved a transesterification between the Mann-(OAc)4-acrylate [15] and the IPA 
solvent, yielding an isopropyl-acrylate compound, which then reacted with APAP [8] 
via aza-Michael-type addition. Such reactions were not observed when reacting the 
galactose equivalent with APAP [8], described in Chapter 4, suggesting that the 
position of the activated acrylate functionality on the ring structure of the saccharide 
is critical to the success of the reaction. Therefore, a solution to this problem may 
involve alternative protection/deprotection strategies to enable the acrylate 
functionality to be introduced to a different position of the saccharide ring structure.  
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6.1. Conclusions 
The application of nanotechnology to medicine (an emerging field known as 
nanomedicine) has resulted in more than 40 nanoparticle based therapeutic products 
in routine clinical use, designed to address the issues of low efficacy and poor 
economic viability associated with some conventional medicinal treatments.1 The 
majority of these products are used in anticancer therapy to transport and deliver 
hydrophobic, toxic anticancer drugs to solid tumours via the enhanced permeability 
and retention (EPR) effect.2 However, one key issue remains; the PEG surface 
functionality required to utilise the EPR effect prevents cellular internalisation after 
accumulation within the tumour tissue.3 Therefore, research is now heavily focused 
on the development of nanoparticle-based therapeutics that will promote entry of the 
drug-carriers into specific cells (a concept known as active targeting), which can be 
achieved by functionalising the surface of the nanomaterials with targeting ligands 
(e.g. carbohydrates, peptides, vitamins, proteins, antibodies, aptamers and 
oligonucleotides) that have a high affinity for specific cell-receptors.4 Such research 
has shown that ligand density has a significant effect on the rate of cellular 
internalisation, with higher ligand densities generally resulting in greater cellular 
uptake;5,6 in this respect, dendrimers are the ideal nanoparticle platform for active 
targeting in drug-delivery applications. However, the synthesis and purification 
procedures of dendrimers are often laborious and expensive, which consequently 
affects their commercial viability. 
To address these issues,  the synthesis of hyperbranched-polydendrons (hyp-
polydendrons) has been developed - a new macromolecular architecture designed to 
combine aspects of reversible-deactivation radical polymerisation, branched vinyl 
polymerisation, and linear-dendritic hybrids, to yield high molecular weight 
macromolecules with ideally branched dendritic chain ends; they are essentially 
regarded as an attractive, versatile alternative to dendrimers, particularly for 
therapeutic applications in nanomedicine.7–9 Currently, the reported synthesis of these 
materials has involved using dendritic ATRP initiators bearing surface functionalities 
that are not capable of actively targeting specific cellular receptors. Furthermore, 
reports of the chemistry of the branched polymer core are currently limited to poly(2-
hydroxypropyl methacrylate) (pHPMA) - a hydrophobic polymer that has 
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demonstrated its ability to encapsulate hydrophobic molecules, such as Nile red and 
pyrene. 
Therefore, the research described within this thesis has aimed to expand the chemistry 
of both the dendritic surface functionalities and the branched polymer core to yield 
amphiphilic materials that have the potential to encapsulate hydrophobic drugs and 
actively target specific cell receptors.  
 6.1.1. Chapter 2 
Chapter 2 demonstrated the synthesis of well-defined hydrophobic p(nBuMA) 
homopolymers in anhydrous MeOH - an anti-solvent for the polymer, often used in 
purification procedures for precipitation purposes. 
The polymerisation of nBuMA was initially performed at 60 °C by Cu-catalysed 
ATRP using bpy as the complexing ligand and ethyl 2-bromoisobutyrate as the 
initiator, with each polymerisation proceeding homogeneously to high conversion, 
yielding polymers with narrow molecular weight distributions (Ð as low as 1.02); 
these results were highly surprising, as the observed dispersity values were 
comparable to those typically associated with living ionic polymerisations. It was 
assumed that the high reaction temperature was critical to its success, but cloud point 
studies revealed a significant co-solvency effect from the unreacted monomer which 
helps retain the polymer in solution as the reaction progresses. This enabled the 
successful methanolic polymerisation of nBuMA at 25 °C, achieving high conversions 
and yielding low dispersity polymers, with the lower reaction temperature also 
improving the Mn control compared to the polymerisations at 60 °C. However, the 
ligand selection for the catalytic complex did prove critical to the reaction, with a 
change from bpy to PMDETA and Me6TREN having a dramatic effect on the control 
of the polymerisation. 
Comparative polymerisations by RAFT at 60 °C were also successful, yielding low 
dispersity polymers that were analogous to those obtained by ATRP but, more 
importantly, achieving high conversions in much shorter reaction times; this proved 
that successful polymerisation was not limited to RDRP techniques based on the 
reversible capping of an active radical species, but could be expanded to include 
techniques based on a degenerative chain transfer mechanism. 
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Furthermore, the monomer chemistry utilised within the methanolic polymerisation 
was extended to include the hydrophobic monomers MMA and tBuMA, with the 
polymerisations of both proceeding homogeneously; however, in the latter case, much 
broader dispersities were observed and the polymerisation rate was significantly lower 
when compared to the nBuMA polymerisations. 
It was hypothesised that the methanolic polymerisations were initiated within a good 
solvent environment enhanced by the unreacted monomer, which progressively 
changed to a poor solvent environment as the monomer was depleted. Therefore, as 
the monomer was consumed, the polymer chains were likely to adopt densely coiled 
structures. However, the fact that the polymers remain solvated after full consumption 
of the monomer means that the polymer-MeOH interactions were sufficient enough to 
prevent the polymer-polymer interactions inducing aggregation and subsequent 
precipitation. 
It is believed that this method of synthesising such well-defined hydrophobic 
p(nBuMA) and p(MMA) homopolymers may prove valuable to the development of 
amphiphilic polymeric nanoparticles capable of the encapsulation of hydrophobic 
drug molecules. 
6.1.2. Chapter 3 
Chapter 3 demonstrated the synthesis of linear amphiphilic copolymers by the 
methanolic Cu-catalysed ATRP of nBuMA using monofunctional and bifunctional 
hydrophilic PEGx-Br macro-initiators. Various degrees of polymerisation (DPn = 60, 
80, 100 monomer units) were targeted, with each series performed at 60 °C yielding 
well-defined AB diblock (Ð = 1.02-1.05) and ABA triblock (Ð = 1.13-1.18) 
amphiphilic copolymers; the results highlight that the presence of the hydrophilic PEG 
block as the chain end functionality did not have an adverse effect on the control of 
the nBuMA polymerisation. However, the calculated Mn values were significantly 
greater than the theoretical values, indicating poor initiation efficiencies. 
The synthesis of PEGx-b-p(nBuMA) diblock copolymers were also achieved at a lower 
temperature of 25 °C, with GPC analysis indicating higher initiation efficiencies but 
showing broader molecular weight distributions (Ð = 1.20-1.32) compared to those 
obtained at 60 °C. 
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Furthermore, the architecture of the amphiphilic copolymers was varied to give 
branched materials that were obtained by polymerisation following the Strathclyde 
approach using the PEG113-Br macro-initiator. This involved the methanolic ATRP of 
nBuMA in the presence of the divinyl monomer EGDMA, whose statistical 
incorporation enabled the inter-chain branching of the primary polymer chains; a 
reaction temperature of 60 °C was selected due to the greater control that was 
demonstrated when polymerising at the elevated temperature during the AB diblock 
copolymer syntheses, but also to provide a greater entropic effect that was more likely 
to promote inter-chain – rather than intra-chain – branching. Triple detection GPC 
(DMF) analysis revealed high molecular weight materials with Mw values as high as 
2.33 x 106 g mol-1. 
Nanoprecipitations of these branched copolymers yielded nanoparticles in aqueous 
media, sterically stabilised by the PEG surface functionalities; DLS analysis showed 
multimodal intensity weighted particle size distributions, however, the number 
weighted distributions showed monomodal traces with Dn = 17-27 nm. 
Although encapsulation and pharmacological studies were not performed, it is thought 
that the synthesised amphiphilic branched copolymers bearing PEG surface 
functionalities are interesting materials with potential drug-delivery applications that 
have high relevance to nanomedicine with regards to passively targeting tumours; 
however, larger particle sizes are required to target tumours via the EPR effect, which 
could be achieved by simply increasing the p(nBuMA) block length that will 
consequently affect their aggregation within the aqueous media during 
nanoprecipitation. 
Finally, the establishment of reaction conditions for the nBuMA polymerisation to 
form amphiphilic materials was a key tool that enabled the development of more 
complex branched structures, described in later chapters. 
6.1.3. Chapter 4 
Chapter 4 demonstrated the synthesis of G0, G1 and G2 dendritic ATRP initiators 
bearing protected galactose functionalities by aza-Michael-type additions and 
esterifications, with the synthesis of each beginning with the commercially available 
1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose (proGal-OH). 
Chapter 6 
 
177 
 
The dendritic initiators were utilised in the methanolic Cu-catalysed ATRP of nBuMA 
at 60 °C, targeting DPn = 60, 80, 100 monomer units, with all polymerisations 
proceeding homogeneously to high conversion (≥ 98 %) to yield low dispersity 
polymers (1.12 ≤ Ð ≤ 1.30); although the observed dispersities were higher than those 
seen in Chapters 2 and 3, they are still highly indicative of a well-controlled 
polymerisation. 1H-NMR analysis of the purified G2-proGal-p(nBuMA)60 polymer 
showed resonances attributed to the protected galactose functionalities, thereby 
confirming that retro-Michael additions had not taken place during the 
polymerisation; however, the analysis did suggest that the MeOH solvent may have 
trans-esterified to the dendritic chain end functionality.  
Despite the possibility of transesterification reactions having taken place, the same 
reaction conditions were utilised to synthesise hyp-glycopolydendrons using each of 
the dendritic initiators, targeting a DPn = 30 nBuMA units; a low concentration of the 
divinyl branching monomer EGDMA was used to promote the statistical inter-chain 
branching of the primary polymer chains. Analysis by 1H-NMR and triple-detection 
GPC (DMF) revealed that each of the branched polymerisations proceeded 
homogeneously to high conversion (99 %) to yield high molecular weight polymers 
with weight average molecular weight (Mw) values ranging from 102,650 g mol-1 to 
159,450 g mol-1. 
Deprotection of the isopropylidene protecting groups from the dendritic chain end 
functionalities was very difficult to achieve, with many attempts following reported 
methods within the literature proving unsuccessful. However, successful deprotection 
was achieved using para-toluene sulfonic acid monohydrate (PTSA) in MeOH, 
utilising the co-solvency effect of the nBuMA monomer to solvate the branched 
polymers. 1H-NMR analysis of the deprotected polymers showed the absence of 
resonances attributed to the protected galactose functionalities, but did not 
conclusively reveal resonances attributed to the deprotected galactose functionalities; 
the results of a proof-of-concept study involving the deprotection of the proGal-OH 
starting material indicated that these resonances are likely to reside beneath the large 
broad peak attributed to the CH2 environment of the p(nBuMA) pendant groups. 
However, IR spectroscopy did reveal a small transmittance at 3,400 cm-1 attributed to 
the O-H stretch, indicating that deprotected galactose functionalities are present within  
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the polymer. Unfortunately, the 1H-NMR analysis also revealed a significantly greater 
intensity for the unexpected peak at 3.65 ppm, which suggests a greater degree of 
transesterification reactions having occurred during the deprotection step, catalysed 
under the acidic reaction conditions. 
Nanoprecipitations of both the protected and deprotected hyp-glycopolydendrons were 
performed to yield stable nanoparticles in aqueous media; DLS analysis and zeta 
potential measurements showed that nanoparticles with smaller hydrodynamic 
diameters and greater negative zeta potentials were obtained when nanoprecipitating 
the deprotected materials compared to their protected equivalents. These results 
strongly suggest that the deprotected galactose functionalities are present on the 
surface of the hyp-glycopolydendrons, providing charge stabilisation. It is important 
to note, however, that a significant amount of precipitate was observed for the 
deprotected G2 hyp-glycopolydendron, and the high attenuator and low derived count 
rate of the measurement suggested that the sample concentration was too low to 
provide a credible result. This is likely attributed to branched materials whose 
galactose functionalities have been displaced by the MeOH solvent during the 
deprotection step. 
It is also worth noting that one of the key issues that prevent dendrimers gaining 
regulatory approval as drug-delivery vehicles is that the structural defects often 
introduced during the synthesis of high generation materials consequently cause 
batch-to-batch variability that have significant effects on the reproducibility of their 
pharmacological assessment. Therefore, despite the analysis suggesting that hyp-
glycopolydendrons bearing deprotected galactose functionalities capable of targeting 
hepatic ASGPR receptors were successfully obtained, it is believed that the 
transesterification reactions during polymer synthesis and the deprotection step cannot 
guarantee reproducible results for numerous batches. For that reason, the deprotection 
strategy certainly requires further work; however, if the modified deprotection step 
still cannot guarantee batch-to-batch reproducibility, then an alternative synthesis of 
the galactosylated hyp-glycopolydendrons will be required. 
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6.1.4. Chapter 5 
Chapter 5 demonstrated the successful synthesis of a G0 mannose functionalised 
ATRP initiator by a 3 step reaction procedure that involved protection of all hydroxyl 
groups, followed by the selective deprotection at the anomeric centre, and finally, a 
bromo-esterification reaction to introduce the tertiary bromide functionality that is 
required for the polymerisation. 
Unfortunately, the synthesis of a G2 dendritic mannose-functionalised ATRP initiator 
using similar chemistry to that described in Chapter 4 was unsuccessful; 1H-NMR and 
13C-NMR analysis strongly suggested that a series of side-reactions had taken place 
that initially involved a transesterification between the Mann-(OAc)4-acrylate and the 
IPA solvent, yielding an isopropyl-acrylate compound that then reacted with the 
APAP AB2 brancher via aza-Michael-type additions. This suggests that the position 
of functionalisation on the ring structure of the saccharide is critical to the successful 
synthesis of mannosylated dendritic compounds. Therefore, alternative protection and 
deprotection strategies may be required. 
The methanolic Cu-catalysed ATRP of nBuMA was performed using the G0-Mann-Br 
initiator, using the same reaction conditions that have been utilised in previous 
chapters. Linear G0-Mann-p(nBuMA) polymers were synthesised at both 60 °C and 
25 °C, targeting a DPn = 60, 80, 100 monomer units, with all polymerisations 
achieving high conversions (≥ 91 %) to yield low dispersity polymers (Ð ≤ 1.08); 
narrower molecular weight distributions and improved Mn targeting were observed 
when polymerising at the reduced temperature. However, phase separation did occur 
when polymerising at 25 °C, targeting a DPn = 100 nBuMA units; this could either be 
due to contamination of the reaction solvent with H2O, or the presence of the protected 
mannose chain-end functionalities having a significant effect on the UCST behaviour 
of the polymer within the methanolic environment. 
Branched polymers were obtained by repeating the polymerisations in the presence of 
a low concentration of the divinyl branching monomer, EGDMA, with only the target 
DPn changing to 30 monomer units; the reaction temperature was varied to study its 
effect on the degree of branching. Once again, phase separation occurred when 
polymerising at 25 °C, suggesting that the polymer architecture may also has an effect 
on the UCST behaviour of the polymer within the methanolic environment. Analysis 
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by 1H-NMR and triple detection GPC (DMF) revealed that higher conversions were 
achieved and higher Mw values (Mw = 89 800 g mol-1) obtained when polymerising at 
60 °C. 
Nanoprecipitations of each of the branched materials were performed to yield stable 
nanoparticles in aqueous media, where DLS analysis showed monomodal and 
symmetrical distributions with Dz values ranging from 120-140 nm, very low PDI 
values (≤ 0.074) and negative zeta potentials (≥ -18.4 mV). The large particle sizes 
show that the nanoparticles are formed via the proposed nucleation/growth mechanism 
that is associated with this technique, and the negative zeta potentials indicated the 
presence of charge stabilisation. Additionally, SEM images confirmed the presence of 
spherical nanoparticles with sizes that correlate well with the DLS data. 
Unfortunately, deprotection of the mannose chain-end functionalities of the branched 
polymers were not attempted due to lack of time, but future attempts would involve 
reactions with PTSA; however, as described in Section 6.1.3, the deprotection strategy 
would require optimisation to avoid transesterification reactions with protic solvents. 
Although mannosylated hyp-polydendrons were not obtained, it is believed that the 
mannose-functionalised branched polymers described within this chapter are still 
interesting materials that have the potential, once successfully deprotected, to actively 
target DC-SIGN and mannose receptors that are abundantly present on latent cellular 
reservoirs of HIV. 
6.2. Future work 
The results of Chapter 4 indicated that the polymerisations conducted at 60 °C resulted 
in - albeit on a small scale - transesterification reactions between the MeOH solvent 
and the dendritic chain end functionality. However, Chapter 5 demonstrated that by 
decreasing the temperature of the branched polymerisations to 25 °C resulted in phase 
separation at some point towards the latter stages of the reaction. Therefore, as part of 
future work, a study involving the methanolic Cu-catalysed ATRP of nBuMA would 
be performed at various reaction temperatures between the two temperatures 
demonstrated within this thesis (i.e. 30 - 55 °C) to attain optimal reaction conditions 
for the synthesis of hyp-glycopolydendrons that avoids both transesterification 
reactions and phase separation. 
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Another future study would involve increasing the hydrophobic p(nBuMA) block 
length of the branched copolymers by simply targeting greater DPn values during 
polymer synthesis. This will consequently affect the aggregation of the branched 
copolymers within the aqueous media during nanoprecipitation, resulting in stable 
nanoparticles with greater hydrodynamic diameters than those seen within this thesis; 
this is particularly important for drug-delivery systems hoping to utilise the EPR effect 
to accumulate within solid tumours before actively targeting cancer cells. 
It was concluded in Chapters 4 and 5 that if modified deprotection strategies could not 
provide batch-to-batch reproducibility regarding the formation and pharmacological 
assessment of amphiphilic nanoparticles capable of actively targeting various cellular 
receptors, then alternative synthesis may be required. An interesting approach would 
involve the synthesis of glycosylated dendritic initiators without utilising 
protection/deprotection strategies, which would enable the synthesis of 
hyp-glycopolydendrons that would no longer require deprotection, thereby preventing 
transesterification reactions and thus batch-to-batch variability. This could potentially 
be achieved by initially performing a Fischer glycosylation using hydrogen bromide 
(HBr), which would introduce an excellent bromide leaving group at the anomeric 
centre of reducing saccharides, thereby enabling nucleophilic substitution using 
amine/thiol functionalised nucleophiles (Scheme 6.1); the latter step could utilise 
either the APAP AB2 branching unit used within this thesis, or alternatively, xanthate 
functional dendritic substrates, whose synthesis has already been developed within the 
Rannard research group.10,11 
Furthermore, in vitro pharmacological studies would be performed to assess the 
viability of the PEGylated branched copolymers, galactosylated hyp-
glycopolydendrons and mannosylated hyp-glycopolydendrons as drug-delivery 
vehicles. This would involve transwell plate assays using the Caco-2 cell line (human 
epithelial colorectal adenocarcinoma cells) to predict the permeability of the 
nanoparticles across the intestinal tract into systemic circulation, and cytotoxicity 
assays. 
Chapter 6 
 
182 
 
 
Scheme 6.1. Reaction scheme detailing the alternative synthesis of glycosylated dendritic 
ATRP initiators by: (A) introducing the bromide leaving group at the anomeric centre of the 
saccharide by a Fischer glycosylation, and (B) nucleophilic substitution at the anomeric centre 
using amine and thiol functionalised dendritic compounds. 
 
Various reports within the literature have recently shown how nanoparticle shape can 
have a dramatic effect on the rate of cellular internalisation.12–16 Furthermore, previous 
work has demonstrated the direct synthesis of polymer nanoparticles with targeted 
shapes without the need for functional groups that induce self-assembly.17,18 Instead, 
well-defined “dumbbell” and “clover-leaf” shaped branched amphiphilic block 
copolymer nanoparticles were synthesised by introducing bifunctional and 
trifunctional initiators, respectively, into the initiating system of a branched ATRP 
reaction; these multifunctional initiators essentially generated tie-chains between 
branched polymer moieties to generate the targeted shape.  
Preliminary studies regarding the synthesis of shaped hyp-glycopolydendrons have 
been conducted during this PhD, which involved the synthesis of G1 and G2 dendritic 
initiators bearing protected amines functionalities; these initiators were used in the 
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branched methanolic ATRP of HPMA at 40 °C, targeting a DPn = 50 monomer units, 
in the presence of a bifunctional initiator; triple detection GPC (THF) analysis 
revealed yield high molecular weight polymers, with Mw values as high as 555,000 g 
mol-1. Cleavage of the tBOC protecting groups under acidic conditions to liberate the 
amine surface functionality, followed by dialysis against H2O, yielded dumbbell 
shaped nanoparticles in aqueous media, whose shape was confirmed by transmission 
electron microscopy (TEM) (Figure 6.1). Therefore, another interesting study would 
involve the synthesis of shaped hyp-glycopolydendrons via the methanolic ATRP of 
nBuMA, using mixed monofunctional dendritic glycosylated initiators and 
multifunctional initiators. The effect of their shape on the rate of cellular 
internalisation could be evaluated by in vitro pharmacological studies. 
 
Figure 6.1. The synthesis of amine functionalised hyp-polydendrons with targeted dumbbell 
shape showing: (A) the monofunctional dendritic initiators and the bifunctional “tie-chain” 
initiator, and (B) a transmission electron microscopy (TEM) image of the shaped 
nanoparticles. 
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7.1. Materials 
Poly(ethylene glycol) methyl ether (average Mn 750, 2000, and 5000), n-Butyl 
methacrylate (BMA, 99%), toluene (anhydrous 99.8 %), methanol-d4 (99.8 atom % 
D), N, N, N’, N’’, N’’ pentamethyl diethylene triamine (PMDETA, 99%), 
triethylamine (99+%), α-bromoisobutyryl bromide (98 %), copper(I) chloride 
(Cu(I)Cl, 99%), CDCl3 (99.8 atom % D), para-toluenesulfonic acid monohydrate 
(98.5%), methanol (MeOH, anhydrous 99.8%), ethylene diamine (99+), sodium 
thiosulfate (99%), iodine (99.8+%), 2,2’-bipyridine (bpy, 99%), tert-butanol 
(anhydrous), propylene oxide (99%), aluminium oxide (activated, neutral, Brockmann 
I), silica gel used for column chromatography, ethylene glycol dimethacrylate 
(EGDMA, 98 %), bis(3-aminopropyl)amine (BAPA, 98%), 1,2:3,4-Di-O-
isopropylidene-α-D-galactopyranose (97%), methyl methacrylate (MMA, 99%), 
ethyl-α-bromoisobutyrate (EBiB, 98%), ethanolamine (99+%), tert-butyl 
methacrylate (tBMA, 98 %), DOWEX marathon ion-exchange resin (hydrogen form), 
4,4’-azobis(4-cyanovaleric acid) (ACVA, 98 %) and 2-cyano-2-propyl benzodithioate 
(CPBD, 97 %) were purchased from Aldrich. 1,1’-Carbonyldi (1H-imidazole) (98%) 
was purchased from Apollo Scientific Ltd. Analytical TLC was performed on 
commercial Merck plates coated with silica gel. Tetrahydrofuran (THF, HPLC-grade), 
chloroform, dichloromethane, methanol (MeOH, analytical grade), diethyl ether, 
acetone (analytical grade), ethyl acetate, n-hexane, petroleum ether (analytical grade, 
bp 40-60 °C), propan-2-ol (IPA, HPLC grade) N,N-dimethylformamide (DMF, 
HPLC-grade) were purchased from Fisher. Poly(ethylene glycol) (average Mn 4000), 
acetic anhydride (99+%), 4-(dimethylamino)pyridine (DMAP, 99%), D-(+)-mannose 
(99%), sodium hydrogen carbonate (99%), acryloyl chloride (96%), Tris(2-dimethyl 
aminoethyl)amine (Me6TREN, 99+%) was purchased from Alfa Aesar. All materials 
were used as received. 
7.2. Characterisation 
1H nuclear magnetic resonance (NMR) spectra were recorded in CDCl3 or MeOD 
using a Bruker Avance spectrometer operating at 400 MHz. 1H-NMR were recorded 
at 400 MHz and 13C-NMR were recorded at 100 MHz. Chemical shifts (δ) are reported 
in parts per million (ppm) and TMS was used as an internal standard for both 1H and 
13C spectra. 
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Electrospray (ESI) mass spectrometry data were recorded in the Mass Spectrometry 
Laboratory at the University of Liverpool using a MicroMass LCT mass spectrometer 
using electron ionisation and direct infusion syringe pump sampling. All materials 
were diluted with methanol. 
Dynamic light scattering (DLS) measurements were performed at 25 °C using a 
Malvern Zetasizer Nano ZS instrument (laser wavelength = 630 nm). 
Scanning electron microscopy (SEM) images were obtained using a Hitachi S-4800 
FE-SEM. Sample preparation involved dropping the aqueous samples on to silicon 
wafers mounted on an aluminium stub with a carbon tab. Samples were left to dry over 
several hours before being subjected to Au sputter at 20 mA for 2 mins prior to 
imaging. 
Triple detection gel permeation chromatography (GPC) was performed using Malvern 
Viscotek instruments. One apparatus is equipped with a GPCmax VE2001 auto-
sampler, two Viscotek D6000 columns (and a guard column) and a triple detector array 
TDA305 (refractive index, light scattering and viscometer) with a mobile phase of 
DMF containing 0.01 M lithium bromide at 60 °C and a flow-rate of 1 mL min-1. The 
second instrument is equipped with a GPCmax VE2001 auto-sampler, two Viscotek 
T6000 columns (and a guard column), a refractive index (RI) detector VE3580 and a 
270 Dual Detector (light scattering and viscometer) with a mobile phase of THF 
containing 2 v/v % of triethylamine and a flow-rate of 1 mL min-1. 
7.3. Methods 
7.3.1. Chapter 2 
All ATRP polymerisations were conducted at a constant ratio to initiator bromine 
atoms of [Br]:[Cu(I)Cl]:[Bpy] = 1:1:2. 
7.3.1.1. Synthesis of p(nBuMA)x homopolymers in anhydrous MeOH 
In a typical synthesis, targeting a DPn = 60 monomer units, p(nBuMA)60, nBuMA 
(0.85 g, 6 mmol) and bpy (31.2 mg, 0.2 mmol) were added to a 15 mL single-neck 
round bottom flask equipped with a magnetic stirrer bar. MeOH (1.07 mL; 50 wt%) 
(deoxygenated via N2 purge prior to use) was added and the resulting solution was 
sparged with N2 for 10 mins. Cu(I)Cl (9.9 mg, 0.1 mmol) was rapidly added to the 
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flask, instantly forming a brown coloured mixture and purged with N2 for a further 5 
mins. The flask was submerged into an oil bath pre- heated at 60 °C or 25 °C and ethyl 
α-bromoisobutyrate (14.7 mL, 0.1 mmol) was added under N2 flow using a micro-
syringe. The mixture was stirred at 60 °C for 24 hours before termination by dilution 
with MeOH until appearance of a blue/green colour. Upon cooling, the polymer 
precipitated and the supernatant containing the catalytic system was discarded. The 
polymer was dissolved in THF, passed through a neutral alumina column to remove 
residual catalyst and concentrated by rotary evaporation. The polymer was 
precipitated into cold MeOH to give a white solid. 
 
Figure 7.1. 1H-NMR (CDCl3) of p(nBuMA)100. 
7.3.1.2. Determination of p(nBuMA) polymerisation kinetics 
Kinetic studies were performed by taking samples from the reaction medium under 
positive N2 pressure with subsequent analysis by 1H NMR in CDCl3 and triple 
detection GPC. Monomer conversion was determined by NMR spectroscopy using 
crude samples of the reaction medium. Integrals of the vinyl protons of the unreacted 
monomer (5.50 ppm and 6.05 ppm) were compared with integration of the CH2 signal 
adjacent to the ester group of the both the polymer repeat units and the monomer 
(3.80 ppm and 4.30 ppm) to determine conversion. Catalyst was removed from the 
samples prior to GPC analysis by passing through a small alumina column. 
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7.3.1.3. Determination of p(nBuMA) UCST cloud point curves 
Cloud points were determined by visual observation. Different p(nBuMA) weight 
fractions in anhydrous MeOH (MeOH–H2O or MeOH–nBuMA mixtures) were 
dissolved in test tubes under stirring/heating and cooled at a rate of approximately 
0.5 °C min-1. Cloud points were determined as the first visual indication of turbidity 
and were performed in triplicate. Errors values were determined by considering the 
difference between the highest and lowest values obtained. Typically, p(nBuMA)60 
(10 mg) and anhydrous MeOH (1.25 mL; 990 mg) was added to a test tube equipped 
with a magnetic flea and a rubber septum pierced with a long, small gauged, stainless 
steel needle. The tube was immersed in an oil bath fitted with a reference test tube 
containing pure MeOH and equipped with a thermocouple. The temperature was 
increased until total dissolution of the polymer followed by switching off of the 
heating element. For this example, three cloud points measurements were recorded 
(using the reference tube) at 52.8 °C, 52.9 °C and 52.9 °C. 
7.3.1.4. Determination of p(nBuMA) UCST cloud point curves studying the 
monomer co-solvency effect 
Cloud points were determined visually. P(nBuMA) was dissolved in anhydrous 
MeOH / nBuMA monomer mixtures within test tubes under stirring/heating, and 
cooled at a rate of approximately 0.5 °C min-1. Cloud points were determined as the 
first visual indication of turbidity. The study began by adding p(nBuMA)x (0.5 g) and 
anhydrous MeOH (0.63 mL; 0.5 g) to a test tube equipped with a magnetic flea and a 
rubber septum pierced with a long, small gauged, stainless steel needle. The tube was 
immersed in an oil bath fitted with a reference test tube containing pure MeOH and 
equipped with a thermocouple. The sample was heated, but it is important to note that 
dissolution within anhydrous MeOH could not be achieved in the absence of 
monomer. The nBuMA monomer was then added in increments of 10 µL and the 
polymer sample was heated; once total dissolution was achieved below the boiling 
point of MeOH, the heating element was switched off and the cloud point temperature 
was recorded. The same polymer sample was subjected to further heating/cooling 
cycles after each incremental 10 µL addition of nBuMA monomer and the cloud point 
temperatures were recorded at each point. 
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7.3.1.5. Synthesis of p(nBuMA)x homopolymers in IPA 
In a typical synthesis, targeting a DPn = 60 monomer units, p(nBuMA)60, nBuMA 
(0.85 g, 6 mmol) and bpy (31.2 mg, 0.2 mmol) were added to a 15 mL single-neck 
round bottom flask equipped with a magnetic stirrer bar. IPA (1.08 mL; 50 wt%) 
(deoxygenated via N2 purge prior to use) was added and the resulting solution was 
sparged with N2 for 10 mins. Cu(I)Cl (9.9 mg, 0.1 mmol) was rapidly added to the 
flask, instantly forming a brown coloured mixture and purged with N2 for a further 5 
mins. The flask was submerged into an oil bath pre-heated at 60 °C and ethyl α- 
bromoisobutyrate (14.7 µL, 0.1 mmol) was added under N2 flow using a micro- 
syringe. The mixture was stirred at 60 °C for 24 hours before termination by dilution 
with THF until appearance of a blue/green colour. The solution was passed through a 
neutral alumina column to remove residual catalyst and concentrated by rotary 
evaporation. The polymer was precipitated into cold MeOH to give a white solid. 
7.3.1.6. Synthesis of p(nBuMA)x homopolymers using PMDETA as catalyst 
ligand 
In a typical synthesis, targeting a DPn = 60 monomer units, p(nBuMA)60, nBuMA 
(1.7 g, 12 mmol) and PMDETA (41.6 µL, 0.2 mmol) were added to a 25 mL single-
neck round bottom flask equipped with a magnetic stirrer bar. MeOH (2.15 mL; 50 
wt%) (deoxygenated via N2 purge prior to use) was added and the resulting solution 
was sparged with N2 for 10 mins. Cu(I)Cl (19.8 mg, 0.2 mmol) was rapidly added to 
the flask, instantly forming a brown coloured mixture and purged with N2 for a further 
5 mins. The flask was submerged into an oil bath pre-heated at 60 °C and ethyl α- 
bromoisobutyrate (29.4 µL, 0.2 mmol) was added under N2 flow using a micro- 
syringe. The mixture was stirred at 60 °C for 48 hours before termination by dilution 
with MeOH until appearance of a blue/green colour. Upon cooling, the polymer 
precipitated and the supernatant containing the catalytic system was discarded. The 
polymer was dissolved in THF, passed through a neutral alumina column to remove 
residual catalyst and concentrated by rotary evaporation. The polymer was 
precipitated into cold MeOH to give a white solid. 
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7.3.1.7. Synthesis of p(nBuMA)x homopolymers using Me6TREN as catalyst 
ligand 
In a typical synthesis, targeting a DPn = 60 monomer units, p(nBuMA)60, nBuMA 
(1.7 g, 12 mmol) and Me6TREN (53.5 µL, 0.2 mmol) were added to a 25 mL single-
neck round bottom flask equipped with a magnetic stirrer bar. MeOH (2.15 mL; 
50 wt%) (deoxygenated via N2 purge prior to use) was added and the resulting solution 
was sparged with N2 for 10 mins. Cu(I)Cl (19.8 mg, 0.2 mmol) was rapidly added to 
the flask, instantly forming a brown coloured mixture and purged with N2 for a further 
5 mins. The flask was submerged into an oil bath pre-heated at 60 °C and ethyl α- 
bromoisobutyrate (29.4 µL, 0.2 mmol) was added under N2 flow using a micro- 
syringe. The mixture was stirred at 60 °C for 48 hours before termination by dilution 
with MeOH until appearance of a blue/green colour. Upon cooling, the polymer 
precipitated and the supernatant containing the catalytic system was discarded. The 
polymer was dissolved in THF, passed through a neutral alumina column to remove 
residual catalyst and concentrated by rotary evaporation. The polymer was 
precipitated into cold MeOH to give a white solid. 
7.3.1.8. RAFT polymerisations 
The DPn of homopolymers synthesised by RAFT were assessed by 1H NMR 
spectroscopy in CDCl3 of purified samples by comparison of the aromatic signal 
attributed to the CTA Z-group with clear resonances assigned to nBuMA monomer 
(e.g. -COO-CH2-CH2- 3.9 ppm and - C(CH3)COO-(CH2)3-CH3 0.5-1.25 ppm) and 
MMA residues (e.g. -C(CH3)COO-CH3 3.3- 3.8 ppm). 
7.3.1.8.1. Synthesis of p(nBuMA)x homopolymers by methanolic RAFT at 60 ºC 
In a typical synthesis, targeting a number average degree of polymerisation DPn = 60 
monomer units, ACVA (17.2 mg, 0.06 mmol), CPBD (67.8 mg, 0.30 mmol) and 
nBuMA (2.55 g, 18.0 mmol) were added to a 25 mL single-neck round bottom flask 
equipped with a magnetic stirrer bar. Anhydrous MeOH (3.22 mL, 50 wt % wrt 
monomer, deoxygenated via N2 purge) was added and the resulting solution was 
sparged with N2 for 15 mins. The reaction flask was placed into a pre-heated oil-bath 
(60 ºC) and stirred for 24 hours after which the reaction medium was observed to be 
slightly turbid. The polymerisation was stopped by cooling the flask to room 
temperature causing the polymer to precipitate and sediment to the bottom of the flask. 
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The MeOH supernatant was decanted and the resultant polymer dissolved in THF. The 
solution was concentrated by rotary evaporation and precipitated into cold MeOH to 
give a pink solid. 
 
Figure 7.2: 1H-NMR (CDCl3) analysis of purified p(nBuMA)60 obtained via RAFT to 
determine the DPn. Inset; magnification of the aromatic region of the spectrum showing 
resonances attributed to the CTA chain-end functionality. 
 
7.3.1.8.2. Kinetic studies of the polymerisation of nBuMA using RAFT at 60 ºC 
To avoid potential precipitation during sampling from a single reaction, multiple small 
reactions were initiated to model individual time points. 
In a typical kinetic experiment, targeting DPn = 100 monomer units, CPBD (98.40 mg, 
0.422 mmol, 1 equivalent), ACVA (23.65 mg, 0.084 mmol, 0.2 equivalents) and 
nBuMA (6.00 g, 42.19 mmol, 100 equivalents) were placed in a single-neck round 
bottom flask fitted with a stirrer bar and a rubber septum. The reactor and its contents 
were degassed (N2 sparge for 20 mins) after which anhydrous MeOH (7.58 mL, 
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50 wt %; degassed via N2 sparge) was added to the round bottom flask under positive 
N2 pressure. The reactor was flushed with argon for an additional 10 mins and the 
homogeneous reaction mixture transferred into several 1.5 mL vials fitted with stirrer 
bars under an argon blanket. The vials were sealed and placed in an oil bath at 60 ºC. 
The samples were removed successively over a period of 34 hours and analysed by 
1H NMR and triple detection GPC (THF). NB Kinetic experiments targeting a DPn = 
1000 monomer units utilised nBuMA (18.00 g) and the reaction was split across four 
10 mL single-neck round bottom flasks fitted with stirrer bars and samples were 
removed over 50 hours. 
7.3.1.8.3. Synthesis of poly(methyl methacrylate) p(MMA) homopolymers by 
methanolic RAFT at 60 °C 
In a typical experiment, targeting a number average degree of polymerisation DPn = 
100 monomer units per chain, 31.13 mg of chain transfer agent CPBD (0.1406 mmol; 
1 equivalent), 7.9 mg of ACVA (0.02812 mmol; 0.2 equivalents) and 1.4077 g of 
MMA (14.06 mmol; 100 equivalents) were placed in a single-neck round bottom flask 
fitted with a stirrer bar and a rubber septum. The reactor and its content were degassed 
by N2 sparge for 15 mins, then 1.82 mL of anhydrous MeOH (50 wt %; thoroughly 
degassed via N2 sparge prior to use) were added to the round bottom flask under 
positive pressure of N2 using a syringe. The reaction mixture was flushed with N2 for 
an additional 5 mins and the reactor was placed in an oil bath at 60 °C. After 27 hours, 
an aliquot of the crude material was taken for NMR analysis in order to assess the 
monomer conversion and the reactor was cooled down to room temperature resulting 
in the phase separation of polymer and MeOH. THF was added to the reaction mixture 
until obtaining a clear homogeneous solution and the material was purified by 
precipitation into MeOH (THF:MeOH = 1:10 v/v). The sample was collected by 
filtration and dried under vacuum at 40 °C overnight. 
Monomer conversion was assessed using 1H-NMR spectroscopy in CDCl3 for the 
crude samples by comparing the integrated signals of the residual MMA at 5.5 ppm 
and 6 ppm with those due to the methacrylic backbone between 0.5 ppm and 2.5 ppm 
and/or - for comparison purposes - with the integrated signals from the pendant group 
(-O-CH3, MMA + p(MMA)) between 3.5 ppm and 3.8 ppm. 
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1H-NMR in CDCl3 at 50 °C was also used to estimate the number average degree of 
polymerisation, DPn, of the precipitated p(MMA) samples. Comparison of the 
integrated signals of the CTA chain-end “Z” group between 7.25 ppm and 7.9 ppm 
with those due to the methacrylic backbone between 0.5 ppm and 2.2 ppm and/or - for 
comparison purposes - with the integrated signals from the pendant group (-O- CH3) 
between 3.3 ppm and 3.8 ppm allowed the assessment of the DPn by NMR. Therefore, 
Mn NMR could be calculated using the following equation Mn NMR = (DPn NMR * 
MMMA) + MCTA and making the assumption that all the polymer chains are initiated 
with the “R” group and terminated with the “Z” group of the CTA (which is evidently 
not the case due to the nature of the RAFT process but allowed a reasonable 
assessment of the molecular weight). 
 
 
Figure 7.3; 1H-NMR (CDCl3) analysis of purified p(MMA)60 obtained via RAFT to determine 
the DPn. Inset; magnification of the aromatic region of the spectrum showing resonances 
attributed to the CTA chain-end functionality. 
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7.3.1.9. Synthesis of p(MMA) homopolymers by methanolic ATRP 
In a typical synthesis, targeting a number average degree of polymerisation DPn = 60 
monomer units and using ethyl-α-bromoisobutyrate (EBiB) as initiator, MMA (2.52g, 
25.2 mmol) and bpy (130 mg, 0.8 mmol) were added to a 25 mL single-neck round 
bottom flask equipped with a magnetic stirrer bar. Anhydrous MeOH (3.16 mL, 
50 wt % wrt. monomer) (deoxygenated via N2 purge prior to use) was added and the 
resulting solution was sparged with N2 for 15 mins. Cu(I)Cl (41.2 mg, 0.4 mmol) was 
rapidly added to the flask whilst maintaining a positive nitrogen flow, instantly 
forming a brown coloured mixture. EBiB (61.1 μL, 0.4 mmol) was added to the  
 
reaction flask which was then submerged into an oil bath pre-heated at 60 °C and left 
to stir for 26 hours. The polymerisation was stopped by cooling the flask to room 
temperature, exposing its contents to air, and diluting the reaction medium with THF 
to poison the catalytic system. The polymer solution was then passed through a neutral 
alumina column to remove the catalytic system using THF as the mobile phase. The 
solution was concentrated by rotary evaporation and precipitated into cold MeOH to 
give a white solid. The sample was dried under vacuum at 40 °C and analysed by 
1H-NMR in CDCl3 and triple-detection GPC with a mobile phase of THF. 
7.3.1.10. Synthesis of poly(tert-butyl methacrylate) p(tBuMA) homopolymers by 
methanolic ATRP at 25 °C or 60 °C 
In a typical synthesis, targeting a number average degree of polymerisation DPn = 80 
monomer units and using ethyl-α-bromoisobutyrate (EBiB) as initiator, tBuMA (1g, 
7.03 mmol) and bpy (27.5 mg, 0.18 mmol) were added to a 25 mL single-neck round 
bottom flask equipped with a magnetic stirrer bar. Anhydrous MeOH (1.33 mL, 
50 wt %) (deoxygenated via N2 purge prior to use) was added and the resulting 
solution was sparged with N2 for 15 mins. Cu(I)Cl (8.7 mg, 0.09 mmol) was rapidly 
added to the flask whilst maintaining a positive nitrogen flow, instantly forming a 
brown coloured mixture. EBiB (12.9 μL, 0.09 mmol) was added to the reaction flask 
which was then submerged into an oil bath pre-heated at 60 °C and left to stir for 25 
hours. The polymerisation was stopped by cooling the flask to room temperature, 
exposing its contents to air, and diluting the reaction medium with THF to poison the 
catalytic system. The polymer solution was then passed through a neutral alumina 
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column to remove the catalytic system using THF as the mobile phase. The solution 
was concentrated by rotary evaporation, precipitated into cold MeOH/water (80/20), 
and washed with MeOH to give a white solid. The sample was dried under vacuum at 
40 °C and analysed by 1H-NMR in CDCl3 and triple-detection GPC with a mobile 
phase of THF. 
 
Figure 7.4. 1H-NMR (CDCl3) of the crude p(tBuMA)60 sample before purification. 
 
7.3.2. Chapter 3 
7.3.2.1. Synthesis of poly(ethylene glycol) mono methyl ether-derived ATRP 
macro-initiators (PEG17- Br, PEG45-Br and PEG113-Br) 
In a typical synthesis, PEG113-OH (30 g, 6 mmol) was dissolved in 100 mL of 
anhydrous toluene in the presence of triethylamine (0.91 g, 9 mmol) in a two-neck 
round bottom flask fitted with an addition funnel, a N2 inlet/outlet and a stirrer bar. α-
Bromoisobutytyl bromide (2.07 g, 9 mmol), diluted with 20 mL of anhydrous toluene, 
was placed in the addition funnel. Whilst stirring the contents of the flask, the α-
bromoisobutyryl bromide solution was added slowly over a period of 20-30 min. After 
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the addition was completed, the reaction was left to stir for 24 hours at room 
temperature. The formation of a white precipitate (triethylammonium bromide salt) 
indicated the progress of the reaction. Once the reaction was complete, the reaction 
medium was warmed in a water bath at about 50 ºC, filtered and concentrated on the 
rotary evaporator. The resulting product was diluted in acetone and purified by 
precipitation in petroleum ether (40-60). The last step was repeated and the product 
was finally dried under vacuum at 40 ºC for 24 hours. The resulting macro-initiator 
was recovered with 70 % yield and its structure was confirmed by 1H-NMR (CDCl3) 
and triple detection GPC with a mobile phase of DMF. 
7.3.2.2. Synthesis of poly(ethylene glycol) bi-functional ATRP macro-initiator 
(Br-PEG91-Br) 
PEG91-diOH (20 g, 5 mmol) was dissolved in 100 mL of anhydrous toluene in the 
presence of triethylamine (1.52 g, 15 mmol) in a two-neck round bottom flask fitted 
with an addition funnel, a N2 inlet/outlet and a stirrer bar. α-Bromoisobutytyl bromide 
(3.45 g, 15 mmol i.e. 1.5 eq. per hydroxyl group = 3 eq. per PEG chain) diluted with 
20 mL of anhydrous toluene was placed in the addition funnel. Whilst stirring, the 
reactor was cooled to 0 °C in an ice bath and the α-bromoisobutyryl bromide solution 
was added slowly over a period of 20-30 min. After the addition was completed, the 
reactor was allowed to reach room temperature and left to stir for 24 hours. After 
purification by filtration and precipitation in petroleum ether (40-60), the structure of 
the resulting bi-functional macro-initiator was confirmed by 1H-NMR in CDCl3 and 
triple detection GPC with a mobile phase of DMF. 
7.3.2.3. Synthesis of poly(ethylene glycol)-b-poly(n-butyl methacrylate) (p(PEGx-
b-nBuMAy)) A-B block copolymers by methanolic ATRP 
In a typical synthesis, targeting DPn = 60 monomer units and using PEG113–Br as the 
macro-initiator, PEG113-Br (0.50 g, 0.1 mmol), nBuMA (0.85 g, 6 mmol) and bpy 
(31.20 mg, 0.2 mmol) were added to a 15 mL single-neck round bottom flask equipped 
with a magnetic stirrer bar. Anhydrous MeOH (1.07 mL, 50 wt % wrt. monomer; 
deoxygenated via N2 purge) was added and the resulting solution was sparged with N2 
for 15 mins. Cu(I)Cl (9.90 mg, 0.1 mmol) was rapidly added to the flask whilst 
maintaining a positive N2 flow, instantly forming a brown coloured mixture. The 
reactor was heated in an oil bath and left to stir. The polymerisation was stopped by 
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cooling the flask to room temperature, exposing its contents to air and diluting the 
reaction medium with THF. The polymer solution was passed through a neutral 
alumina column to remove the catalyst using THF as the mobile phase and the 
resulting solution was concentrated by rotary evaporation and precipitated into cold 
petroleum-ether (40-60) to give a white solid. The sample was dried under vacuum at 
40 °C for 24 hours and analysed by 1H-NMR in CDCl3 (50 °C) and triple-detection 
GPC with a mobile phase of DMF. 
 
Figure 7.5. 1H-NMR (CDCl3) of PEG17-b-p(nBuMA60). 
7.3.2.4. Synthesis of p(nBuMA)-PEG-p(nBuMA) A-B-A triblock copolymers 
In a typical synthesis, targeting a number average degree of polymerisation DPn = 80 
monomer units on each side of the PEG bi-functional macro-initiator (in this specific 
case, DPn total = 160 monomer units), Br-PEG91-Br initiator (0.473 g, 0.11 mmol), 
nBuMA (2.5 g, 17.6 mmol), bpy (69 mg, 0.44 mmol) were placed into a 25 mL single-
neck round bottom flask and deoxygenated via N2 sparge for 10 mins under stirring. 
Anhydrous MeOH (3.75 mL, 50 wt %) (deoxygenated via N2 purge prior to use) was 
added and the resulting solution was purged with N2 for a further 5 mins. Finally, 
Cu(I)Cl (22 mg, 0.22 mmol) was added rapidly to the solution whilst maintaining a 
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positive N2 flow and the reactor was placed in a preheated oil bath at 60 °C. After 
27 hours, the reaction was stopped by exposure to air and addition of THF 
(approximately 10 mL) until appearance of a green colour which is evidence of the 
catalytic system being oxidised. The reaction medium was transferred into a larger 
container at room temperature, another addition of THF (approximately 50 mL) was 
performed and the catalytic system was removed by addition of ion-exchange resin 
beads followed by filtration. Finally, the resulting solution was concentrated on the 
rotary evaporator, diluted in THF and precipitated in cold petroleum ether (40-60). 
After collection, the sample was dried under vacuum at 40 °C for 24 hours and 
analysed by 1H NMR in CDCl3 and triple-detection GPC with a mobile phase of DMF. 
For all the p(PEG-block-nBuMA) copolymers after purification, the DPn of the 
nBuMA block could be assessed by 1H-NMR spectroscopy in CDCl3 at 50 °C. The 
proton signal due to the PEG block is apparent at 3.6 ppm. The intensity of this signal 
is proportional to the known DPn of the PEG block. Comparison of this integrated 
signal with those due to the p(nBuMA) repeat units (e.g. -COO-CH2- CH2- at 3.9 ppm 
or -C(CH3)COO-(CH2)3-CH3 between 0.5 ppm and 1.25 ppm) allowed the DPn of the 
p(nBuMA) block to be calculated. 
7.3.2.5. Kinetic studies of the polymerisation of nBuMA using the PEG macro-
initiators 
Kinetic studies (i.e. plots ln([M]0/[M]) = f(t) and Mn = f(conversion)) were performed 
by taking samples from the reaction medium under positive pressure of N2 and 
analysing them by 1H-NMR in CDCl3 and triple detection GPC. The monomer 
conversion was determined by 1H-NMR spectroscopy in CDCl3 for crude samples of 
the reaction medium. The vinyl protons (CH2=C(CH3)COO-n-Bu) due to the residual 
monomer can be seen at 5.5 ppm and 6.05 ppm. Comparison of these integrated signals 
with those due to the CH2 next to the ester group for both the polymer repeat units and 
the monomer (between 3.8 ppm and 4.3 ppm) allowed the conversion to be estimated 
using the following equation: Conversion = [1 – (2*I6 / I4)] x 100, where I6 and I4 
are respectively the integrals of the NMR signals at 5.5 ppm (or 6.05 ppm) and 
between 3.8 ppm and 4.3 ppm. Alternatively, it is also possible to calculate the 
conversion by comparing the signals due to the vinyl protons with those due to the 6 
protons from the two methyl groups of the polymer repeat units (both backbone and 
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pendant group) between 0.5 ppm and 1.25 ppm. The catalytic system was removed 
from the kinetic samples prior to triple-detection GPC analysis by passing them 
through an alumina column. 
7.3.2.6. Synthesis of branched poly(ethylene glycol)-b-poly(n-butyl methacrylate-
co-ethylene glycol dimethacrylate) (p(PEG113-b-(nBuMA-co-EGDMA)) 
copolymers by methanolic ATRP at 60 °C. 
In a typical synthesis, targeting DPn = 60 monomer units of nBuMA in the primary 
polymer chains, PEG113-Br (0.50 g, 0.1 mmol), nBuMA (0.85 g, 6 mmol), EGDMA 
(16.80 mg, 0.085 mmol; 0.85 equiv. relative to initiator) and bpy (31.20 mg, 0.2 mmol) 
were added to a 15 mL single-neck round bottom flask equipped with a magnetic 
stirrer bar. Anhydrous MeOH (1.07 mL, 50 wt % wrt. monomer; deoxygenated via N2 
purge) was added and the resulting solution was sparged with N2 for 15 mins. Cu(I)Cl 
(9.9 mg, 0.1 mmol) was rapidly added to the flask whilst maintaining a positive N2 
flow, instantly forming a brown coloured mixture. The reactor was submerged into an 
oil bath pre-heated at 60 °C, and left to stir. The polymerisation was stopped by cooling 
the flask to room temperature, exposing its contents to air, and diluting the reaction 
medium with THF. The polymer solution was passed through a neutral alumina 
column to remove the catalyst using THF as the mobile phase. The solution was 
concentrated by rotary evaporation and precipitated into cold petroleum-ether (40-60) 
to give a white solid. The sample was dried under vacuum at 40 °C for 24 hours and 
analysed by 1H-NMR in CDCl3 and triple-detection GPC with a mobile phase of DMF. 
7.3.2.7. Nanoprecipitations of branched (p(PEG113-b-(nBuMA-co-EGDMA)) 
copolymers 
Nanoparticles were prepared following a rapid nanoprecipitation approach. The 
branched copolymers were dissolved in THF-H2O (1/1) binary solution at a 
concentration of 5 mg mL-1. Once fully dissolved, the polymer solution (1 mL, 
5 mg mL-1) was added rapidly to a vial of water (4.5 mL) stirring at ambient 
temperature. The solvent was allowed to evaporate overnight to give a final 
concentration of 1 mg mL-1 polymer in water. 
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7.3.3. Chapter 4 
7.3.3.1. Synthesis of G0-proGal-Br [2] 
In a typical synthesis, 1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose (2g, 
7.68 mmol) was dissolved in 20 mL of anhydrous dichloromethane in a two-neck 
round bottom flask fitted with an addition funnel, N2 inlet/outlet and a stirrer bar. 
Triethylamine (1.61 mL, 11.5 mmol) was added to the reaction flask, followed by 
4-dimethylamino)pyridine (94 mg, 0.768 mmol). The reaction flask was cooled in an 
ice-bath for approximately 10 min. α-Bromoisobutytyl bromide (1.42 mL, 11.5 mmol) 
was added to the addition funnel containing 10 mL of anhydrous dichloromethane, 
and the resulting solution was added dropwise over a period of 20 min to the reaction 
flask, instantly forming a precipitate upon addition. The reaction was left to stir 
overnight under an inert N2 atmosphere at ambient temperature to form a brown 
coloured mixture. After reaction completion, the solvent was removed on the rotary 
evaporator to give a brown coloured oily residue. The crude product was extracted 
with diethyl ether (3 x 100 mL), with each extract filtered to remove the 
triethylammonium bromide (Et3N+Br−) salt. The solvent was removed on the rotary 
evaporator, and the crude product was purified by normal phase flash chromatography 
using silica gel as the stationary phase and ethyl acetate/hexane (gradient: 10/90 to 
20/80) as the mobile phase. The purified product was dried in vacuo to give 
G0-proGal-Br [2] as a white solid in 60 % yield. 1H-NMR (400 MHz, CDCl3): δ ppm 
= 1.34 (d, J = 4.5 Hz, 6H), 1.49 (d, J = 19.7 Hz, 6H), 1.95 (s, 6H), 4.06 (ddd, J = 7.7, 
4.4, 1.8 Hz, 1H), 4.30 (m, 3H), 4.41 (dd, J = 11.5, 4.4 Hz, 1H), 4.63 (dd, J = 7.9, 
2.5 Hz, 1H), 5.54 (d, J = 5.0 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ ppm = 24.43, 
24.99, 25.94, 26.02, 30.82, 55.68, 64.74, 65.92, 70.51, 70.72, 71.02, 96.27, 108.84, 
109.72, 171.59. ESI-MS: [M+Na]+ m/z = 433.1, required [M]+ m/z = 408.08. 
7.3.3.2. Synthesis of proGal-acrylate [3] 
In a typical synthesis, 1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose (12.78 g, 
49.1 mmol) was dissolved in 80 mL of anhydrous dichloromethane in a two-neck 
round bottom flask fitted with an addition funnel, N2 inlet/outlet and a stirrer bar. 
Triethylamine (17.1 mL, 123 mmol) was added to the reaction flask, followed by 4-
(dimethylamino)pyridine (0.6 g,  4.91 mmol). The reaction flask was cooled in an ice-
bath for approximately 10 min. Acryloyl chloride (7.98 mL, 98.2 mmol) was added to 
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the addition funnel containing 30 mL of anhydrous dichloromethane, and the resulting 
solution was added dropwise over a period of 20 min to the reaction flask, instantly 
forming a precipitate upon addition. The reaction was left to stir overnight under an 
inert N2 atmosphere at ambient temperature to form an orange/brown coloured 
mixture. After reaction completion, the salt was filtered off and washed with cold 
dichloromethane, and the solvent was removed on the rotary evaporator (35 °C) to 
give a brown coloured oily residue. The crude product was extracted with diethyl ether 
(3 x 100 mL), with each extract filtered to remove residual triethylammonium chloride 
(Et3N+Cl−) salt. The solvent was removed on the rotary evaporator (35 °C), and the 
crude product was purified by normal phase flash chromatography using silica gel as 
the stationary phase and ethyl acetate/hexane (gradient: 10/90 to 20/80) as the mobile 
phase, to give the proGal-acrylate [3] as a yellow coloured oil in 81 % yield. 1H-NMR 
(400 MHz, CDCl3): δ ppm = 1.34 (d, J = 5.4 Hz, 6H), 1.49 (d, J = 20.5 Hz, 6H), 4.08 
(m, 1H), 4.32 (m, 4H), 4.63 (dd, J = 7.9, 2.5 Hz, 1H), 5.55 (d, J = 5.0 Hz, 1H), 5.84 
(dd, J = 10.4, 1.4 Hz, 1H), 6.17 (dd, J = 17.3, 10.4 Hz, 1H), 6.43 (dd, J = 17.3, 1.4 Hz, 
1H). 13C NMR (100 MHz, CDCl3): δ ppm = 24.47, 24.95, 25.94, 25.97, 63.50, 66.00, 
70.46, 70.69, 71.07, 96.28, 108.77, 109.64, 128.19, 131.06, 166.03. 
7.3.3.3. Synthesis of G1-proGal-OH [4] 
In a typical synthesis, proGal-acrylate [3] (3 g, 9.54 mmol) was dissolved 15 mL of 
2-propanol (IPA) in a single-neck round bottom flask equipped with a magnetic stirrer 
bar, to give a yellow coloured solution. Ethanolamine (0.144 mL, 2.39 mmol) was 
added to the reaction flask, and the solution was allowed to stir at ambient temperature 
for 4 days. After reaction completion, the solvent was removed on the rotary 
evaporator, and the crude product was purified by normal phase flash chromatography 
using silica gel as the stationary phase and ethyl acetate (100 %) as the mobile phase. 
The purified product was dried in vacuo to give G1-proGal-OH [4] as a yellow 
coloured viscous syrup in 74 % yield. 1H-NMR (400 MHz, CDCl3): δ ppm = 1.31 (d, 
J = 3.8 Hz, 12H), 1.48 (d, J = 27.6 Hz, 12H), 2.50 (t, J = 6.9 Hz, 4H), 2.58 (m, 2H), 
2.82 (m, 4H), 2.91 (s, broad, 1H), 3.57 (m, 2H), 4.04 (m, 2H), 4.26 (m, 8H), 4.62 (dd, 
J = 7.9, 2.5 Hz, 2H), 5.53 (d, J = 5.0 Hz, 2H).  13C NMR (100 MHz, CDCl3): δ ppm = 
24.42, 24.87, 25.84, 25.97, 48.96, 55.78, 59.07, 63.51, 65.82, 70.34, 70.62, 70.95, 
96.21, 108.68, 109.57, 172.42. ESI-MS: [M+H]+ m/z = 690.3, required [M]+ m/z = 
689.33. 
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7.3.3.4. Synthesis of G1-proGal-Br [5] 
In a typical synthesis, G1-proGal-OH [4] (2.13 g, 3.09 mmol) was dissolved in 30 mL 
of anhydrous dichloromethane in a two-neck round bottom flask fitted with an addition 
funnel, N2 inlet/outlet and a stirrer bar. Triethylamine (0.86 mL, 6.18 mmol) was 
added to the reaction flask, followed by 4-(dimethylamino)pyridine (37.8 mg, 
3.09 mmol). The reaction flask was cooled in an ice-bath for approximately 10 min. 
α-Bromoisobutytyl bromide (0.57 mL, 4.63 mmol) was added to the addition funnel 
containing 10 mL of anhydrous dichloromethane, and the resulting solution was added 
dropwise over a period of 20 min to the reaction flask. The reaction was left to stir 
overnight under an inert N2 atmosphere at ambient temperature to form a brown 
coloured mixture. After reaction completion, the solvent was removed on the rotary 
evaporator to give a brown coloured oily residue. The crude product was extracted 
with diethyl ether (3 x 100 mL), with each extract filtered to remove the 
triethylammonium bromide (Et3N+Br−) salt. The solvent was removed on the rotary 
evaporator, and the crude product was purified by normal phase flash chromatography 
using silica gel as the stationary phase and ethyl acetate/hexane (40/60) as the mobile 
phase. The purified product was dried in vacuo to give G1-proGal-Br [5] as a yellow 
coloured viscous syrup in 82 % yield. 1H-NMR (400 MHz, CDCl3): δ ppm = 1.34 (d, 
J = 4.3 Hz, 12H), 1.48 (d, J = 26.7 Hz, 12H), 1.92 (s, 6H), 2.51 (t, J = 7 Hz, 4H), 2.78 
(t, J = 5.7 Hz, 2H), 2.86 (t, J = 7.0 Hz, 4H), 4.03 (m, 2H), 4.25 (m, 10H), 4.62 (dd, 
J = 7.9, 2.4 Hz, 2H), 5.53 (d, J = 5.0 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ ppm = 
24.48, 24.94, 25.95, 26.03, 30.75, 49.67, 51.66, 55.71, 63.42, 65.85, 70.40, 70.66, 
70.99, 96.26, 108.71, 109.58, 171.53, 172.14. ESI-MS: [M+H]+ m/z = 838.3, required 
[M]+ m/z = 837.28. 
7.3.3.5. Synthesis of APAP [8] 
7.3.3.5.1. Step 1 – synthesis of intermediate [6] 
CDI (39.14 g, 241 mmol) was added to a 500 mL 2-neck round bottom flask equipped 
with magnetic stirrer, reflux condenser, and dry N2 inlet.  The flask was purged with 
N2 for approximately 15 mins, and anhydrous toluene (350 mL) was added. Whilst 
stirring at 60 oC, tertiary butanol (46 mL, 483 mmol) was added to the flask via a warm 
syringe, and the mixture was then stirred at 60 oC for 6 hours under a positive flow of 
N2, forming a pale-yellow coloured solution.  Afterwards, BAPA (17.15 mL, 
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121 mmol) was added to the flask drop-wise whilst maintaining the temperature at 
60 oC.  The reaction was allowed to stir for a further 18 hours at 60 oC under a positive 
flow of N2.  The remaining solution was filtered to remove any solid imidazole, and 
the solvent removed in vacuo to give a yellow coloured oil.  This was then dissolved 
in DCM (250 mL) and washed with distilled water (3 x 250 mL), followed by a 
saturated brine solution (100 mL).  The organic layer was collected, dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to give a white solid in 84 % 
yield.  1H-NMR (400 MHz, CDCl3): δ ppm =  5.19 (s, br, NH ), 3.21 (m, 4H), 2.65 (t, 
J = 6.5 Hz, 4H), 1.65 (q, J = 6.4 Hz, 4H), 1.44 (s, 18H). 13C NMR (100 MHz, CDCl3): 
δ ppm = 156.48, 79.34, 47.77, 39.29, 30.11, 28.79. m/z (ES MS) 332.3 [M+H]+. 
7.3.3.5.2. Step 2 – synthesis of intermediate [7] 
Intermediate [6] (20 g, 60 mmol) was weighed out into a 500 mL 2-neck round bottom 
flask equipped with a magnetic stirrer, reflux condenser and dry N2 inlet.  The flask 
was purged with N2 for approximately 15 mins, anhydrous ethanol was then added to 
the flask, which was then heated to 30 oC.  Propylene oxide (11.2 mL, 181 mmol) was 
added to the flask drop-wise, and the reaction was then left stirring for 24 hours at 
30 oC, under a positive flow of N2, yielding a pale-yellow coloured solution. After 
reaction completion, the solvent was removed on the rotary evaporator and the crude 
product was purified by normal phase flash chromatography using silica gel as the 
stationary phase and ethyl acetate/methanol (75/25) as the mobile phase. The purified 
product was dried in vacuo to give the intermediate [7] in 85 % yield. 1H-NMR (400 
MHz, CDCl3): δ ppm = 4.94 (s, broad, NH), 3.79 (m, 1H), 3.17 (m, 4H), 2.62 (m, 2H), 
2.41 (m, 2H), 2.32 (d, J = 6.1 Hz, 2H), 1.65 (m, 4H), 1.44 (s, 18H), 1.13 (d, J = 6.2 
Hz, 3H). 13C NMR (100 MHz, CDCl3): δ ppm = 156.08, 79.18, 63.45, 62.55, 51.77, 
38.75, 27.48, 20.14. m/z (ES MS) 390.3 [M+H]+, required [M]+ m/z = 389.29. 
7.3.3.5.3. Step 3 – synthesis of APAP [8] 
The intermediate [7] (33.7 g, 86.5 mmol) was weighed out into a 1 L single-neck round 
bottom flask, and dissolved in ethyl acetate (300 mL).  Concentrated hydrochloric acid 
(30 mL) was added drop-wise, causing significant effervescence to occur.  The 
solution was allowed to stir at ambient temperature for 4 hours and then at 50 °C for 
3 hours, whilst keeping the reaction flask open.  The solvent was then removed in 
vacuo to give a yellow coloured viscous oil.  The oil was then dissolved in 4M NaOH 
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(300 mL) and then the solvent was reduced down to approximately 150 mL.  This was 
then transferred to a 500 mL separating funnel, and washed with chloroform 
(2 x 250 mL).  The organic layers were then combined, dried over anhydrous MgSO4, 
filtered and concentrated in vacuo to give the desired compound APAP [8] as a yellow 
coloured viscous oil in 82 % yield.  Final product stored under an inert N2 atmosphere. 
1H-NMR (400 MHz, CDCl3): δ ppm = 3.78 (m, 1H), 2.75 (m, 4H), 2.62 (m, 2H), 
2.44 (m, 2H), 2.32 (m, 2H), 1.89 (s, broad, 5H), 1.62 (m, 4H), 1.12 (d, J = 6.2 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ ppm = 63.95, 62.56, 52.10, 40.31, 30.80, 20.03. ESI-
MS: [M+H]+ m/z = 190.3, required [M]+ m/z = 189.18. 
7.3.3.6. Synthesis of G2-proGal-OH [9] 
In a typical synthesis, proGal-acrylate [3] (6 g, 19.1 mmol) was dissolved in 25 mL of 
2-propanol (IPA) in a 100 mL single-neck round bottom flask equipped with a 
magnetic stirrer bar, to give a yellow coloured solution. APAP [8] (0.452 g, 
2.39 mmol) was added to the reaction flask, and the solution was allowed to stir at 
ambient temperature for 7 days. After reaction completion, the solvent was removed 
on the rotary evaporator, and the crude product was purified by normal phase flash 
chromatography using silica gel as the stationary phase and 
dichloromethane/methanol (gradient elution: 95/5 to 90/10) as the mobile phase. The 
purified product was dried in vacuo to give G2-proGal-OH [9] as a yellow coloured 
viscous syrup in 86 % yield. 1H-NMR (400 MHz, CDCl3): δ ppm = 1.36 (m, 55H), 
2.39 (m, 18H), 2.77 (t, J = 7.1 Hz, 8H), 3.69 (m, 1H), 4.03 (m, 4H), 4.25 (m, 16H), 
4.62 (d, J = 7.8 Hz, 4H), 5.53 (d, J = 4.9 Hz, 4H). 13C NMR (100 MHz, CDCl3): δ ppm 
= 19.96, 24.50, 24.97, 25.97, 26.07, 32.10, 48.91, 51.56, 52.11, 62.20, 63.38, 65.90, 
70.45, 70.68, 71.02, 96.27, 108.74, 109.59, 172.42. ESI-MS: [M+H]+ m/z = 1446.7, 
required [M]+ m/z = 1445.73. 
7.3.3.7. Synthesis of G2-proGal-Br [10] 
In a typical synthesis, G2-proGal-OH [9] (11.02 g, 7.62 mmol) was dissolved in 
60 mL of anhydrous dichloromethane in a two-neck round bottom flask fitted with an 
addition funnel, N2 inlet/outlet and a stirrer bar. Triethylamine (3.19 mL, 22.9 mmol) 
was added to the reaction flask, followed by 4-(dimethylamino)pyridine (93.1 mg, 
0.76 mmol). The reaction flask was cooled in an ice-bath for approximately 10 min. 
α-Bromoisobutytyl bromide (1.88 mL, 15.2 mmol) was added to the addition funnel 
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containing 20 mL of anhydrous dichloromethane, and the resulting solution was added 
dropwise over a period of 20 min to the reaction flask. The reaction was left to stir 
overnight under an inert N2 atmosphere at ambient temperature to form a brown 
coloured mixture. After reaction completion, the solvent was removed on the rotary 
evaporator to give a brown coloured oily residue. The crude product was extracted 
with diethyl ether (3 x 150 mL), with each extract filtered to remove the 
triethylammonium bromide (Et3N+Br−) salt. The solvent was removed on the rotary 
evaporator, and the crude product was purified by normal phase flash chromatography 
using silica gel as the stationary phase and dichloromethane/methanol (gradient 
elution: 95/5 to 90/10) as the mobile phase. Further purification involved dissolving 
the compound in 60 mL of THF, to which 2 mL of 4M NaOHaq was added; the solution 
was stirred for 30 min before removing the solvent on the rotary evaporator and 
repeating the purification by flash chromatography. The purified product was dried in 
vacuo to give G2-proGal-Br [10] as a yellow coloured viscous syrup in 68 % yield. 
1H NMR (400 MHz, CDCl3): δ ppm = 1.10-1.70 (m, 55H), 1.91 (m, 6H), 2.20-3.00 
(m, 26H), 4.02 (m, 4H), 4.25 (m, 16H), 4.62 (d, J = 7.8 Hz, 4H), 4.99 (s, broad, 1H), 
5.52 (d, J = 4.9 Hz, 4H). 13C NMR (100 MHz, CDCl3): δ ppm = 17.94, 24.51, 24.97, 
25.97, 26.07, 30.77, 32.25, 49.04, 51.75, 52.71, 56.28, 60.22, 63.35, 65.90, 67.94, 
70.47, 70.70, 71.03, 96.28, 108.73, 109.58, 171.04, 172.42. ESI-MS: [M+H]+ m/z = 
1596.7, required [M]+ m/z = 1593.68. 
7.3.3.8. Methanolic ATRP of nBuMA using galactosylated dendritic initiators 
(G0-proGal-Br [2], G1-proGal-Br [5] and G2-proGal-Br [10]) 
All ATRP polymerisations were conducted at a constant ratio to initiator bromine 
atoms of [Br]:[Cu(I)Cl]:[Bpy] = 1:1:2. 
In a typical synthesis, targeting a DPn = 60 monomer units and using 
G2-proGal-Br [10] as initiator, G2-proGal-Br [10] (187 mg, 0.117 mmol), nBuMA 
(1 g, 7.03 mmol) and bpy (36.5 mg, 0.234 mmol) were added to a 15 mL single-neck 
round bottom flask equipped with a magnetic stirrer bar. MeOH (1.56 mL; 50 wt%) 
(deoxygenated via N2 purge prior to use) was added and the resulting solution was 
sparged with N2 for 20 mins. Cu(I)Cl (11.6 mg, 0.117 mmol) was rapidly added to the 
flask, instantly forming a brown coloured mixture and purged with N2 for a further 5 
mins. The flask was submerged into an oil bath pre-heated at 60 °C. The mixture was 
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stirred at 60 °C for 22 hours before termination by exposing the reaction flask to air 
and diluting with THF until appearance of a green colour. The polymer solution was 
passed through a neutral alumina column (using THF as eluent) to remove residual 
catalyst and concentrated by rotary evaporation. The polymer was precipitated into 
cold hexane within a dry-ice bath to give a white solid. 
Monomer conversion was assessed using 1H-NMR spectroscopy in CDCl3 for the 
crude samples by comparing the integrated signals of the residual nBuMA at 5.5 ppm 
and 6 ppm with those at 0.5-1.15 ppm due to the C(CH3)COO-(CH2)3-CH3 of 
p(nBuMA) and C(CH3)COO-(CH2)3-CH3 of nBuMA monomer. 
 
Figure 7.6. 1H-NMR (CDCl3) analysis of G2-proGal-p(nBuMA)60 after purification; the 
resonance potentially due to transesterification reactions is highlighted by the yellow box. 
7.3.3.9. Synthesis of hyp-glycopolydendrons by methanolic ATRP using 
galactosylated initiators (G0-proGal-Br [2], G1-proGal-Br [5] and G2-proGal-Br 
[10]) 
All ATRP polymerisations were conducted at a constant ratio to initiator bromine 
atoms of [Br]:[Cu(I)Cl]:[Bpy] = 1:1:2. 
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In a typical synthesis, targeting a DPn = 30 monomer units and using 
G2-proGal-Br [10] as initiator, G2-proGal-Br [10] (493 mg, 0.309 mmol), EGDMA 
(49.0 mg, 0.247 mmol), nBuMA (1.32 g, 9.27 mmol) and bpy (96.5 mg, 0.618 mmol) 
were added to a 15 mL single-neck round bottom flask equipped with a magnetic 
stirrer bar. Anhydrous MeOH (2.52 mL; 50 wt%) (deoxygenated via N2 purge prior to 
use) was added and the resulting solution was sparged with N2 for 20 mins. Cu(I)Cl 
(30.6 mg, 0.309 mmol) was rapidly added to the flask, instantly forming a brown 
coloured mixture and purged with N2 for a further 5 mins. The flask was submerged 
into an oil bath pre-heated at 60 °C. The mixture was stirred at 60 °C for 12 hours 
before termination by exposing the reaction flask to air and diluting with THF until 
appearance of a green colour. The polymer solution was passed through a neutral 
alumina column (using THF as eluent) to remove residual catalyst and concentrated 
by rotary evaporation. The polymer was precipitated into cold hexane within a dry-ice 
bath to give a white solid. 
Monomer conversion was assessed using 1H-NMR spectroscopy in CDCl3 for the 
crude samples by comparing the integrated signals of the residual nBuMA at 5.5 ppm 
and 6 ppm with those at 0.5-1.15 ppm due to the C(CH3)COO-(CH2)3-CH3 of 
p(nBuMA) and C(CH3)COO-(CH2)3-CH3 of nBuMA monomer. 
7.3.3.10. Deprotection of proGal-OH [1] using PTSA 
In a typical synthesis, proGal-OH [1] (200 mg, 0.768 mmol) was dissolved in 2 mL of 
MeOH in a 10 mL single-neck round bottom flask, to which para-toluenesulfonic acid 
monohydrate (14.6 mg, 0.008 mmol) was then added. The reaction was stirred at 50 °C 
for 6 hours. The crude product was dried in vacuo and analysed by 1H-NMR and 
infrared spectroscopy. 
7.3.3.11. Deprotection of galactosylated hyp-glycopolydendrons 
In a typical synthesis, G1-proGal-p(nBuMA30-co-EGDMA0.8) (100 mg) was dissolved 
in 1.5 mL of MeOH in a 10 mL single-neck round bottom flask. Para-toluenesulfonic 
acid monohydrate (15 mg) and nBuMA (0.3 mL) were added, and the reaction flask 
was submerged into a pre-heated oil bath at 50 °C. The reaction was stirred at 50 °C 
for 24 hours before cooling the reaction flask and removing the solvent on the rotary 
evaporator. The crude polymer was dissolved in 2 mL of THF, and 4M NaOHaq 
(20 µL) was added to neutralise the acid, forming a sodium para-toluenesulfonate 
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(PTSA-Na+) salt that precipitated from solution. The salt was filtered off and washed 
with THF before dialysing the polymer-THF solution against THF for 48 hours using 
a regenerated cellulose dialysis tubing with a molecular weight cut-off of 2000 g mol-1. 
The purified polymer was dried in vacuo and analysed by 1H-NMR and infrared 
spectroscopy. 
7.3.3.12. Nanoprecipitations of hyp-glycopolydendrons 
Nanoparticles were prepared following a rapid nanoprecipitation approach. The hyp-
glycopolydendrons were dissolved in THF at a concentration of 5 mg mL-1. Once fully 
dissolved, the polymer solution (1 mL, 5 mg mL-1) was added rapidly to a vial of water 
(5 mL) stirring at ambient temperature. The solvent was allowed to evaporate 
overnight to give a final concentration of 1 mg mL-1 polymer in water. 
 
7.3.4. Chapter 5 
7.3.4.1. Synthesis of Mann-(OAc)5 [12] 
In a typical synthesis, D-(+)-mannose (6g) and iodine (300 mg) were weighed out into 
a 100 mL single-neck round bottom flask equipped with a magnetic stirrer bar. The 
reaction flask was cooled in an ice-bath for 10 min before slowly adding acetic 
anhydride (40 mL). The reaction was stirred at ambient temperature for 30 min; 
initially, the reaction begun as a brown coloured mixture, but quickly formed a brown 
coloured solution as the acetylated mannose product formed. After reaction 
completion, a pressure-equalising dropping funnel was fitted to the reaction flask, to 
which 30 mL of water and crushed ice were added. The ice-water was added to the 
reaction flask drop-wise over 20 min to hydrolyse the remaining acetic anhydride, and 
the reaction media was stirred at ambient temperature for 2 hours. The contents of the 
flask were added to a 1 L separating funnel, diluted with 200 mL of chloroform and 
washed with 100 mL of 0.4M aqueous sodium thiosulfate solution to remove the 
iodine, where the organic phase changed colour from brown/purple to yellow. The 
organic phase was washed with (5 x 200 mL) saturated aqueous solution of sodium 
bicarbonate to remove the acetic acid by-product: it is important to note that the initial 
few washes produced a lot of CO2 gas, and therefore extreme caution is required 
during this step. The organic phase was then washed with (2 x 100 mL) of water, 
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followed by 200 mL saturated brine solution. Finally the organic phase was dried over 
sodium sulfate, filtered and concentrated on the rotary evaporator to give the 
Mann-(OAc)5 [12] as a pale yellow coloured syrup in 98 % yield. 1H-NMR (400 MHz, 
CDCl3): δ ppm = 1.96-2.20 (m, 15H), 4.00-4.40 (m, 3H), 5.00-5.50 (m, 3H), 5.80-6.30 
(m, 1H). 13C NMR (100 MHz, CDCl3): δ ppm = 20.62, 20.64, 20.69, 20.75, 20.84, 
62.06, 65.45, 68.24, 68.72, 70.61, 90.49, 168.04, 169.53, 169.74, 169.96, 170.61. ESI-
MS: [M+Na]+ m/z = 413.1, required [M]+ m/z = 390.12. 
7.3.4.2. Synthesis of Mann-(OAc)4 [13] 
In a typical synthesis, Mann-(OAc)5 [12] (5.21 g, 13.3 mmol) was dissolved in 150 mL 
of THF in a 500 mL single-neck round bottom flask equipped with a magnetic stirrer. 
Acetic acid (1.23 mL, 21.4 mmol) and ethylene diamine (1.43 mL, 21.4 mmol) were 
added to the reaction flask, with the addition of the latter instantly forming a white 
coloured precipitate. The reaction mixture was allowed to stir overnight at ambient 
temperature. After reaction completion, the precipitate was filtered off and washed 
with THF before removing the solvent on the rotary evaporator to give a yellow 
coloured crude oil. The crude product was dissolved in 200 mL of chloroform, 
transferred to a 1L separating funnel and washed with: 120 mL 2M HClaq, 100 mL sat. 
NaHCO3, 100 mL H2O, and 100 mL sat. brine. The organic phase was dried over 
sodium sulfate, filtered and concentrated on the rotary evaporator. The crude product 
was purified further by normal phase flash chromatography using silica gel as the 
stationary phase and ethyl acetate/hexane (40/60) as the mobile phase. The purified 
product was dried in vacuo to give Mann-(OAc)4 [13] as a yellow coloured oil in 56 % 
yield. 1H-NMR (400 MHz, CDCl3): δ ppm = 1.93 (s, 3H), 1.99 (s, 3H), 2.04 (s, 3H), 
2.10 (s, 3H), 3.23 (d, J = 4.2 Hz, 1H), 4.13 (m, 3H), 5.24 (m, 4H). 13C NMR (100 
MHz, CDCl3): δ ppm = 20.70, 20.73, 20.79, 20.92, 62.57, 66.16, 68.58, 68.71, 69.94, 
92.24, 169.81, 170.02, 170.19, 170.82. ESI-MS: [M+Na]+ m/z = 371.1, required [M]+ 
m/z = 348.11. 
7.3.4.3. Synthesis of G0-Mann-(OAc)4-Br [14]  
In a typical synthesis, Mann-(OAc)4 [13] (7.1 g, 20.4 mmol) was dissolved in 100 mL 
of anhydrous dichloromethane in a two-neck round bottom flask fitted with an addition 
funnel, N2 inlet/outlet and a stirrer bar. Triethylamine (5.69 mL, 40.8 mmol) was 
added to the reaction flask, followed by 4-(dimethylamino)pyridine (249 mg, 
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2.04 mmol). The reaction flask was cooled in an ice-bath for approximately 10 min. 
α-Bromoisobutytyl bromide (3.78 mL, 30.6 mmol) was added to the addition funnel 
containing 25 mL of anhydrous dichloromethane, and the resulting solution was added 
dropwise over a period of 20 min to the reaction flask. The reaction was left to stir 
overnight under an inert N2 atmosphere at ambient temperature to form a brown 
coloured mixture. After reaction completion, the solvent was removed on the rotary 
evaporator to give a brown coloured oily residue. The crude product was extracted 
with diethyl ether (3 x 150 mL), with each extract filtered to remove the 
triethylammonium bromide (Et3N+Br−) salt. The solvent was removed on the rotary 
evaporator, and the crude product was purified by normal phase flash chromatography 
using silica gel as the stationary phase and ethyl acetate/hexane (gradient elution: 
30/70 to 40/60 ) as the mobile phase. The purified product was dried in vacuo to give 
G0-Mann-(OAc)4-Br [14] as an orange coloured viscous syrup in 95 % yield. 1H-NMR 
(400 MHz, CDCl3): δ ppm = 1.80-2.30 (m), 3.87 (m), 3.95-4.70 (m), 4.90-5.60 (m), 
5.70-6.30 (m). ESI-MS: [M+Na]+ m/z = 519.0, required [M]+ m/z = 496.06. 
7.3.4.4. Synthesis of Mann-(OAc)4-acrylate [15] 
In a typical synthesis, Mann-(OAc)4 [13] (6.67 g, 19.1 mmol) was dissolved in 50 mL 
of anhydrous dichloromethane in a two-neck round bottom flask fitted with an addition 
funnel, N2 inlet/outlet and a stirrer bar. Triethylamine (6.68 mL, 47.9 mmol) was 
added to the reaction flask, followed by 4-(dimethylamino)pyridine (233 mg,  
1.91 mmol). The reaction flask was cooled in an ice-bath for approximately 10 min. 
Acryloyl chloride (3.30 mL, 38.3 mmol) was added to the addition funnel containing 
20 mL of anhydrous dichloromethane, and the resulting solution was added dropwise 
over a period of 20 min to the reaction flask, instantly forming a precipitate upon 
addition. The reaction was left to stir overnight under an inert N2 atmosphere at 
ambient temperature to form an orange/brown coloured mixture. After reaction 
completion, the salt was filtered off and washed with cold dichloromethane, and the 
solvent was removed on the rotary evaporator (35 °C) to give a brown coloured oily 
residue. The crude product was extracted with diethyl ether (3 x 100 mL), with each 
extract filtered to remove residual triethylammonium chloride (Et3N+Cl−) salt. The 
solvent was removed on the rotary evaporator (35 °C), and the crude product was 
purified by normal phase flash chromatography using silica gel as the stationary phase 
and ethyl acetate/hexane (40/60) as the mobile phase, to give the 
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Mann-(OAc)4-acrylate [3] as a yellow coloured oil in 66 % yield. 1H-NMR (400 MHz, 
CDCl3): δ ppm = 2.02 (s, 3H), 2.05 (s, 3H), 2.09 (s, 3H), 2.19 (s, 3H), 3.90-4.40 (m, 
3H), 5.10-5.60 (m, 3H), 5.98 (dd, J = 10.5, 1.1 Hz, 1H), 6.17 (m, 2H), 6.51 (dd, 
J = 17.3, 1.1 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ ppm = 23.34, 23.37, 23.42, 
23.49, 63.11, 64.76, 68.22, 71.08, 71.49, 93.54, 129.76, 136.20, 165.81, 172.25, 
172.44, 172.69, 173.35. ESI-MS: [M+Na]+ m/z = 425.1, required [M]+ m/z = 402.12. 
7.3.4.5. Methanolic ATRP of nBuMA using G0-Mann-(OAc)4-Br [14] 
All ATRP polymerisations were conducted at a constant ratio to initiator bromine 
atoms of [Br]:[Cu(I)Cl]:[Bpy] = 1:1:2. 
In a typical synthesis, targeting a DPn = 60 monomer units and using 
G0-Mann-(OAc)4-Br [14] as initiator, G0-Mann-(OAc)4-Br [14] (58.3 mg, 
0.117 mmol), nBuMA (1 g, 7.03 mmol) and bpy (36.5 mg, 0.234 mmol) were added 
to a 15 mL single-neck round bottom flask equipped with a magnetic stirrer bar. 
MeOH (1.40 mL; 50 wt%) (deoxygenated via N2 purge prior to use) was added and 
the resulting solution was sparged with N2 for 20 mins. Cu(I)Cl (11.6 mg, 0.117 mmol) 
was rapidly added to the flask, instantly forming a brown coloured mixture and purged 
with N2 for a further 5 mins. The flask was submerged into an oil bath pre-heated at 
60 °C. The mixture was stirred at 60 °C for 24 hours before termination by exposing 
the reaction flask to air and diluting with THF until appearance of a green colour. The 
polymer solution was passed through a neutral alumina column (using THF as eluent) 
to remove residual catalyst and concentrated by rotary evaporation. The polymer was 
precipitated into cold hexane within a dry-ice bath to give a white solid. 
Monomer conversion was assessed using 1H-NMR spectroscopy in CDCl3 for the 
crude samples by comparing the integrated signals of the residual nBuMA at 5.5 ppm 
and 6 ppm with those at 0.5-1.15 ppm due to the C(CH3)COO-(CH2)3-CH3 of 
p(nBuMA) and C(CH3)COO-(CH2)3-CH3 of nBuMA monomer. 
7.3.4.6. Branched methanolic ATRP using G0-Mann-(OAc)4-Br [14] 
All ATRP polymerisations were conducted at a constant ratio to initiator bromine 
atoms of [Br]:[Cu(I)Cl]:[Bpy] = 1:1:2. 
In a typical synthesis, targeting a DPn = 30 monomer units and using 
G0-Mann-(OAc)4-Br [14] as initiator, G0-Mann-(OAc)4-Br [14] (233 mg, 
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0.469 mmol), EGDMA (74.3 mg, 0.375 mmol), nBuMA (2 g, 14.1 mmol) and bpy 
(146.5 mg, 0.938 mmol) were added to a 15 mL single-neck round bottom flask 
equipped with a magnetic stirrer bar. Anhydrous MeOH (3.16 mL; 50 wt%) 
(deoxygenated via N2 purge prior to use) was added and the resulting solution was 
sparged with N2 for 20 mins. Cu(I)Cl (46.4 mg, 0.469 mmol) was rapidly added to the 
flask, instantly forming a brown coloured mixture and purged with N2 for a further 5 
mins. The flask was submerged into an oil bath pre-heated at 60 °C. The mixture was 
stirred at 60 °C for 21 hours before termination by exposing the reaction flask to air 
and diluting with THF until appearance of a green colour. The polymer solution was 
passed through a neutral alumina column (using THF as eluent) to remove residual 
catalyst and concentrated by rotary evaporation. The polymer was precipitated into 
cold hexane within a dry-ice bath to give a white solid. 
Monomer conversion was assessed using 1H-NMR spectroscopy in CDCl3 for the 
crude samples by comparing the integrated signals of the residual nBuMA at 5.5 ppm 
and 6 ppm with those at 0.5-1.15 ppm due to the C(CH3)COO-(CH2)3-CH3 of 
p(nBuMA) and C(CH3)COO-(CH2)3-CH3 of nBuMA monomer. 
7.3.4.7. Nanoprecipitations of G0-Mann-p(nBuMA30-co-EGDMA0.8) 
Nanoparticles were prepared following a rapid nanoprecipitation approach. The 
branched copolymers were dissolved in THF at a concentration of 5 mg mL-1. Once 
fully dissolved, the polymer solution (1 mL, 5 mg mL-1) was added rapidly to a vial 
of water (5 mL) stirring at ambient temperature. The solvent was allowed to evaporate 
overnight to give a final concentration of 1 mg mL-1 polymer in water. 
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Figure A1: Studies of p(nBuMA) solubility in MeOH-d4. 1H NMR spectra of i) p(nBuMA) 
heated to 60 °C, ii) p(nBuMA) after heating and cooling to 25 °C. In ii) the intensity of the 
peaks owing to residual polymer in solution has been increased in order to compare the 
resolution to that in spectrum i). 
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Table A1: Cloud point temperatures for p(nBuMA) in MeOH with varying water content 
within the organic solvent. Measurements recorded in triplicate for each composition. 
 Anhyd. MeOH 
Analytical Grade 
MeOH 
Anhyd. MeOH:H20 
(1wt %)  
 
Cloud Point 
Temperature (°C) 
Cloud Point 
Temperature (°C) 
Cloud Point 
Temperature (°C) 
Composition 
(wt %) 
#1 #2 #3 #1 #2 #3 #1 #2 #3 
0.5 47.6 47.5 47.5 47.7 47.5 47.4 52.1 52.2 52.1 
1 52.8 52.9 52.9 53.1 53.1 53.2 58.3 58.2 58.4 
1.5 56.1 56.0 56.0 56.7 56.4 56.5 62.1 62.1 62.0 
2 57.9 57.7 58.0 58.1 58.3 58.1 63.8 63.7 63.7 
2.5 59.6 59.7 59.8 59.9 59.6 59.8 --- --- --- 
3 61.2 61.4 61.4 61.8 61.8 61.7 --- --- --- 
3.5 62.1 62.0 61.9 62.7 62.5 62.5 --- --- --- 
4 62.9 62.9 62.8 63.9 63.8 63.7 --- --- --- 
4.5 64.0 64.0 63.9 64.1 64.2 64.1 --- --- --- 
5 64.6 64.6 64.7 --- --- --- --- --- --- 
 
 
Figure A2: Cloud Point behaviour for p(nBuMA) in MeOH with varying water content within 
the organic solvent. The reagent grade methanol was reported by the supplier to contain 
< 0.05 % H2O content. Asymmetric error bars shown. 
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Table A2: Calculation of an average dn/dc value obtained over 18 
samples of p(nBuMA) analysed via THF triple-detection GPC. 
Target DPn dn/dc 
60 0.0809 
80 0.0786 
100 0.0848 
100 0.0712 
150 0.0787 
200 0.0763 
300 0.076 
400 0.0772 
500 0.0865 
1000 0.0901 
60 0.0755 
100 0.0747 
200 0.0683 
60 0.0709 
100 0.0688 
200 0.0697 
60 0.0734 
200 0.0708 
Average 0.0762 
 
 
 
 
Table A3: Cu-catalysed methanolic ATRP of nBuMA at 60 °C, targeting DPn = 60 monomer 
units; reactions were performed over 2, 7, 10 and 14 days to determine whether termination 
reactions, either by combination or disproportionation, take place. 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(days) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 99 % [59] 2 8 675 13 550 13 950 1.03 
60 99 % [59] 7 8 675 13 200 13 750 1.04 
60 99 % [59] 10 8 675 13 550 14 150 1.05 
60 99 % [59] 14 8 675 13 100 13 650 1.04 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue. c Triple-detection GPC utilising 
THF eluent and dn/dc = 0.0762 mL g-1 (averaged across 18 samples; Table A2, Appendix). 
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Table A4: Cloud point temperatures for p(nBuMA)x (0.5 g) in anhydrous MeOH (0.5 g) with 
increasing concentrations of n(BuMA) monomer. 
  Cloud Point Temperature (°C) 
Monomer 
Addition 
(µL) 
Mass of 
monomer / 
mass of 
solvent 
p(nBuMA)60 p(nBuMA)200 p(nBuMA)300 
50 0.089 53.6 61.3 insoluble 
60 0.107 51.5 --- --- 
70 0.125 49.3 --- --- 
80 0.143 47.0 --- --- 
90 0.161 44.9 --- --- 
100 0.179 43.0 54.5 56.9 
110 0.197 40.8 --- --- 
120 0.215 39.1 --- --- 
130 0.232 37.0 --- --- 
140 0.250 35.4 --- --- 
150 0.268 33.4 45.2 47.6 
160 0.286 31.7 --- --- 
170 0.304 30.9 --- --- 
180 0.323 28.8 --- --- 
190 0.340 27.2 --- --- 
210 0.376 24.4 --- --- 
 
 
Figure A3: GPC chromatograms (RI) showing p(nBuMA) molecular weight distributions 
across targeted DPn = 60 – 200 monomer units; polymerised in IPA at 60 °C. 
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Figure A4: GPC chromatograms (RI) showing p(nBuMA) molecular weight distributions 
across targeted DPn = 60 – 200 monomer units; polymerised in IPA at 25 °C. 
 
 
Table A5: Cu-catalysed ATRP of nBuMA at 60 °C in IPA, targeting DPn = 60 monomer units; 
reactions were performed over 2 and 7 days to determine whether termination reactions, either 
by combination or disproportionation, take place. 
    Triple-detection GPCc (THF) 
Targeta 
 DPn 
Conversion 
[actual DPn] 
Time 
(days) 
Mn 
theoryb 
Mn  
(g mol-1) 
Mw  
(g mol-1) 
Ð 
60 99 % [59] 2 8 675 11 850 13 500 1.14 
60 99 % [59] 7 8 675 14 400 16 950 1.18 
a Target DPn calculated as [nBuMA]/[initiator]. b Theoretical Mn calculated as (target DPn x 
actual conversion achieved and includes initiator residue. c Triple-detection GPC utilising 
THF eluent and dn/dc = 0.0762 mL g-1 (averaged across 18 samples; Table A2, Appendix). 
 
 
Table A6: Methanolic ATRP of nBuMA at 60 °C using various catalyst ligands 
    Triple-detection GPC (THF)c 
Targeta 
DPn 
Ligand 
Conversion 
(%) 
Mn 
Theoryb 
Mn 
(g/mol) 
Mw 
(g/mol) 
Ð 
60 Bpy 99 8640 13570 13950 1.03 
60 PMDETA 99 8640 20350 29800 1.46 
60 Me6TREN 87 7620 38550 44550 1.16 
a Target DPn calculated as [nBuMA]/[initiator]; b Theoretical Mn calculated as (Target DPn x 
142.2 gmol-1)*actual fractional conversion achieved and includes initiator residue; c Triple-
detection GPC utilising THF eluent and dn/dc = 0.0762 (averaged across 18 samples; Table 
A2, Appendix). 
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Figure A5: 1H-NMR (CDCl3) analysis of purified p(nBuMA)60 obtained via RAFT to 
determine the DPn. Inset; magnification of the aromatic region of the spectrum showing 
resonances attributed to the CTA chain-end functionality. 
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Figure A6; 1H-NMR (CDCl3) analysis of purified p(MMA)60 obtained via RAFT to determine 
the DPn. Inset; magnification of the aromatic region of the spectrum showing resonances 
attributed to the CTA chain-end functionality. 
 
 
Figure A7; RAFT polymerisation of MMA in anhydrous methanol at 60°C. SEC 
chromatograms (RI) showing p(MMA) molecular weight distributions across targeted DPn = 
60-200 monomer units. Analysis performed in THF (+ 2 v/v % TEA) at 1 mL/min, 35 °C. 
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Figure A8; Cu-catalysed ATRP of MMA in anhydrous methanol at 60 °C. SEC 
chromatograms (RI) showing p(MMA) molecular weight distributions across targeted DPn = 
60-100 monomer units. Analysis performed in THF (+ 2 v/v % TEA) at 1mL/min, 35 °C. 
 
 
 
Table A7; Calculation of an average dn/dc value obtained over 6 samples of p(MMA) 
analysed via triple-detection SEC (THF). 
  Triple-detection GPC (THF) a 
Sample Technique dn/dc Average dn/dc 
p(MMA)105 
Standard 
 0.0865 
0.084 
p(MMA)60 
RAFT 
0.0825 
p(MMA)100 0.0941 
p(MMA)200 0.0731 
p(MMA)60 
ATRP 
0.0810 
p(MMA)100 0.0853 
aDetermined by triple detection GPC (THF (+ 2 v/v % TEA), 1mL/min, 35 °C). 
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Figure A9; 1H-NMR (CDCl3) analysis of PEG17Br macro-initiator. 
 
Figure A10; 13C-NMR (CDCl3) analysis of PEG17Br macro-initiator. 
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Figure A11; 1H-NMR (CDCl3) analysis of PEG113Br macro-initiator. 
 
 
 
Figure A12; 13C-NMR (CDCl3) analysis of PEG113Br macro-initiator. 
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Figure A13: 1H-NMR (CDCl3) analysis of PEG91Br2 α,ω-bifunctional macro-initiator. 
 
 
Figure A14; 13C-NMR (CDCl3) analysis of PEG91Br2 α,ω-bifunctional macro-initiator. 
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Figure A15; Cu-catalysed ATRP of nBuMA in anhydrous methanol at 60 °C using the 
Br-PEG113-Br macroinitiator. SEC chromatograms (RI) showing p(nBuMA-b-PEG91-b-
nBuMA) molecular weight distributions across targeted DPn = 80-160 monomer units – Br-
PEG91-Br macroinitiator and p(MMA)649 standard shown for comparison. Analysis performed 
in DMF (+ 0.01M LiBr) at 1 mL/min, 60 °C. 
 
 
 
 
 
 
Table A8; Calculation of an average dn/dc value for PEG (averaged over 3 polymer standards) 
and for p(nBuMA) (averaged over three polymer samples) for use in equation [1] in order to 
generate a (dn/dc)copolym. for the p(PEG-b-nBuMA) A-B block copolymers. Analysed by triple-
detection GPC (DMF). 
 Triple-detection GPC (DMF) a 
Sample dn/dc Average dn/dc 
PEO 19kDa 0.0571 
0.0566 PEO 32.6 kDa 0.0553 
PEO 32.6 kDa 0.0573 
p(nBuMA)80 0.0616 
0.0624 p(nBuMA)80 0.0627 
p(nBuMA)80 0.0630 
a Determined by triple detection GPC (DMF (+ 0.01M LiBr), 1 mL/min, 60 °C). 
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Table A9: Methanolic Cu-catalysed ATRP of MMA at 60 °C and 25 °C using PEG113Br 
     Triple-detection GPC (DMF) 
Targeta 
DPn 
Conv. 
(%) 
Time         
(hrs) 
Mn 
Theoryb 
Mn 
1H NMR 
Mn 
(g/mol) 
Mw 
(g/mol) 
Ð 
        
60 °C        
60 99+ 29 11100 11250 14600 17000 1.16 
80 99+ 49 13100 12050 14900 18200 1.22 
100 99+ 67 15100 15050 18200 22300 1.23 
        
25 °C        
80 91 27 12400 12950 12800 15750 1.23 
a Theoretical Mn includes initiator residue and was calculated as [(Target DPn x 100.12 g mol-1) 
x experimental monomer conversion. 
 
 
 
 
Figure A16; Cu-catalysed ATRP of MMA in anhydrous methanol at 60 °C using the PEG113Br 
macroinitiator. SEC chromatograms (RI) showing p(PEG113-b-MMA) molecular weight 
distributions across targeted DPn = 60-100 monomer units. Analysis performed in DMF (+ 
0.01M LiBr) at 1 mL/min, 60 °C. 
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Figure A17; Cu-catalysed ATRP of MMA (target DPn = 80 monomer units) in anhydrous 
methanol performed at 25 °C and 60 °C using the PEG113Br macroinitiator. GPC 
chromatograms (RI) showing p(PEG113-b-MMA80) molecular weight distributions for each A-
B block copolymer. Analysis performed in DMF (+ 0.01M LiBr) at 1 mL/min, 60 °C. 
 
Figure A18; Cu-catalysed branched methanolic ATRP of nBuMA (target DPn = 60 monomer 
units) at 60 °C using the PEG113Br macroinitiator and varying equivalents (0.75-0.95 wrt, 
initiator) of divinyl monomer, EGDMA. A graph showing the evolution of molecular weight 
with increasing levels of EGDMA – Mw decreases when using 0.95eqv. EGDMA due to partial 
microgelation which was filtered off prior to SEC (DMF) analysis. 
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Figure A19: 13C-NMR (CDCl3) APT spectrum of G0-proGal-Br [2]. 
 
 
Figure A20: 2-Dimensional 1H-NMR (CDCl3) COSY spectrum of G0-proGal-Br [2]. 
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Figure A21: 2-Dimensional 1H-13C HSQC (CDCl3) spectrum of G0-proGal-Br [2]. 
 
 
Figure A22: 1H-NMR (CDCl3) of proGal-acrylate [3], showing the assignment and 
integrations of each environment after normalising the integration of the anomeric proton (1) 
to 1H. 
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Figure A23: 13C-NMR (CDCl3) of proGal-acrylate [3], showing the assignment of each 
carbon environment. 
 
Figure A24: 1H-NMR (CDCl3) of G1-proGal-OH [4], showing the assignment and 
integrations of each environment after normalising the integration of the anomeric protons (1) 
to 2H. 
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Figure A25: 13C-NMR (CDCl3) of G1-proGal-OH [4], showing the assignment of each carbon 
environment. 
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Figure A26: 1H-NMR (CDCl3) of intermediate [6] of the APAP synthesis, showing the 
assignment and integrations of each environment after normalising the integration of the 
proton environment (5) to 4H. 
 
 
Figure A27: 1H-NMR (CDCl3) of intermediate [7] of the APAP synthesis, showing the 
assignment and integrations of each environment after normalising the integration of the tBOC 
protons (1) to 18H. 
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Figure A28: ESI mass spectrometry analysis of intermediate [7] of the APAP synthesis 
showing the [M+H]+ molecular ion peak, and its fragments. 
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Figure A29: 1H-NMR (CDCl3) of G2-proGal-OH [9], showing the assignment and 
integrations of each environment after normalising the integration of the anomeric protons (1) 
to 4H. 
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Figure A30: 13C-NMR (CDCl3) of G2-proGal-OH [9], showing the assignment of each carbon 
environment. 
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Figure A31: 1H-NMR (CDCl3) analysis of G2-proGal-p(nBuMA30-co-EGDMA0.8) after 
purification; the resonance potentially due to transesterification reactions can be seen at 
approximately 3.65 ppm, integrating to 3.27H. 
 
 
Figure A32: IR spectroscopy analysis of G2-Gal-p(nBuMA30-co-EGDMA0.8) showing a 
small transmittance at approximately 3,400 cm-1 (attributed to the O-H stretch) after 
deprotection. 
Appendix 
 
239 
 
 
Chapter 5 
 
Figure A33: 1H-NMR (CDCl3) of Mann-(OAc)5 [12], showing the assignment and 
integrations of the environments after normalising the integration of the acetyl protons (8, 9, 
10, 11, 12) to 15H. 
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Figure A34: 13C-NMR (CDCl3) of Mann-(OAc)5 [12], showing the assignment of the carbon 
environments. 
 
 
Figure A35: ESI mass spectrometry analysis of Mann-(OAc)5 [12], showing the [M+Na]+ and 
[M+K]+ molecular ion peaks. 
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Figure A36: 1H-NMR (CDCl3) of Mann-(OAc)4 [13], showing the assignment and 
integrations of the environments after normalising the integration of the acetyl protons (9, 10, 
11, 12) to 12H. 
 
 
Figure A37: 13C-NMR (CDCl3) of Mann-(OAc)4 [13], showing the assignment of the carbon 
environments. 
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Figure A38: ESI mass spectrometry analysis of Mann-(OAc)4 [13], showing the [M+Na]+ and 
[M+K]+ molecular ion peaks. 
 
Figure A39: 1H-NMR (CDCl3) of Mann-(OAc)4-acrylate [15], showing the assignment and 
integrations of the environments after normalising the integration of the acetyl protons (11, 
12, 13, 14) to 12H. 
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Figure A40: 13C-NMR (CDCl3) of Mann-(OAc)4-acrylate [15], showing the assignment of 
the carbon environments. 
 
 
Figure A41: ESI mass spectrometry analysis of Mann-(OAc)4-acrylate [15], showing the 
[M+Na]+ and [M+K]+ molecular ion peaks. 
 
